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1. Introduction 
Drug delivery to skin includes a wide array of therapeutic technologies and pharmaceutical applications. 
In general, these techniques can be broken down into 1) topical applications, when the drugs are 
delivered locally to treat skin conditions and 2) transdermal applications, when drug is delivered across 
the skin for absorption into the systemic circulation for therapeutic effect somewhere else in the body. 
Examples of topically delivered drugs include antifungals, antibacterials, antivirals, corticosteroids, 
local anesthetics, anticancer drugs etc. Transdermal delivery on the other hand is an alternative route for 
the systemic drug delivery and as a result has much broader applications. Transdermal delivery offers 
advantages like, avoiding the first pass effect, control over rate of drug release, better patient 
compliance, possibility of immediate termination of the therapy etc. Advantages of topical drug delivery 
over oral delivery include, fast onset of action and substantially reduced dose of drug as formulation is 
applied directly to the affected area region of the body.  
According to 2012 statistics, transdermal drug delivery systems represent over 12% of global market 
share in pharmaceutical sales with topical delivery systems accounting for about 6% (Markets and 
Markets, 2013). Since their introduction in 1981, twenty-two transdermal prescription products were 
approved by the US-FDA till 2014. Despite their success and market growth, only a handful molecules 
have been approved for transdermal delivery. This is mainly because skin forms a very effective barrier 
against drugs and to passively transport drugs across this barrier drugs must be in a narrow window of 
physicochemical properties. These ideal properties include, low molecular weight (preferably < 600 
Da), adequate solubility in water and oil (water/octanol partition coefficient in the range of 1 – 3) and 
low melting point (Barry, 2001). Apart from physicochemical requirements, drugs must also possess 
relatively high potency otherwise large doses of drug can render dimensions of the transdermal system 
impractical. Also skin barrier properties can change significantly based on age, race, location of 
application etc. (Kenneth and Michael, 2002). All these requirements mean that number of available 
drugs that are suitable for transdermal drug delivery are limited. To overcome this limitation, several 
strategies have been introduced which range from using penetration enhancers to assist the drug 
penetrate into the skin by modulating the barrier function of the stratum corneum (SC) to physically 
bypassing the SC using techniques such as microneedles, laser ablation etc. The following section will 
focus on structure of the skin and understanding the role of liposomes in the grand theme of drug delivery 
to the skin followed by a brief introduction to the tip-enhanced Raman scattering spectroscopy. 
1.1 Structure of skin 
Skin is the largest organ of the human body weighing at approximately 10 % of the body weight in 
adults and with an impressive surface area of about 20,000 cm² (Schaefer and Redelmeier, 1996). Skin 
forms a vital barrier between the environment and our organs. This barrier function protects us from 
harmful effects of chemicals, microorganisms, allergens and UV radiation. Skin barrier is 100 – 10,000 
times less permeable compared to a blood capillary wall (Cevc and Vierl, 2010). Other major functions 
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of the skin include homeostasis by thermoregulation and sensory function by detecting heat, pressure, 
pain and allergen mediated stimuli. Thickness of skin varies between 0.5 – 4 mm depending upon the 
anatomical location, which subsequently means based on the location, skin barrier can also vary 
considerably. Briefly, skin can be considered to be divided in four layers, outermost stratum corneum 
(non-viable epidermis), viable epidermis, dermis, and bottom most subcutaneous tissue. Apart from 
different layers, skin also contains appendages like hair follicles, sweat glands and sebaceous glands. 
Figure 1 shows a schematic representation of the human skin. For many years role of appendages has 
been neglected as they cover less than 0.1 % of surface area on the skin however, in the last decade drug 
delivery through the appendages has gained interest (Patzelt and Lademann, 2013).  
1.1.1 Stratum corneum 
Stratum corneum is the outermost layer of the epidermis formed by 10-15 layers of highly flattened, 
highly differentiated, non-nucleated cells called corneocytes. Typically the SC is 10-20 µm thick 
however, its thickness can vary greatly depending on body site, age, gender and race (Cevc and Vierl, 
2010). Corneocytes are terminally differentiated keratinocytes originating from basal layers of viable 
epidermis. Corneocytes typically have a diameter of 40 – 50 µm and are 0.5 – 1 µm in thickness. 
Corneocytes are devoid of any cytoplasmic organelle, their plasma membrane is replaced by a cornified 
envelope and they chiefly contain bundles of keratin and lipids. Intercellular spaces within the 
corneocytes are surrounded by complex lipid domains which are secreted by the terminally 
differentiating keratinocytes from viable epidermal layer called stratum granulosum (Schaefer and 
Redelmeier, 1996). Intercellular spaces are typically 0.2 µm wide and contain high concentrations of 
saturated lipids. In a simplistic approach, arrangement of corneocytes and intercellular lipid can be 
described by the ‘brick and mortar’ model where corneocytes form the bricks (proteins) and intercellular 
lipids form the mortar (lipids) holding the bricks together (Elias, 1983). This stacked arrangement of 
alternating hydrophilic and lipophilic layers is responsible for the barrier properties of the SC. 
Intercellular lipids mainly contain ceramides, cholesterol and free fatty acids. Ratios of these lipids 
depend upon location within the epidermis. SC lipid contains approximately 50 % by weight of 
ceramides. So far, 342 different ceramides belonging to 11 different classes have been extracted and 
identified in the human SC. Typically, the SC lipids are characterized by long saturated acyl chains 
ranging from 18 to 72 carbon atoms (Masukawa et al., 2008). Within the intercellular spaces lipids are 
arranged in multi-lamellae with alternating wide bands (6.5 nm) and narrow bands (4.5 nm) (Iwai et al., 
2012). It must be pointed out that there is no clear consensus between the scientists about the molecular 
arrangements in the lipid lamellae. Different theories for molecular arrangement predict different 
lamellar repeat distances ranging from 4.5 nm up to 13 nm (Bouwstra et al., 1991; Garson et al., 1991; 
Madison et al., 1987; White et al., 1988).  
Corneocytes are connected to each other by structural proteins called ‘corneodesmosomes’ (Skerrow et 
al., 1989). In the SC these proteins do not have any other function but supporting the neighboring 
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corneocytes. SC can be divided further in two layers, stratum disjunctum which comprises of top 3-5 
layers of the SC and stratum compactum located at the bottom. Stratum compactum as the name suggests 
contains more compact arrangement of the corneocytes whereas corneocytes in the stratum disjunctum 
are relatively loosely arranged due to a process called ‘desquamation’ which is responsible for shedding 
of the skin (Fartasch, 1996). An important feature of the SC is its low water content. SC contains only 
15 – 30 % water by weight as compared to about 70 % water present in the viable epidermis (von 
Zglinicki et al., 1993). 
It is well established that the SC is responsible for a major fraction of the barrier to the percutaneous 
absorption of topically applied compounds. A strong evidence for this was provided in the form of 
increased transdermal flux for different penetrating compounds when the SC was physically removed 
by tape stripping (Feldmann and Maibach, 1965; Kranz et al., 1977; Malkinson, 1962; Schaefer et al., 
1982; Scheuplein and Blank, 1971; Washitake et al., 1973). Removal of the SC can increase transdermal 
permeability by a factor of 10 – 20 (Schaefer and Redelmeier, 1996). Also skin disorders such as 
ichthyosis and dermatitis which alter structure of stratum corneum have been associated with increased 
trans-epithelial water loss and higher absorption of compounds like hydrocortisone, hexyl nicotinate etc. 
(Aalto-Korte, 1995; Lavrijsen et al., 1993; Levin et al., 2013). Although SC is the major skin barrier, 
deeper layers also possess a small barrier function. 
1.1.2 Viable epidermis 
Viable epidermis is the layer directly below SC and is responsible for producing the highly differentiated 
corneocytes of the SC. Viable epidermis is typically 50 – 100 µm thick and contains three distinct layers 
based on the state differentiation of keratinocytes. At the bottom, stratum basale which produces 
columnar keratinocytes capable of undergoing large but finite number of cell divisions. After 
detachment from stratum basale, keratinocytes migrate through stratum spinosum and stratum 
granulosum. Cytoplasm of keratinocytes in granulosum is characterized by granules of keratohyalin 
(Schaefer and Redelmeier, 1996). As differentiating keratinocytes migrate upwards, they begin to flatten 
and the transition between stratum granulosum and stratum corneum is characterized by excretion of 
lamellar bodies into the extracellular space which forms the intercellular lipid matrix of the stratum 
corneum. Apart from keratinocytes viable epidermis also contains Langerhans cells responsible for 
immune response, melanocytes which produce melanin and Merkel cells which are involved in the 
somatosensory functions (Winkelmann and Breathnach, 1973). Viable epidermis does not contain any 
blood capillaries but does contain nerve fibers (Nolano et al., 1999). Due to a lack of vascular network, 
nutrients are delivered to the keratinocytes by passive diffusion through the interstitial fluid. Water 
content of the viable epidermis is approximately 70% by weight (Schaefer and Redelmeier, 1996). 
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Figure 1: a) Schematic diagram of human skin showing different layers and appendages. Reproduced 
from Barry (2005) b) Human skin cross section stained using Mayer’s hemalaun and congo red 
(Unpublished data). 
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1.1.3 Dermis 
Dermis is the layer below viable epidermis, it forms the major bulk of the skin and is the thickest layer 
of the skin at 0.5 – 3 mm depending on the location on the body. Dermis is divided in to outer papillary 
dermis and inner reticular dermis. Papillary dermis contains papillae which interdigitate with the 
stratum basale of the viable epidermis. A large proportion of the dermis by weight contains a relatively 
loose fibrous connective tissue matrix. Cellular component of the dermis comprises of fibroblasts, 
epithelial cells, mast cells and cells of immune system such as lymphocytes and leukocytes. Fibroblasts, 
as the name suggests are responsible for producing connective tissue components like collagen, elastin, 
fibronectin etc. Mast cells play an important role in tissue regeneration and provide defense reactions 
against invading pathogens through release of histamine, protease enzymes and chemotactic factors 
(Goldsmith and Fitzpatrick, 2012; Schaefer and Redelmeier, 1996). The connective tissue matrix is 
composed of high amounts (approximately 70 % of dry weight of dermis) of collagenous fibers (Cevc 
and Vierl, 2010). Elastin fibers present in the connective tissue provide elasticity to this layer. The water 
retaining ability of the dermis originates from a class of compounds known as proteoglycans and 
glycosaminoglycans which are present in the connective tissue matrix. These compounds can retain 
water up to 1000 times their own weight. Dermis also provides physical support for skin appendages, 
nerve fibers and network of lymphatic and blood vessels. Microvasculature of the dermis is responsible 
for maintaining the sink conditions for the drug molecules that have penetrated through the primary skin 
barrier into the dermis (Ng and Lau, 2015). Dermis does not pose as a major barrier to drugs unless 
drugs are susceptible to enzymatic degradation then dermis can pose as a relevant barrier for absorption 
of drugs into systemic circulation. 
1.1.4 Skin appendages  
Most important skin appendages include, sweat glands, hair follicles and sebaceous glands. These 
appendages originate from lower dermis and reach the skin surface by penetrating through viable 
epidermis and the stratum corneum. Skin appendages occupy about 0.1 % of the total skin area (Higuchi, 
1962) and as a result in the past they were not considered to be significant in the overall theme of 
percutaneous absorption. In past couple of decades better understanding of the structure of these 
appendages has reignited the interest in trans-appendageal drug delivery for both local and systemic 
delivery.  
Amongst all appendages sweat glands are the most abundant with approximately 400 glands/cm² 
(Schaefer and Redelmeier, 1996). There are two types of sweat glands, ‘eccrine’ glands which are more 
abundant and are located throughout the body and ‘apocrine’ glands which are limited to axilla, anus 
and areolar regions of the breast. Eccrine glands are highly coiled and extend from deep dermis or upper 
subcutaneous regions (Eroschenko and Fiore, 2013). Their secretions are watery, hypotonic and are 
mainly responsible for temperature regulation of the body surface. Apocrine glands on the other hand 
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are associated with hair follicles and secrete viscous fluids which has an unpleasant odor after bacterial 
decomposition.  
Hair follicles are the second most abundant skin appendages. Entire human body is covered with hair 
follicles except on the palms and soles. Humans on average have about 5 million hair follicles in total, 
about 80,000 to 150,000 are located on the scalp (Krause and Foitzik, 2006). Based on their length, hair 
can be classified as ‘vellus’ hair which extend about 1 mm into the dermis and ‘terminal’ hair which 
give rise to relatively coarse hair and extend more than 3 mm into the subcutaneous tissue. In brief, hair 
follicles consist of a hair bulb and a hair shaft. Hair bulb contains hair papilla and hair matrix and are 
responsible for the growth of the hair. Infundibulum is a funnel shaped region of the hair follicle near 
the opening of the hair follicle on surface of the skin. Infundibulum is about 0.6 – 0.8 mm in length and 
is characterized by lining of epithelial cells which are well perfused due to the capillary network in the 
surrounding region (Krause and Foitzik, 2006). Upper part of the infundibulum is lined with keratinized 
epidermis and has a structure similar to the SC however; in the lower region of the infundibulum the 
epithelial lining is interrupted. Due to this structural peculiarity transfollicular drug delivery is 
conceivable and has gained momentum in the past years (Patzelt and Lademann, 2013). Due to secretion 
of sweat, pH of the skin surface is mildly acidic and can be in the range of 4 – 7.0 (Herrmann and 
Mandol, 1955). Skin pH is an important parameter and should be taken into consideration during 
formulation development as variation in pH could affect the stability of the formulation or even irritate 
the skin.  
Hair follicles are associated with one or more sebaceous glands towards the mouth of the hair follicles. 
Sebaceous glands are holocrine glands which secrete an oily fluid called sebum. Activity of sebaceous 
glands is age dependent and commonly peaks around puberty and is reduced in infants and in old age 
(Krause and Foitzik, 2006). Density of sebaceous glands is the highest on face and forehead. Sebum 
typically is composed of mixtures of triglycerides, free fatty acids, squalene and waxes. Excretion rate 
of sebum averages around 0.1 mg/cm²/h (Krause and Foitzik, 2006). It is a common consensus that 
sebum does not have a skin barrier function. However, it may have a beneficiary or a retarding effect on 
the percutaneous penetration of the drug applied to the skin, depending on the nature of formulation and 
physicochemical properties of the drug.  
1.2 Strategies for overcoming the skin barrier function in dermal delivery 
A very small number of drugs have the ability to effectively cross the skin barrier and reach target sites 
in therapeutic concentrations, therefore various strategies can be employed to help the drug cross the 
skin barrier effectively. In this section a brief snapshot of the various strategies developed over past 
decades in drug delivery to or through the skin is presented. In skin delivery, first objective must be to 
identify the location of target sites for action of the drug applied on the skin. Based on the distance from 
site of application, drug targets can be classified as 1) local, drug penetration only in the near-surface 
skin layers such as epidermis and dermis. For example topical formulations for treatment of skin 
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conditions like eczema, psoriasis etc. 2) deep local regions, drug must penetrate the skin deep in 
therapeutic concentrations to act on local targets 3) systemic circulation, site of application of drug and 
target sites are far apart (Flynn and Weiner, 1991). Identification of the target sites is an important 
consideration because it influences drug selection and transdermal strategy selection as different 
techniques tend to deposit different amounts of drug into the skin. For simplicity, strategies for topical 
drug delivery are classified topical, chemical and physical. For in-depth overview about transdermal 
penetration strategies, interested readers are urged to discover following publications, Atkinson et al. 
(2015); Barry (2005); Narasimha Murthy and Shivakumar (2010); Prausnitz and Langer (2008). 
 
Figure 2: An overview of the various strategies for enhancing drug delivery to or through the skin 
1.2.1 Topical drug delivery 
Drugs delivered topically include antibiotics, antivirals, antifungals, corticosteroids, anti-inflammatory, 
anesthetics etc. Typically, conventional formulations like creams, ointments, gels, lotions, emulsions, 
solutions etc. are employed in the topical drug delivery. Drug penetration from conventional 
formulations is usually limited to upper layers of skin only. However, conventional formulations benefit 
from the fact that in dermatological conditions or skin infections, the skin barrier function is impaired 
thus formulations typically do not employ complex penetration enhancing strategies to improve drug 
penetration into the skin. It does not mean however that conventional formulations cannot be used for 
transdermal applications. Gels and creams containing chemical penetration enhancers such as short 
chain alcohols, propylene glycol, surfactants etc. have been employed e.g. doc® ibuprofen gel in the 
treatment of muscle pain.  
Strategies for enhancement of transdermal drug penetration 
Topical delivery
e.g. creams, ointments, 
gels etc 
Chemical methods
- Chemical penetration 
enhancers
- Liposomal vesicles
- Salt formation
- Drug-ion pair
- Eutectic mixture
Physical methods
- Iontophoresis
- Electroporation
- Sonophoresis
- Microneedles
- Stratum corneum 
ablation
- Magnetophoresis
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1.2.2 Chemical methods for penetration enhancement 
Chemical penetration enhancers are a wide class of compounds which temporarily reduce the skin 
barrier function which can lead to increased drug penetration into the skin (Barry, 2001). For example, 
water, short chain alcohols like ethanol, propanol, dimethylsulfoxide and analogs, fatty acids, 
surfactants, pyrrolidones, urea, polyols, terpenes, essential oils etc. Chemical penetration enhancement 
for increased drug penetration is by far the most studied strategy as these penetration enhancers can 
enhance penetration of a wide variety of drugs (Atkinson et al., 2015). For example, fatty acids have 
shown to increase skin penetration of flurbiprofen (Chi et al., 1995), vasopressin, levosimendan 
(Valjakka-Koskela et al., 2000), diclofenac sodium (Escribano et al., 2003), ondansetron (Takahashi 
and Rytting, 2001), tenoxicam (Gwak and Chun, 2002) etc. Increased drug penetration is achieved by 
one or more of the following mechanisms depending on the chemical nature of the penetration enhancer; 
1) lipid modification – by disrupting the intercellular lipid organization in the SC 2) protein modification 
– by interacting with the corneocyte proteins 3) partitioning promotion – alters the chemical environment 
of the SC which increases partitioning of drug into the SC (Barry, 2005). Chemical penetration 
enhancers are usually only effective in increasing drug penetration of small molecules. Also to achieve 
a substantial penetration enhancement, high concentrations of penetration enhancers are required which 
can be irritating to the skin. Due to the irritation potential of these chemical agents, they are not used as 
a stock vehicle for the drug but rather used in small concentrations as excipients in creams, gels, 
transdermal patches etc.  
Phospholipid vesicles (liposomes) are spherical, self-contained amphiphilic bilayer membranes 
containing an aqueous interior, usually in the colloidal size range. As the name suggests, most commonly 
liposomes are prepared from phospholipids and can contain excipients like surfactants, ethanol, 
cholesterol etc. There exists a group of liposomes which were specifically designed for dermal drug 
delivery, e.g. Transfersomes®, invasomes, ethosomes, niosomes etc. Role of liposomes in drug delivery 
to skin is discussed in much greater detail in the following section 1.3. 
A group of strategies to chemically modify the drug to improve its physicochemical properties for better 
skin penetration include, salt formation, ion-pair formation and prodrug formation. Solubility of the drug 
in a vehicle or a solvent can be affected by salt formation. Such increase in solubility can often lead to 
increased transdermal penetration. Cheong and Choi have shown that percutaneous permeation of 
piroxicam in hairless mouse skin can be increased significantly by forming mono and diethylamine salts 
of piroxicam (Cheong and Choi, 2003). Hydrophilic ionic-drugs tend to have poor skin permeability. 
Skin permeability of ionic drugs can be improved by using a counter ion to form a sufficiently lipophilic 
and neutral drug-ion pair (Fang et al., 2015). Ionic species such as p-toluenesulfonic acid, 2-
naphthalenesulfonic acid, 1-hydroxy-2-naphthoic acid, ethanolamines, N-(2’-hydroxyethanol)-
piperidine, long chain fatty acids etc. can be used to increase the lipophilic properties of the parent drug 
molecule (Miller et al., 2009; Xi et al., 2012). Penetration behavior of such ion pairs usually depends 
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upon the non-drug part of the ion pair. Physicochemical properties of drugs with poor percutaneous 
permeation can also be improved by forming a prodrug which has suitable properties for skin 
permeation. Prodrugs can penetrate the SC and get converted to the active parent drug by hydrolysis or 
by enzymatic conversion within the viable epidermis or dermis thereby making the active parent drug 
available for the target site. When designing prodrug strategies for transdermal permeation, prodrug 
moieties are selected based upon the physicochemical properties of the parent drug (Sloan et al., 2015). 
Jona et al. have shown a 10 fold improvement in transdermal flux through human cadaver skin for 
indomethacin when it was esterified with 3-diethylamino-1-propanol (Jona et al., 1995). 
Eutectic mixtures are physical mixtures of two or more components such that melting point of the 
mixture is lower than the melting point of the individual ingredients. It is hypothesized that lower the 
melting point of a drug higher the solubility of the drug in skin lipids (Benson, 2005; Kasting et al., 
1987; Touitou et al., 1994). Therefore forming a eutectic mixture of the drug can enhance its solubility 
in a solvent vehicle and as a result may also increase the transdermal permeation. For example, Stott et 
al. (1998) have shown that terpenes can form eutectic mixture with ibuprofen causing a significant 
depression of the melting point resulting in an increased transdermal permeation. 
1.2.3 Physical methods for penetration enhancement 
Methods discussed in this section are relatively new and encompass a wide variety of techniques which 
deliver drug in the skin or through the skin either by bypassing the SC, by removing the SC or by 
temporarily decreasing the barrier function of the SC. These methods often use a combination of 
physical and chemical penetration enhancement strategies in order to maximize the amount of drug 
being delivered.  
Iontophoresis utilizes application of low voltage electrical currents (0.5 mA/cm²) to the skin providing 
an electrical driving force which assists in drug permeation into the skin (Barry, 2005). Typically, 
electricity is applied through a drug reservoir and an electrode placed on the skin. Both charged and 
uncharged drugs can be delivered by iontophoresis. Charged drugs are acted upon by the electrophoretic 
force while weakly charged and uncharged drugs are affected by electroosmotic flow of water generated 
by the preferential movement of ions such as Na+ (Barry, 2005; Prausnitz and Langer, 2008). Because, 
skin barrier properties are not altered in iontophoresis, drug must possess adequate physicochemical 
properties to be able to penetrate the SC. The biggest advantage of this method is that rate of drug 
delivery is proportional to the electric current applied therefore, rate of drug delivery can be controlled 
very effectively. However, moderate to high electrical currents passing through the skin can cause skin 
irritation which makes drug delivery rates dependent of skin irritation and pain experienced by the 
individual patient (Prausnitz and Langer, 2008). Recently, US-FDA has approved Zecuity® for 
delivering sumatriptan in the management of migraine and Ionsys® delivering fentanyl for management 
of pain in hospitalized patients.  
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In electroporation, increased drug permeation through skin is achieved by applying short (micro to 
millisecond) high-voltage (100 – 1000 V/cm) pulses to the skin which disrupt the intercellular lipid 
bilayer structures of the SC (Barry, 2005; Denet et al., 2004; Lucille et al., 2014). Drugs permeation 
through the skin is either due to short lived electrophoretic forces or by simple diffusion through the 
electropores which can last for a few hours. Because skin is anatomically altered, small as well large 
molecules can be delivered using electroporation (Blagus et al., 2013; Denet and Preat, 2003). Despite 
their early promises transdermal drug delivery by electroporation is mainly confined to animal models 
and in vitro studies. 
Sonophoresis or phonophoresis refer to delivering drugs through the skin with the aid of ultrasound. 
Both high frequency (0.7 – 16 MHz) and low frequency (20 – 100 MHz) ultrasound can be used (Polat 
et al., 2011). In low frequency ultrasound sonophoresis, acoustic cavitation just above the skin, in the 
liquid or semisolid formulation, forms shockwaves which alter the inter-corneocyte lipid arrangement 
leading to a higher permeation of the drug (Tezel and Mitragotri, 2003). Whereas in high frequency 
ultrasound sonophoresis, cavitation occurs within the skin. In general, high frequency sonophoresis is 
more effective in increasing transdermal flux of small molecules while low frequency ultrasound 
sonophoresis has demonstrated capacity to deliver larger molecules like proteins, hormones, vaccines 
and even nanoparticles (Polat et al., 2011).  
Microneedles are micron sized array of solid or hollow needles which can pierce through and make 
channels in the SC through which drug can penetrate deep into the skin. Dimensions of the microneedles 
are such that they do not reach deep enough to innervate the nerves in the lower epidermis (Sivamani et 
al., 2007). Microneedles have successfully deposited low as well as high molecular weight molecules 
such as proteins, DNA, vaccines (Gill and Prausnitz, 2007). For drug delivery using microneedles 
different strategies have been explored such as, piercing the skin with solid microneedles first followed 
by application of a transdermal patch; coating the solid microneedles with a drug formulation; 
application of hollow microneedles which can deliver drug formulation like an injection needle; drug 
can also be encapsulated within biodegradable microneedles and as microneedles are degrade drug is 
released in the skin (Atkinson et al., 2015; Sivamani et al., 2007). Different materials like silicon, glass, 
titanium, polymers and even sugars have been used in the past to manufacture microneedles (Sivamani 
et al., 2007). Precise and reproducible fabrication of microneedles and drug loading is one of the biggest 
challenge in this field. 
Stratum corneum ablation is controlled removal of the SC to produce micro-channels in the epidermis 
through which drug can permeate easily. Ablation can be achieved with the help of high power laser 
beams or precisely controlled local heating of the skin (Atkinson et al., 2015). In laser ablation usually 
an infrared laser (λ = 1 to 5 µm) which can excite water molecules in the tissue is used. Application of 
laser causes local water molecules to excite and eventually epidermis undergoes an explosive 
evaporation which leaves a micro-pore in the epidermis through which drugs can access deeper layers 
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of the skin (Bachhav et al., 2013). Laser can either be used in the form of a large few mm diameter beam 
or in the form of a large grid of micro-pores. Enhancement of transdermal delivery of small molecules, 
various proteins and vaccines by application of laser ablation has been demonstrated (Bachhav et al., 
2013; Gomez et al., 2008). In thermal ablation using specialized heating blocks, surface of the skin is 
heated to a few hundred Celsius for very short periods. Such rapid heating can vaporize the SC cells 
locally and with precise control leaving micro-pores through the epidermis (Bramson et al., 2003; Levin 
et al., 2005; Park et al., 2008).  
Magnetophoresis, Murthy and group reported for the first time that a static magnetic field can be used 
for increasing transdermal penetration of drugs (Krishnan et al., 2010; Murthy et al., 2010). Although 
enhancement of various small and large molecules has been demonstrated, the exact mechanism of 
action behind the increased drug permeation is not clear. 
Over the past few decades different strategies have evolved for improving the transdermal permeation 
of small as well as large therapeutic molecules. These strategies can be either employed alone or in 
combination to bring the drug in therapeutic concentrations to the target site. Most importantly, in 
transdermal drug delivery there is no ‘one-stop’ solution for all therapeutic requirements and each 
therapy must be customized as per the requirements presented by the target site, active ingredients, 
anatomical considerations etc. In the following section a more comprehensive overview about liposomal 
formulations for transdermal drug delivery is discussed. 
1.3 Current status of liposomes in transdermal drug delivery systems 
In the previous section, some of the strategies for delivering drug to or through the skin were discussed. 
This section will take a closer look at the liposomal formulations for drug delivery to skin. Liposomes 
were first suggested by Mezei and Gulasekharam in 1980 as a drug delivery system for depositing 
triamcinolone in skin (Mezei and Gulasekharam, 1980). Liposomes are phospholipid vesicles containing 
one or more bilayers containing an aqueous core. A detailed review for different preparation methods, 
characterization and properties of liposomes can be found elsewhere (Barenholz and Lasic, 1996; 
Gregoriadis, 2006; Torchilin and Weissig, 2003).  
Liposomes in skin drug delivery applications have a rather controversial history. Ambiguity originates 
from the wide array of results that have been reported by various work groups. Some groups have 
suggested liposomes for topical drug delivery because liposomes tend to accumulate the drug in upper 
layers of skin and even act as drug-depot reducing the systemic absorption of the drug. Whereas some 
groups have found liposomes to increase transdermal drug penetration. Liposomes have been even 
shown to accumulate in the hair follicles (Patzelt and Lademann, 2013; Verma et al., 2004; Vogt et al., 
2005). Liposomes have also shown the ability to improve transdermal delivery of small molecules as 
well as peptides and proteins (Benson, 2009; El Maghraby et al., 2008b). Reasons for the disparity 
between different results of different studies likely originate from; differences in composition of 
liposomes, different physicochemical properties of the liposomal vesicles like charge, size, and different 
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drugs employed in the studies, additives to the liposomes such as ethanol, edge activators, penetration 
enhancers also modify the bilayer characteristics and drug transfer from the liposomal bilayer, use of 
different animal models etc. 
Interactions of liposome with the skin and drug transfer from liposome to skin are influenced by the 
thermodynamic state of the liposomal bilayers and therefore influenced by the nature of phospholipids 
used in the preparation of the liposomes. Depending on the composition, liposomal bilayers can exist in 
gel state, characterized by rigid and unyielding bilayers or liquid crystalline state where bilayers are 
flexible and accommodating. Liposomal formulations in gel state are usually associated with drug 
accumulation in the upper layers of the skin and even reduced transdermal drug penetration (Hofland et 
al., 1994; Knepp et al., 1987; Mezei and Gulasekharam, 1980). For skin application, liposomal 
formulations can be divided in two broad categories as, conventional liposomes and novel liposomes 
(deformable or ultradeformable or elastic liposomes) (Dragicevic-Curic and Fahr, 2012). Conventional 
liposomes are mainly composed of pure or mixtures of phospholipid(s) and may or may not contain 
cholesterol. Although a few studies have suggested possibility of transdermal drug delivery using 
conventional liposomes, a vast number of studies suggest conventional liposomes are more suitable for 
topical or local delivery of drug in the skin (Deo et al., 1997; Yu and Liao, 1996). Second category 
represents an array of different liposomal systems which apart from phospholipids contain other 
additives which essentially imparts the liposome bilayer deformability or elasticity which has been 
correlated to increased drug permeability in skin (Celia et al., 2012; Cevc and Blume, 2003; Cevc et al., 
2008; Touitou et al., 2000; Wo et al., 2011). Few of such liposomal systems are described in table 2. A 
review of the important findings in the drug delivery to skin using liposomes is presented in table 5 & 
6 however a much more in depth and elaborate review is presented by Benson (2009); Elsayed et al. 
(2007); Hamishehkar et al. (2012). 
Table 2: A brief description of the deformable or elastic liposomal systems for skin drug delivery 
Formulations 
Work group 
Bilayer forming lipid and other additives 
Transfersomes® 
Cevc et al. 
Soya phosphatidylcholine (S100, Lipoid GmbH). See table 3 for composition. 
Edge activators, sodium cholate, polysorbate 80, sorbitan monooleate 80 etc.  
Ethosomes 
Touitou et al. 
Soya phosphatidylcholine (S100, Lipoid GmbH) 
10-50% ethanol by weight which fluidizes the phospholipid bilayers 
Invasomes 
Fahr et al. 
Soya phospholipid (NAT 8539, Lipoid GmbH) See table 4 for composition. 
Lyso phosphatidylcholine as an edge activator, 1% terpenes and 10% ethanol 
by weight as penetration enhancers 
Niosomes 
Handjani et al. 
Non-ionic surfactants such as dicetylphosphate, hexadecyl diglycerol ether, 
polysorbates, sorbitan monooleates etc and cholesterol  
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Table 3: Composition of soy-phosphatidylcholine LIPOID S100 
Phospholipid composition  Fatty acid composition 
Phosphatidyl choline > 94%  Palmitic acid  12 – 17% 
Phosphatidyl ethanolamine < 0.1%  Stearic acid 2 – 5% 
N-acyl-phosphatidyl ethanolamine < 0.5%  Oleic acid 11 – 15% 
Phosphatidyl inositol < 0.1%  Linoleic acid 59 – 70% 
Lyso-phosphatidyl choline < 3.0  Linolenic acid 3 – 7% 
 
Table 4: Composition of soy-phosphatidylcholine NAT8539 
Phospholipid composition  Fatty acid composition 
Phosphatidyl choline > 73%  Palmitic acid  10 – 15% 
Phosphatidyl ethanolamine < 7%  Stearic acid 1 – 4% 
Phosphatidic acid < 7%  Oleic acid 6 – 13% 
Phosphatidyl inositol < 5%  Linoleic acid 60 – 70% 
Lyso-phosphatidyl choline < 6  Linolenic acid 4 – 7% 
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Table 5: A brief review of the conventional liposomes in topical drug delivery 
Formulation details Criteria investigated, test model  Results / Remarks 
 
Drug deposition in upper layers of the skin following application of liposomal formulation 
Mezei and Gulasekharam (1980) 
Multilamellar liposomes,  
DPPC : chol (1.1:0.5) 
Drug: C14 labeled triamcinolone 
Liposomes dispersed in an ointment base 
Drug deposition in skin, organs, 
blood and urine measured in New 
Zealand white rabbits 
Approx. 4-5 times higher deposition of triamcinolone in upper skin layers from liposomal 
formulation compared to a conventional ointment and reduced urinary excretion of 
triamcinolone.  
 
 
Gesztes and Mezei (1988) 
Soya phosphatidylcholine (7%), stearic 
acid (0.7%), cholesterol (0.7%) 
Drug: tetracaine (0.5%) 
24 healthy human adults, pain scores 
measured using pin prick method 
Liposomal tetracaine produced significantly stronger and longer lasting local anesthesia 
compared to a cream. 
Lipids and drug were dispersed in a medium containing 10% ethanol and 7% propylene 
glycol to prepare liposomes. Both ethanol and propylene glycol have a penetration 
enhancing effect 
Foldvari et al. (1990) 
Soya PC : chol (6.5:1) 
Drug: C14 lidocaine 
MLVs were dispersed in a gelling agent to 
increase viscosity 
Five healthy human adults, pain 
scores measured using pin prick 
method 
Liposomal lidocaine produced a much stronger local anesthesia compared to lidocaine 
ointment.  
(Fresta and Puglisi, 1996) 
DMPC : chol : DPPS (7:5:3) 
Ceramides : chol : palmitic acid : 
cholesteoryl sulphate (4:2.5:2.5:1) 
Soya phosphatidylcholine : chol (2:1) 
Drug/marker: [C14]Inulin 
MLVs subjected to freeze thaw cycles 
In vitro, permeation and penetration 
of [C14]inulin was measured in 
hairless mouse skin mounted on 
Franz diffusion cell  
In vivo, distribution of [C14]inulin in 
various orangs and blood was 
determined in female piglets  
Stratum corneum lipid (ceramide) liposomes deposited higher amounts of [C14]inulin in 
epidermis and dermis with very minor systemic absorption as compared to DMPC 
liposomes.  
Highest transdermal penetration of [C14]inulin was observed for fluid soya 
phosphatidylcholine liposomes 
(Kitagawa and Kasamaki, 2006) 
Egg PC : retinoic acid (4:1), 
Egg PC : DOTAP : retinoic acid (2:2:1), 
DMPC : DOTAP :retinoic acid (2:2:1) 
DPPC : DOTAP : retinoic acid (2:2:1) 
Drug: retinoic acid 
Skin deposition of retinoic acid 
measured in excised guinea pig 
dorsal skin mounted on Franz cells 
Two fold increase in deposition of retinoic acid in skin from egg PC liposomes compared 
to retinoic acid delivered from isopropyl myristate solution. 
Incorporation of cationic surfactant DOTAP further increased retinoic acid deposition by 
3.7 fold compared to non-ionic egg PC liposomes. 
Replacing egg PC with either DMPC or DPPC did not result in significant change in 
retinoic acid deposition.  
Chol cholesterol, DPPC dipalmitoylphosphatidylcholine, DMPC dimyristoylphosphatidylcholine, DOTAP 1,2-dioleoyl-3-trimethylammonium-propane, MLV multilamellar vesicles  
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Effect of change in physiochemical properties of liposomes on drug delivery to skin 
Sinico et al. (2005) 
Soya PC : chol : retinoic acid : stearylamine 
or dicetylphosphate (5:0.6:2:1) 
Stearylamine => cationic liposomes 
Dicetylphosphate => anionic liposomes 
Both MLVs and UVs were prepared 
Drug: retinoic acid 
Skin penetration and permeation 
studies using newborn pig skin 
mounted on Franz diffusion cells. 
Positively charged liposomes were associated with higher and faster permeation of 
retinoic acid compared with negatively charged liposomes.  
MLVs and UVs did not have a significant effect on the penetration of retinoic acid 
Replacing soya PC with a hydrogenated PC increased permeation of retinoic acid by a 
factor of 2 to 2.35 for both cationic and anionic liposomes. 
Yu and Liao (1996) 
Egg PC : chol (2:1) 
Egg PC : chol : dicetylphosphate (2:1:0.25) 
Egg PC : chol : stearylamine (2:1:0.25) 
Skin lipid liposomes: Ceramide : chol : 
palmitic acid : cholesteryl sulphate 
(4:2:2.5:1)  
Drug: Triamcinolone 
Drug permeation study using Wistar 
rat skin mounted on Franz diffusion 
cells 
 
Effect of liposome size was tested by 
applying 1, 0.4 0.2 µm MLVs and 
SUVs. 
Negatively charged SUVs showed significantly higher permeation and deposition of 
triamcinolone. 
Comparing vesicle charge in MLVs and SUVs, amount of drug permeated was not 
statistically significant however deposition of triamcinolone was significantly higher from 
cationic MLVs. 
Replacing Egg PC with DPPC (neutral liposomes) significantly reduced the amount of 
triamcinolone deposited and permeated through the skin. 
All liposomes showed better permeability of triamcinolone compared to ointment. 
Manosroi et al. (2004) 
HPC : chol (1:1) & (7:2) 
HPC : chol : stearylamine (7:2:1) 
HPC : chol : dicetylphosphate (7:2:1) 
Drug: AmB (0.05mg/mg of lipid) 
MLVs were probe sonicated 
Drug permeation and deposition was 
studied in full thickness abdominal 
skin of Wistar rats mounted on 
Franz diffusion cells. 
Highest flux of AmB across the skin was observed for cationic liposomes while nutral 
liposomes showed the lowest permeated AmB.  
Flux for cationic liposomes (57.6 ± 29.1 ng/cm²/h) through the SC was higher than anionic 
liposomes (39.5 ± 6.3 ng/cm²/h) however flux through viable epidermis was higher for 
anionic liposomes (22.8 ± 2.5 ng/cm²/h) compared to cationic liposomes (10.9 ±3.3 
ng/cm²/h) 
PC phosphatidylcholine, SUV small unilamellar vesicles, HPC hydrogenated soya phosphatidylcholine, AmB amphotericin B 
 
Delivery to hair follicles   
Jung et al. (2006) 
DPPC : DPPG : chol (5:1:4) (Anionic) 
DPPC : DC-chol: chol (5:1:4) (Cationic) 
DMPC : HCS : chol (5:1:4) (Amphoteric) 
DMPC : TES : chol (5:1:4) (Cationic) 
Label: carboxyfluorescein 
Pig ear skin, skin biopsies were 
taken after 1 hour, 1, 3, 5 and 7 days 
after application of liposomes. 
Analyzed by cryo sectioning and 
confocal microscope 
All liposomal formulations had higher carboxyfluorescein deposition in the hair follicles 
compared to a carboxyfluorescein containing cream. 
Cationic and amphoteric liposomes reached the highest penetration depth on day-5 after 
application.  
Liposomes had size range between 200 – 450 nm.  
Li and Hoffman (1997) 
Egg PC 10 mg/ml 
In vivo application of fluorescent 
liposomes to dorsal skin of mice. 
Deposition of calcein deep in the hair follicles was observed when applied in the form of 
liposomes as compared to topically applied solution. 
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MLVs are probe sonicated  
Label: Calcein or melanin 
Unentrapped label separated by gel 
filtration chromatography 
Punch biopsies taken at 0.5, 1, 2, 4, 
6, 16 and 24 hours. Fluorescent label 
deposition in skin and blood is 
measured along with microscopy  
Melanin showed similar results to calcein but distribution of melanin was not as uniform 
as calcein.  
Trauer et al. (2014) 
DPPC : DPPG (9:1) 
Invasomes (Table-2) 
Label: Carboxyfluorescein, Rh-DOPE  
MLVs extruded to obtain LUVs 
Excised breast or abdominal human 
skin. Effect of massage and 
occlusion on penetration of 
fluorescent dye was investigated 
using confocal microscope 
Carboxyfluorescein penetrated significantly deeper from both liposomal formulations 
compared to lipid marker Rh-DOPE.  
Massage increased the penetration achieved for fluorescent markers for both rigid and 
flexible liposomal formulations.  
Occlusive application increased penetration of carboxyfluorescein only from rigid 
liposomes. For invasomes penetration depth decreased after occlusive application. 
DC-chol 3β-[N-(dimethylaminoethane) carbamoyl]cholesterol, TES trimethylammonium methyl sulfate, DPPG dipalmitoylphosphatidylglycerol, Rh-DOPE 1,2-Diol- 
eoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B) 
 
Table 6:  
Formulation type Drug / label, test model Results / remarks 
 
Transfersomes® 
  
Cevc and Blume (2003) Triamcinolone. In vivo measurement of drug distribution 
and murine ear edema model 
Triamcinolone applied from Transfersomes® showed higher and prolonged anti-
inflammatory activity compared to cream and ointment formulations. 
Prolonged anti-inflammatory activity can decrease dose of triamcinolone by a factor 
of 10 compared to the conventional cream and ointment. 
Cevc et al. (1998),  
Cevc (2003) 
Insulin, in vivo distribution and hypoglycemia in mice 
and humans 
Hypoglycemia induced by transfersomal insulin was comparable to insulin delivered 
by sub cutaneous injection. Lag time of approx. 45-145 min was observed. 
Mixed micelles and conventional liposomes did not induce hypoglycemia. 
Cevc and Blume (2001) Diclofenac transfersomal gel, in vivo distribution of 
radioactive drug in NMRI mice, Wistar rats and pigs 
High levels of diclofenac was found in muscle tissue in all three animal models 
compared to a commercially available gel. 
Gupta et al. (2005) Tetanus toxoid, albino Wistar rats for immunization 
study 
Topically applied tetanus toxoid transfersomes after secondary immunization 
elicited an anti-TT-IgG immune response comparable to immune response elicited 
by intramuscular administration of alum adsorbed tetanus toxoid. 
Mishra et al. (2006) Immune response to topically applied hepatitis B surface 
antigen in BALB/c mice 
A strong immune response comparable to intramuscularly administered alum 
adsorbed hepatitis B surface antigen was observed.  
Ex vivo penetration studies revealed penetration of antigen to the Langerhan’s cells 
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Ethosomes 
Horwitz et al. (1999) Acyclovir, double blind randomized clinical study to 
determine efficacy of acyclovir loaded ethosomes in 
patients with recurrent herpes labialis  
Time to crusting of lesions and time to loss of crust were significantly shorter with 
ethosomal acyclovir as compared to a commercially available cream. 
Paolino et al. (2005) Ammonium glycyrrhizinate, anti-inflammatory activity 
was determined in healthy human volunteers and 
percutaneous permeation was determined using human 
epidermis ex vivo 
Significantly higher anti-inflammatory activity was seen when drug was 
administered from ethosomes as compared with ethanolic and aqueous solutions of 
the drug.  
Ex vivo permeation of ammonium glycyrrhizinate was higher from ethosomes 
compared to its ethanolic and aqueous solutions. 
Zhang et al. (2014) Psoralen loaded ethosomes, ex vivo permeation studied in 
rat skin 
Transdermal flux and skin deposition of psoralen was 3.5 and 2.15 times higher for 
ethosomes compared to conventional liposomal psoralen.  
 
Invasomes 
  
Shah et al. (2015) Anti-acne efficacy of azelaic acid loaded invasomal gel 
was determined in vivo in by inducing acne in female 
Wistar rats 
Invasomal gel showed significantly higher anti-acne activity compared to 
conventional liposomes and a cationic liposomal formulation. Complete recovery 
from acne was observed in 7 days in invasomal gel compared to 10 or more days 
for the conventional liposomes and cationic liposomes. 
Dragicevic-Curic et al. 
(2008) 
Photodynamic therapy using temoporfin loaded 
invasomes for subcutaneously implanted human 
colorectal tumor HT29 in mice 
Invasomal temoporfin showed significantly slower increase in tumor size 
compared to controls 
Chen et al. (2010) Penetration and permeation of ferrulic acid across human 
epidermis was studied when delivered in the form of 
invasomes, ethosomes and transfersomes 
Invasomal ferrulic acid penetration and permeation was about two times higher 
compared to conventional liposomes. Highest amount of ferrulic acid permeation 
was from ethosomes while for transfersomes ferrulic acid penetrated and permeated 
was not significantly different from invasomes. 
 
Niosomes 
  
Maheshwari et al. (2011) Niosomes encapsulating Hepatitis B surface antigen and 
cholera toxin B as an adjuvant were tested on human 
cadaver skin ex vivo to test skin deposition and 
permeation. Immune response was tested in vivo using 
BALB/c mice 
Permeation of the antigen was significantly higher when delivered from niosomes 
compared to application of aqueous solution. Immune response measured by 
determining IgG titers 21 days after topical immunization was similar to 
intramuscular injection of alum adsorbed Hepatitis B antigen. 
 
Manosroi et al. (2012) Follicular penetration from cationic niosomes 
encapsulating semipurified fraction of Oryza sativa 
containing unsaturated fatty acids (treatment against male 
pattern baldness) was determined in excised porcine skin 
Enhanced delivery of unsaturated fatty acids from cationic niosomes was observed 
compared to neutral niosomes. 
Lakshmi et al. (2007) Efficacy study of niosomal methotrexate gel in a double 
blind clinical trial in patients with psoriasis 
Significantly reduced erythema scores were obtained when methotrexate was 
delivered via niosomal gel compared to a commercially available methotrexate gel 
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1.4 Mechanisms of drug penetration in skin from liposomes 
Previous section demonstrated that application of liposomes as a drug delivery to or through the skin is 
dependent on the lipid composition of liposomal bilayers, size and charge of the vesicles, 
physicochemical properties of the drug and state of the skin barrier. Despite the variability seen in the 
outcomes from liposomal drug delivery to skin, some general rules can be established. Liposomes with 
rigid bilayers tend to confine the drug locally in the skin. For deeper penetration, liposomes with flexible 
bilayers perform better. This flexibility is often induced by incorporation of surfactants often termed as 
‘edge activators’ which reduce the elastic modulus of the phospholipid bilayer. Also size of liposomes 
is an important factor, large multilamellar vesicles are mainly associated with topical drug delivery 
whereas liposomes around 100 nm can deliver drug deeper in the skin or even across the skin.  
 
Figure 3: Schematic showing various mechanisms by which liposomes can facilitate drug delivery to 
skin. (A) The free drug mechanism (B) Penetration enhancement achieved by components of the 
liposomal formulation (C) Adsorption or fusion of liposomal vesicles with the SC (D) penetration of 
intact vesicles into or through the SC (E) Transfollicular delivery. Redrawn from El Maghraby et al. 
(2008a). Not to scale. 
Liposomal drug delivery to the skin can be classified in five different mechanisms or pathways as shown 
in Figure 3 (El Maghraby et al., 2008a). According to this classification, liposomes can either act as 
drug carriers bringing different lipophilic and hydrophilic drugs in close proximity to the SC from where 
drug partitions into the SC independent of the liposomal components. Second mechanism suggests that 
components of the liposomes act as penetration enhancers which facilitate in the penetration of the drugs. 
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Third mechanism suggests that liposomal bilayers can fuse or get adsorbed on the surface of the SC 
where they release their drug cargo. Forth and the most controversial mechanism suggests that flexible 
liposomes such as Transfersomes can penetrate the SC intact and therefore taking the drug cargo along 
with them. Fifth mechanism is the transfollicular mechanism, where liposomes can enter the hair 
follicles which typically penetrate the dermis and release the drug in the hair follicles which can diffuse 
out in the dermis or viable epidermis from within the hair follicle. Which mechanism or combination of 
two or multiple mechanisms dominate in any given drug – liposomal system combination would depend 
on the physicochemical properties of the drug and liposomal system. Mechanisms for drug penetration 
are discussed in much greater detail in publication-3 and 4 and in chapter 4. 
 
1.5 Introduction to tip-enhanced Raman scattering 
Vibrational spectroscopic techniques such as infrared and Raman microscopy are able to provide a 
wealth of information by identifying molecular structures and conformations at cellular and molecular 
level without requiring dyes, stains, radioactive labels etc. Application of these techniques for diagnostic 
purposes and in pathophysiology of various diseases and disorders such as, carcinomas (Lasch et al., 
2007), brain tumors (Krafft and Salzer, 2008), bone diseases (Boskey and Mendelsohn, 2005), 
atherosclerosis (Kodali et al., 1991), diabetes (Hosafci et al., 2007), osteoarthritis (West et al., 2004) 
etc. has been demonstrated. In skin related fields, these techniques have been used to study skin 
hydration status (Vyumvuhore et al., 2013), penetration of various compounds like, metronidazole 
(Tfayli et al., 2007), caffeine (Tfaili et al., 2013), deuterated water (Ashtikar et al., 2013), beta carotene 
(Ashtikar et al., 2013; Ermakov et al., 2004), ibuprofen (Mateus et al., 2013) etc. and in diagnostics of 
skin related disorders such as melanoma (Gniadecka et al., 2004), basal cell carcinoma (Nijssen et al., 
2007), squamous cell carcinoma (Lieber et al., 2008) etc.  
Despite the great potential of these microspectroscopic techniques, they are limited by the Abbe’s 
diffraction limit. Which means the highest resolution for these techniques is roughly in the range of 200-
300 nm. However, to study the interactions between the SC and liposomes a microspectroscopic 
technique with high spatial resolution is desired, especially given the liposomes used for transdermal 
drug delivery have size around 100 nm. Tip-enhanced Raman scattering (TERS) is capable of providing 
a sub-nanometer spatial resolution and spectroscopic information with single-nanometer resolution 
(Treffer et al., 2012). Simplified, TERS can be described as a combination of scanning probe 
microscopy (SPM) and surface enhanced Raman scattering (SERS). SPM provides the high resolution 
topographical imaging mode whereas SERS provides the chemical signatures for identification and 
detection.  
Raman scattering is an inherently weak phenomenon where about one out of a million photons 
undergoes an inelastic scattering or Raman scattering. In SERS, weak Raman scattering is enhanced up 
to a factor of 1014 if the compound whose Raman spectra is to be measured is adsorbed on heavy metal 
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nanoparticles like silver, gold, iron or copper. The SERS enhancement is due to combination of two 
mechanisms, electromagnetic effect and chemical effect. Incident laser light can excite the surface 
plasmons on the metal nanoparticles and if resonance conditions are met, electromagnetic fields 
involved in the scattering event can be strongly enhanced. The product of the incident laser field and the 
scattered Raman yields the overall electromagnetic SERS effect (Barber et al., 1983; Wokaun et al., 
1982). In the chemical enhancement effect a charge transfer between the metal nanoparticle and the 
adsorbed molecule results in an amplification of the polarizability of the adsorbed molecule and 
enhanced Raman scattering (Moskovits, 1985).  
In TERS, field enhancement is achieved by confining the SERS effect to a sharp metal tip of SPM probe 
(Anderson, 2000; Hayazawa et al., 2001; Stöckle et al., 2000). Usually, either atomic force microscope 
(AFM) or scanning tunneling microscope (STM) can be used for this purpose. Here, to study the 
interactions between the stratum corneum and liposomal formulations, AFM tips coated with silver 
nanoparticles were employed as shown in Figure 4. A much more comprehensive review of the TERS 
is presented by Bailo and Deckert (2008); Blum et al. (2014) and a review of the biomedical applications 
of TERS is presented by Deckert-Gaudig and Deckert (2011); Treffer et al. (2012). 
 
Figure 4: Schematic for the TERS setup showing AFM tip coated with silver nanoparticles. Scanning 
electron micrograph of the silver nanoparticle coated AFM tip was taken from (Sharma et al., 2015) 
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1.6 Aim of the Study 
Stratum corneum forms the most significant fraction of the skin barrier for percutaneous absorption of 
topically applied substances. Various strategies have been employed to enhance drug penetration 
through the SC such as chemical penetration enhancers, microneedles, iontophoresis etc. Incorporation 
of drugs within liposomal membranes have also shown to enhance the drug penetration within the skin 
as already discussed in the previous section. When drug substances are applied in the solution form to 
the skin, drug penetration mainly depends on the physicochemical properties of the drug however, 
incorporation of drugs in the liposomal membrane results in a rather complex interaction between the 
stratum corneum, phospholipid membrane and drug. Objective of this thesis was to probe the 
interactions between stratum corneum and liposomes in order to gain a better understanding of the 
mechanisms involved in the skin-drug delivery from topical liposomal formulations, especially 
‘invasomes’.  
1) Confocal Raman microscopy study 
Objective in this study was to study the diffusion patterns of liposomally entrapped drugs and the 
liposome-forming phospholipids after topical application of liposomes on intact human skin. We were 
particularly interested in understanding the behavior of our in-house topical liposomal system 
‘invasomes’. Understanding the diffusion behavior of both, drug and phospholipid can directly shed 
light on the mechanism(s) involved in drug delivery to skin by topically applied liposomal formulation. 
Confocal Raman microscopy was the preferred choice of imaging technique as it facilitates possibility 
of a label-free identification of externally applied substances. In the first part of this study, a method for 
obtaining XZ non-invasive optical biopsies in human skin was established. Second part of this study 
investigated co-diffusion of drug and phospholipids in the stratum corneum after topical application of 
liposomally entrapped drugs on human skin ex vivo. 
2) Tip-enhanced Raman scattering study 
Our results of Raman microscopy experiments suggested that upon topical application of phospholipids 
in the form of liposomes, only a fraction of applied phospholipid found its way into the skin. Similar 
findings were also reported by Röding and Artmann (1992) who measured diffusion of radioactive 
phospholipids in the pig skin. Despite of this finding, a link between liposomes and enhanced skin 
penetration of a wide range of drugs has been established. This study investigated the interactions 
between liposomes and the stratum corneum at a nanoscale using tip-enhanced Raman scattering 
(TERS) in order to get a deeper understanding of the mechanism(s) involved in the liposomal drug 
delivery to the skin. TERS was the tool of choice for this study as it is not limited by the Abbe’s 
resolution limit and is an excellent tool for providing chemical and structural information in great detail.  
Motivation for this study was taken from work published by the Bouwstra group (Bouwstra and 
Honeywell-Nguyen, 2002; Hofland et al., 1995) where freeze-fracture transmission electron microscopy 
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was employed to study the interactions between the stratum corneum and liposomes. One of the 
objectives in the current study was to keep the sample preparation as simple as possible in order to 
eliminate artifacts.  
3) LeciPlex, invasomes and liposomes: a skin penetration study 
LeciPlex are cationic extemporaneous liposomal formulations developed by the Nagarsenkar group 
(Date et al., 2011) whereas invasomes are deformable liposomes developed by the Fahr group (Fahr and 
Muller, 2003) for skin delivery. In this study three vesicular systems, cationic LeciPlex, amphoteric 
invasomes and conventional liposomes were compared for their ability to deliver idebenone and azelaic 
acid into the deeper layers of human skin. Formulations were also characterized and their efficacy was 
measured using in vitro cell assays and in vivo animal model. Observations were discussed based on the 
drug-liposomal membrane interactions. 
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2. Publication Overview 
Publication-1 
Book chapter 
Confocal microscopy for visualization of skin penetration 
Mukul A. Ashtikar, Daya D. Verma, Alfred Fahr 
Accepted for publication after peer review in the 5th volume of book series ‘Percutaneous Penetration 
Enhancers - Chemical methods in penetration enhancement’ Publisher - Springer-Verlag Berlin 
Heidelberg.  
Revised proofs of the book chapter were submitted on 17th March 2013. 
 
Abstract: 
Book chapter provides an overview of various commercial confocal techniques that have emerged over 
a few decades discussing in brief their conception and working principle. Techniques discussed in the 
book chapter include, confocal laser scanning microscopy, two-photon fluorescence microscopy, 
confocal Raman microscopy and coherent Raman microscopy. Applications of these techniques to 
understand the skin penetration of various drugs, labels and chemical substances and in understanding 
the barrier function of skin is reviewed. Book chapter also presents different experimental results 
obtained in our lab, using confocal laser scanning microscopy, Raman microscopy and multimodal 
coherent anti-stokes Raman microscopy. 
Contributions to the publication: 
 Preparation of the manuscript 
 Review of microscopic techniques including two-photon fluorescence microscopy, confocal 
Raman microscopy and coherent Raman microscopy 
 Preparation of formulations, skin samples and spectral acquisition for confocal Raman 
microscopy and for multimodal coherent anti-stokes Raman spectroscopy and experiments 
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Abstract: 
Confocal Raman microscopy offers an opportunity for label-free imaging and can provide information 
about the chemical integrity of the drug as well as the tissue. This publication demonstrated a relatively 
simple method for obtaining XZ-Raman profiles of human stratum corneum using a confocal Raman 
microscope. XZ-Raman profiles for untreated human skin and human skin treated with beta-carotene 
and deuterated water were measured to demonstrate the method. Vertex component analysis was 
employed to analyze the spectral dataset and differentiate the skin components and applied substances. 
The method was developed with an aim of studying the patterns of drug diffusion in the SC.  
Contributions to the study: 
 Study design  
 Preparation of skin samples and confocal Raman microscopy measurements 
 Data interpretation, data analysis except for vertex component analysis. 
 Preparation of the manuscript 
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Tip-enhanced Raman scattering for tracking of invasomes in the stratum corneum 
Mukul Ashtikar*, Lucas Langelüddecke*, Alfred Fahr, Volker Deckert 
Manuscript in preparation.  
*Equal first authorship 
 
Abstract: 
Transdermal drug delivery from liposomal vesicles has been explained based several mechanisms. 
Straightforward observation of the interaction between liposome and skin is difficult due to the scale of 
this interaction. To study the effects of treatment of invasomes in human stratum corneum and in turn 
comment on the skin penetration mechanism of liposomes, a new sampling technique was developed to 
enable application of tip-enhanced Raman scattering to the layers of stratum corneum. Individually 
removed layers of corneocytes from invasome treated skin were first analyzed using atomic force 
microscopy, where presence of flattened vesicle-like structures was observed. TER spectra measured on 
the surface of these vesicle-like flattened structures reveled presence of head deuterated phospholipids 
which confirmed that the flattened vesicles were topically applied invasomes. For the first time a 
spectroscopic evidence for the penetration of intact liposomal vesicles in the human SC has been 
presented in this study. Presence of diffused deuterated phospholipid on the surface of corneocytes was 
also observed. Findings of this study point towards a penetration enhancement by phospholipid diffusion 
through the intercellular lipids of the SC and penetration of intact invasomes in the SC.  
Contributions to the study: 
 Development and calibration of stripping technique  
 Preparation of invasomes, preparation of supported bilayers and all skin samples for atomic 
force microscopy and tip-enhanced Raman scattering measurements 
 Atomic force microscopy and tip-enhanced Raman scattering measurements  
 Data analysis and interpretation 
 Manuscript preparation 
Publication Overview 
26 
Publication-4 
Research article 
LeciPlex, invasomes, and liposomes: A skin penetration study 
Sanket M. Shah*, Mukul Ashtikar*, Ankitkumar S. Jain, Dinesh T. Makhija, Yuvraj Nikam, Rajiv P. 
Gude, Frank Steiniger, Aarti A. Jagtap, Mangal S. Nagarsenker, Alfred Fahr 
International Journal of Pharmaceutics, Vol 490 (2015) 391-403. Published on 19th May 2015. 
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Abstract: 
This study compares three liposomal systems, cationic Leciplex, invasomes and conventional liposomes 
for their ability to deliver idebenone and azelaic acid deep into the skin. Efficiency of all liposomal 
vesicles was compared based on ex vivo human skin penetration studies, in vitro cytotoxicity studies, in 
vitro antimicrobial activity studies and in vivo anti-acne efficacy studies in rats. In ex vivo human skin 
penetration studies, the highest deposition of idebenone was observed from Leciplex formulations 
whereas from invasomes least amount of idebenone penetrated the skin. For azelaic acid, this trend was 
reversed and highest penetration was observed for invasomes and least for Leciplex. Similar trend was 
observed in the in vivo experiments for azelaic acid formulations. These contradictory trends were 
explained based on different partition coefficients between the liposomal formulations and skin. The 
study highlights the importance of apprehending the interactions between phospholipid bilayers and 
drugs when designing a formulation. 
Contributions to the study: 
 Preparation and characterization of formulations  
 Human skin preparation and ex vivo skin penetration experiments 
 Data interpretation 
 Preparation of manuscript 
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Abstract 21 
Confocal microscopic techniques have been around for over 50 years. However only in the last two 22 
decades there has been a truly widespread use of this technology in life sciences. Today there are 23 
different confocal techniques available and at the heart of all these techniques is the ability to 24 
differentiate between the light originated from different planes of the specimen. This ability is quite 25 
important when studying thick biological specimen such as skin microscopically, otherwise a lot of the 26 
information can get lost in the form of blur. In addition, due to advances in the material sciences and 27 
photonics, microscopes are able to image in vitro as well as in vivo and have allowed us to couple 28 
microscopes with spectroscopic techniques which provide valuable information in identification and 29 
characterization of structures. In this book chapter, we discuss basic principles of confocal laser scanning 30 
microscopy, 2-photon fluorescence microscopy, confocal Raman microscopy, coherent Raman 31 
microscopy and their applications in understanding the skin penetration of various substances. 32 
 33 
Key words: Confocal laser scanning microscopy; Fluorescence microscopy; Two-photon fluorescence 34 
microscopy, Confocal Raman microscopy, Coherent anti-stokes Raman scattering microscopy, 35 
Stimulated Raman scattering microscopy, Skin penetration; Liposomes; Hair follicle targeting. 36 
  37 
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1. Introduction 66 
Over the years various methods such as diffusion experiments (Addicks et al., 1987; du Plessis et al., 67 
1994), microdialysis (Benfeldt, 1999; Fang et al., 1999; Murakami et al., 1998; Schnetz and Fartasch, 68 
2001), visualization by microscopic techniques like conventional fluorescence microscopy (Kriwet and 69 
Müller-Goymann, 1995; Yarosh et al., 1994), electron microscopy (Bouwstra and Honeywell-Nguyen, 70 
2002; Hashimoto et al., 1991; Hofland et al., 1995; Kanerva, 1990; Schreiner et al., 2000; van den Bergh 71 
et al., 1999), confocal laser scanning microscopy (Betz et al., 2001; Kirjavainen et al., 1996; Schatzlein 72 
and Cevc, 1998; van Kuijk-Meuwissen et al., 1998; van Kuijk-Meuwissen et al., 1998; Vardaxis et al., 73 
1997; Veiro and Cummins, 1994) etc. have been exploited by researchers for studying percutaneous 74 
penetration and gain a better understanding of the skin barrier. Tape stripping and microdialysis 75 
experiments though extensively used to measure the amount and rate of penetration of the model 76 
compound, are lacking in providing information about the effect of the model drug on cells and lipid 77 
organization or particular pathways for the penetration of the model drug. These techniques also do not 78 
give much information about spatial distribution of the model drug inside the tissue or comment on the 79 
mechanism of penetration and more importantly, these are destructive methods where tissue has to be 80 
carefully removed or homogenized to quantify the amount of drug. 81 
Electron microscopy has been extremely useful in understanding the structure of the stratum corneum 82 
(SC) and intercellular lipid organization. Bouwstra and coworkers have made important contributions 83 
to the understanding of the interactions between vesicles and human skin (Hofland et al., 1995; Hofland 84 
et al., 1994; Schreiner et al., 2000). They employed freeze fracture electron microscopy and small angle 85 
X-ray scattering to study the effects of vesicular formulations on the SC. Their results indicated 86 
increased diffusion of the drug due to adsorption and fusion of drug loaded vesicles to the surface of the 87 
skin. They also reported perturbations in the ultrastructure of the SC intercellular lipid domains due to 88 
mixing of liposomal components with SC lipids, which could have also enhanced penetration of the 89 
model drug. Although freeze fracture electron microscopy provides rather useful information about the 90 
effect of liposomal vesicles on the ultrastructure of the skin barrier it lacks in providing information of 91 
penetration pathways and depth up to which the model drug has penetrated.  92 
Another widely appreciated technique is the conventional fluorescence microscopy. Evaluation of skin 93 
treated with fluorescently labeled liposomes by fluorescence microscopy has demonstrated that the 94 
fluorescent marker remained in the SC (Kriwet and Müller-Goymann, 1995) or penetrated deeper in the 95 
epidermis mainly along the hair shaft (Yarosh et al., 1994). However, during the sample preparation the 96 
tissue needs to be (cryo-) fixed which might lead to the alteration of the original specimen by the change 97 
in skin lipid organization, redistribution of the marker etc.  98 
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Confocal microscopy has evolved over last 5-6 decades and today it is an essential tool for a life-sciences 99 
laboratory; it has emerged as a sophisticated tool for tracking and studying transport phenomena of 100 
different compounds with high degree of precision. Confocal microscopy offers significant advantages 101 
over other microscopic techniques in evaluation of thick specimens due to their inherent ability to 102 
distinguish photons generated from different focal planes of the specimen. This ability is mainly 103 
achieved in two ways, either by introducing a pinhole aperture in front of the detector which limits the 104 
out of focus light or by utilizing a non-linear technique such as 2-photon fluorescence, which excites the 105 
specimen only in a very small focal plane at a time. Confocal microscopes create quite sharp images 106 
compared to conventional microscopes where light coming from different planes of the specimen is not 107 
differentiated, resulting in blurry and low resolution images. Confocal microscopy on a broad basis can 108 
be classified as an imaging and spectroscopic technique. Confocal techniques that are discussed in this 109 
chapter are confocal laser scanning microscopy (CLSM), two-photon microscopy and Raman 110 
microspectroscopic techniques. Although these techniques are based on different principles, they all 111 
have something in common and that is confocality, ability to image one small focal volume at a time to 112 
construct a high-resolution image. Thanks to the modern electronics and optics, we are able to image 113 
deeper into a thick biological specimen like skin at high resolution, high speed and in-vitro as well as 114 
in-vivo conditions. Sophisticated lasers and detection systems have enabled us to exploit non-linear 115 
excitation phenomena such as 2-photon fluorescence, coherent anti-stokes Raman scattering, stimulated 116 
Raman scattering etc. The following chapter reviews these techniques and discusses some of the results 117 
obtained pertaining to dermal delivery. 118 
2. Confocal laser scanning microscope 119 
In the last two decades, CLSM has been extensively used as a tool to visualize the fluorescent model 120 
compounds in the skin. CLSM examination revealed valuable additional morphological information of 121 
porcine skin in wound healing studies which was not obtained by conventional microscopy (Vardaxis 122 
et al., 1997). CLSM was also used to understand the mechanism by which nanoparticulate systems 123 
facilitate skin transport. The surface images revealed that (a) polystyrene nanoparticles accumulated 124 
preferentially in the follicular openings (b) this distribution increased in a time-dependent manner and 125 
(c) the follicular localization was favored by particles of smaller size (Alvarez-Roman et al., 2004). 126 
Simonetti et al. visualized diffusion pathways across the SC of native and in-vitro reconstructed 127 
epidermis by using CLSM (Simonetti et al., 1995). 128 
Many researchers used CLSM to evaluate the penetration of liposomes into human or animal skin using 129 
a fluorescent compound or a fluorescent model drug. It was demonstrated that flexible liposomes 130 
penetrated deeper into the skin in non-occlusive conditions than after occlusive application (van Kuijk-131 
Meuwissen et al., 1998) as measured by a fluorescent liposome marker. Touitou and coworkers 132 
Publication-1 
33 
 
examined the penetration of fluorescent probes into fibroblasts and nude mice skin by CLSM and 133 
showed that ethosomes facilitated the penetration of all probes into the cells, as evident from the high-134 
intensity fluorescence as compared to the hydroethanolic solution or conventional liposomes (Touitou 135 
et al., 2001). 136 
Many research groups examined different lipid combinations for their potential to influence the skin. 137 
Zellmer et al. used CLSM to demonstrate that vesicles made of native human SC lipids interact rapidly 138 
with phosphatidylserine liposomes, weakly with human SC lipid liposomes and do not interact with 139 
phosphatidylcholine (PC) liposomes (Zellmer et al., 1998). Kirjavainen et al. reported that lipophilic 140 
fluorescent marker, L-α-phosphatidylethanolamine-N-lissamine rhodamine B sulfonyl (N-Rh-PE) was 141 
able to penetrate deeper into the SC from liposomal vesicles containing dioleylphosphatidyl-142 
ethanolamine (DOPE) than from liposomes without DOPE. A pretreatment of the skin with unlabeled 143 
liposomes containing DOPE or lyso-phosphatidylcholine (lyso-PC) enhanced the subsequent 144 
penetration of the fluorescent markers, N-Rh-PE and sulforhodamine B into the skin, suggesting a 145 
possible penetration enhancing activity (Kirjavainen et al., 1996). 146 
Procedures like iontophoresis which enhance the percutaneous flux of model drugs like calcein (Turner 147 
and Guy, 1998) and mannitol (Kirjavainen et al., 2000) were also examined by CLSM in animal models. 148 
Grams et al. used CLSM to visualize time resolved diffusion of a lipophilic dye into the hair follicle of 149 
fresh and unfixed piece of human scalp skin. The authors claimed that this technique was able to 150 
visualize the diffusion of a dye into the upper hair follicle at different time points (Grams et al., 2004). 151 
In another study, they also report that follicular accumulation of lipophilic dyes increased when applied 152 
in combination of surfactant-propylene glycol (Grams et al., 2003). 153 
2.1. Principle of CLSM 154 
Confocality is achieved in CLSM by using a point illumination and point detection. Marvin Minsky 155 
constructed the first confocal microscope in 1957 at Harvard (Semwogerere and Weeks, 2008). He used 156 
a zirconium arc lamp and two pinholes, one in front of the lamp and another in front of the detector to 157 
achieve the confocality, while the sample was scanned through the light beam to generate the image. 158 
Today’s confocal microscopes although different are based on the same principle of point illumination 159 
and detection, and their ability to image thick samples with high resolution have enabled their use in 160 
studying skin penetration of various molecules and delivery systems. 161 
A CLSM can create a very sharp and high-resolution image of a specimen compared to a conventional 162 
microscope. This ability arises from the fact that CLSM is able to filter light coming from parts of the 163 
specimen that are not in focus, and in the process as much as 95% of the light coming from the specimen 164 
can be blocked to generate an image. As a result, very few photons actually make it to the detector 165 
therefore a very high intensity light source in the form of laser is used in modern CLSMs. One 166 
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disadvantage of this is that more than one laser might be required in order to have multiple excitation 167 
wavelengths. 168 
The principle of confocality is explained in the schematic diagram in figure-1A where light coming from 169 
the specimen is focused on the detector with the help of two lenses. Due to the pinhole in front of the 170 
detector only the light coming from a very small focal point reaches the detector and light from out of 171 
focus regions of the specimen is blocked by the pinhole. The second pinhole is employed in front of the 172 
light source, which limits the amount of specimen that is illuminated at any time, and as a result reduces 173 
the background scatter from out of focus region of the specimen. Two pinholes of the confocal 174 
microscope are able to significantly reduce the background blur and produce very high-resolution 175 
images (Hollricher and Ibach, 2011; Nwaneshiudu et al., 2012). 176 
 177 
Figure-1: A) Pinhole in front of the detector rejects light emerging from out of focus regions B) Schematic 178 
representation of CLSM optics (redrawn from Semwogerere and Weeks, 2008). 179 
Schematic representation of a CLSM is provided in figure-1B. In a modern CLSM a beam of light is 180 
provided by a laser which passes through a pinhole onto a dichroic mirror which directs the light to a 181 
scanning mirror assembly and onto the specimen through the microscope objective. The scanning 182 
mirrors scan the laser across the specimen in order to generate the image. Light reflected from the 183 
specimen is de-scanned at the scanning mirrors and passes to the photo-multiplier tube (PMT) detectors 184 
through the dichroic mirror (Semwogerere and Weeks, 2008). Light coming from out of focus regions 185 
of the specimen is blocked at the detector by a pinhole. Image of the specimen is reconstructed by a 186 
computer from the spatial coordinates and corresponding light intensity at the detector.  187 
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2.2. Major advantages of CLSM 188 
Blurring effect observed in the conventional microscope is either eliminated or reduced to a great extent 189 
in CLSM, and as a result, images generated are very sharp, have a high contrast and a higher resolution. 190 
In practice a CLSM can have at best a horizontal resolution of 0.2 µm and a best vertical resolution of 191 
0.5 µm. Further, a 3D sectioning or optical sectioning of the sample is possible as very small focal point 192 
is imaged at a time which also gives possibility to image thicker specimens using a confocal microscope. 193 
Using multiple lasers, it is possible to excite different fluorophores simultaneously.  194 
2.3. Major disadvantages of CLSM 195 
CLSM has an inherent resolution limitation of about 0.2 µm and is dependent on the wavelength of 196 
excitation. Due to the high intensity light source, photo bleaching and photo-damage in the illuminated 197 
region of the specimen is possible and repeated scans with high-energy light beam greatly reduce the 198 
viability of biological tissues and thereby the available time for studying a given specimen. For a high 199 
quality image, CLSM usually needs long scan times and as a result, CLSM is not suitable for imaging 200 
rapid physiological events in a cell or a tissue. In addition, because lasers emit light only at certain 201 
narrow bandwidths, in order to be able to excite a large range of fluorophores, multiple lasers need to 202 
be employed which along with the complex electronics, scanning mirrors and sophisticated data 203 
acquisition system raise the cost.  204 
2.4. CLSM used for tracking liposomal formulations in the skin 205 
Liposomes have been extensively studied and suggested as a vehicle for topical drug delivery(Chen et 206 
al., 2010; Chen et al., 2011; Dragicevic-Curic et al., 2008; Dragicevic-Curic et al., 2009; Ntimenou et 207 
al., 2012). However, the mechanism of penetration of liposomes as drug carriers into the intact skin is 208 
not fully understood. In this section, we will discuss the interactions between liposomes, containing 209 
hydrophilic and lipophilic fluorescent probes, and human as well as rat skin using CLSM. 210 
2.4.1. Tracking skin penetration of liposomally entrapped or un-entrapped hydrophilic 211 
fluorescent model drug 212 
The mechanism of action of liposomes as penetrable drug carriers in topical delivery is not completely 213 
understood. In order to evaluate if liposomes are able to increase skin penetration of only entrapped 214 
hydrophilic drugs or also of unentrapped hydrophilic drugs, three different liposomal formulations using 215 
carboxyfluoresceine (CF) as a fluorescent hydrophilic model drug were prepared: ‘CF in-out’ (non-216 
entrapped CF was not removed), ‘CFin’ (non-entrapped CF was removed) and ‘CFout’ (a precalculated 217 
amount of CF was added to empty liposomes). All the liposomal formulations had similar size of 218 
liposomes and the concentration of CF was the same in all formulations (Verma et al., 2003). After 6 h 219 
incubation of the skin with different formulations, the skin was cryofixed and 7 µm thick sections were 220 
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cut using a cryo-microtome. These cross sections were investigated using CLSM for the skin penetration 221 
of CF. 222 
 223 
Figure-2: Fluorescence micrographs of cross-sections of human abdominal skin incubated on Franz diffusion cells 224 
with different formulations containing CF. Formulations were applied without occlusion for 6 h. (A) liposomes 225 
CFin; (B) liposomes CFin-out; (C) liposomes CFout; CF outside liposomes and (D) CF dissolved in Tris buffer. Scale 226 
bar represents 100 µm. 227 
The penetration studies and CLSM images showed that liposomes CFin-out exhibited maximum 228 
deposition of CF in the SC, whereas liposomes CFin showed higher penetration of CF into the deeper 229 
skin layers such as the viable epidermis (Figure-2), and through the skin to the acceptor compartment 230 
of the Franz diffusion cell. These results were comparable to the data obtained from tape stripping 231 
experiments. This study confirmed the assumption that liposomes CFin-out were not under osmotic stress 232 
and will, therefore, transfer themselves more easily into the SC. The results indicated further that 233 
phospholipid vesicles not only carry the entrapped hydrophilic substance, but also the non-encapsulated 234 
hydrophilic substance into the SC and possibly to the deeper layers of the skin. Although CLSM served 235 
as useful tool to estimate skin penetration, CLSM images do not provide the visualization of single 236 
liposomes, so the exact mechanism of penetration of liposomes still remains an unsolved question. 237 
2.4.2. Effect of vesicle diameter on skin penetration of liposomally entrapped drugs 238 
The influence of vesicle size on the penetration of fluorescently labeled liposomes into the human skin 239 
was investigated using lipophilic fluorescent label, 1,1’-dioctadecyl-3,3,3’,3’-240 
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tetramethylindocarbocyanine percholate (DiI) (Verma et al., 2003). In all CLSM images (Figure-3) very 241 
high fluorescence was observed in the SC, which was expected due to the lipophilic nature of the 242 
fluorescent label, DiI. This study indicated that large vesicles with a size  600 nm were not able to 243 
deliver their contents into the deeper layers of the skin. These liposomes probably stayed in/on the SC 244 
and after drying they formed a layer of lipid, which would have further strengthened the barrier 245 
properties of the SC. The liposomes with size  300 nm were able to deliver their contents to some 246 
extent into the deeper layers of the skin. However, the liposomes with size  70 nm were most promising 247 
for dermal drug delivery into the deeper skin layers as they showed maximum fluorescence both in 248 
viable epidermis, as well as in dermis.  249 
 250 
Figure-3: Fluorescence micrographs of cross-sections of human abdominal skin incubated on Franz diffusion cells 251 
with different formulations containing DiI. The vesicles were applied non-occlusively for 12h. (A) Ethanolic 252 
solution of DiI; (B) NAT8539/ethanol (10/3.3); (C) NAT8539/ethanol (10/10); (D) NAT8539/ethanol (10/20). 253 
Scale bar represents 50 µm. 254 
2.4.3. Synergistic penetration enhancement effect of ethanol and phospholipids on topical drug 255 
delivery 256 
It was observed that the composition of liposomal formulation had an appreciable effect on the 257 
penetration of compounds into and through the skin (Hofland et al., 1994; Jimbo et al., 1983; Loftsson 258 
et al., 1989; Tenjarla et al., 1999).  Hence, the effect of lipid vesicular systems embodying ethanol in 259 
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relatively high concentrations on the percutaneous penetration of cyclosporin A (CyA) was investigated 260 
using a standardized skin stripping technique and CLSM (Verma and Fahr, 2004). Ethanol has been 261 
widely reported as an efficient skin penetration enhancer in the concentration of 5% to 100% (Bhatia 262 
and Singh, 1999; Kobayashi et al., 1994; Simonetti et al., 1995). In a preliminary study, we have seen 263 
that, not only the amount and the type of phospholipids are important for skin penetration enhancement, 264 
but also the amount of ethanol has a significant role in delivering the fluorescent model compounds into 265 
the skin (Figure-4) (Verma, 2002). We hypothesized that ethanol and phospholipids might have 266 
synergistic skin penetration enhancing effect.  267 
 268 
Figure-4: Fluorescence micrographs of cross sections of human skin incubated with vesicles with different lipid 269 
content for 12 h. A & B: ethanolic solution of N-Rh-PE (A) and CF (B). C & D: Flexible liposomes with N-Rh-270 
PE (C) and CF (D). E & F: PL 90H-liposomes with N-Rh-PE (E) and CF (F); G & H: PL25 liposomes with N-Rh-271 
PE (G) and CF (H). 272 
In order to evaluate synergistic effect of the ethanol and phospholipids on penetration of DiI, vesicles 273 
with composition of 10% (w/v) phospholipid mixture NAT 8539 (Lipoid, Germany) and ethanol at 274 
different concentrations ranging from 0-20% w/v were prepared. The results of the CLSM studies are 275 
represented in Figure-5. Ethanolic solution of the DiI dye was able to deliver only weak fluorescence 276 
into the SC, and no fluorescence was noticeable in the viable epidermis and dermis (Figure-5A). 277 
Formulation, NAT 8539/ethanol (10/3.3), produced a homogeneous bright fluorescence throughout the 278 
SC, but no fluorescence was observed in the viable epidermis and dermis (Figure-5B). Formulation, 279 
NAT 8539/ethanol (10/10), produced a bright fluorescence throughout the SC with very weak to weak 280 
fluorescence observed in the viable epidermis and dermis (Figure-5C). Formulation NAT 8539/ethanol 281 
(10/20), produced a homogeneous bright fluorescence throughout the SC and very a weak fluorescence 282 
was noticeable in the viable epidermis and dermis (Figure-5D). CLSM experiments have shown that the 283 
ethanolic solution of DiI was not even able to deliver the fluorescent label into the SC. In contrast, all 284 
the formulations with NAT 8539 and ethanol produced a bright fluorescence homogeneously throughout 285 
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the SC. Formulations prepared with NAT 8539 containing 10 and 20% ethanol were also able to show 286 
very weak fluorescence in the viable epidermis and dermis. The results above were confirmed by in 287 
vitro penetration studies followed by tape stripping and extraction of the radioactively labeled CyA from 288 
various layers of the skin. Ethanol, together with NAT 8539 had synergistic effects on the delivery of 289 
the CyA into the skin, and the enhancement effect of ethanol was concentration dependent. Although 290 
CLSM images do not provide pure quantitative data regarding the skin penetration, they are, however, 291 
extremely useful as a comparative tool and give useful information about the distribution of the drug 292 
within the skin. 293 
 294 
Figure-5: Fluorescence micrographs of cross-sections of human abdominal skin incubated on Franz diffusion cells 295 
with different formulations containing DiI. The vesicles were applied without occlusion for 12 h. (A) Ethanolic 296 
solution of DiI; (B) NAT8539/ethanol (10/3.3); (C) NAT8539/ethanol (10/10); (D) NAT8539/ethanol (10/20). 297 
Scale bar represents 50 µm. 298 
2.4.4. Terpenes as penetration enhancers in liposomes 299 
In this study, CLSM was used to investigate if incorporation of penetration enhancers (terpenes) into 300 
liposomal formulations had an effect on their percutaneous penetration enhancing ability in human and 301 
rat skin (Verma, 2002). Fluorescent derivative of CyA, D-Ala-8-CS-beta-aminebenzofurazan (Fl-CyA) 302 
and DiI, were used as lipophilic markers while Alexa Fluor-488® (Life Technologies GmbH, Germany) 303 
was used as a hydrophilic fluorescent marker. Vesicles with and without terpenes were compared with 304 
ethanolic and hydro-alcoholic solutions of the fluorescent labels. Double-labeled vesicles, vesicles 305 
containing both DiI and Alexa Fluor-488®, were applied to skin for 6 and 12h. Penetration of the 306 
fluorescent labels was visualized by CLSM both in terms of depth and intensities of the fluorescence. 307 
Fluorescent intensities of the CLSM images were semi-quantitatively scored ranging from no 308 
fluorescence to bright fluorescence. Further details regarding imaging and formulations can be found 309 
elsewhere, (Verma, 2002). 310 
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Cross sections of human skin treated with double-labeled (DiI and Alexa Fluor 488®) liposomes with 330 
and without terpenes are represented in Figure-7. Incubation period of formulation with the skin was 6 331 
h (Figure-7A-C) and 12 h (Figure-7D-F). Control was provided by skin samples treated with hydro 332 
alcoholic solution containing both dyes mentioned above. In all the samples the fluorescence was 333 
restricted mainly to the SC and to a smaller or larger extent, to the viable epidermis. Samples treated 334 
with hydroalcoholic solutions of the dyes exhibited fluorescence for both DiI and Alexa Fluor-488® only 335 
in the SC. Increasing the incubation period from 6 h to 12 h only increased the fluorescence intensities 336 
for both the labels (Figure-7A & 7D). In samples treated with dual labeled liposomes without terpenes, 337 
fluorescent markers after 6 h diffusion are restricted to the SC only. DiI penetrated upto deeper layers 338 
of the SC however no fluorescence was observed in the viable epidermis and dermis (Figure-7B). 339 
Increasing the incubation period to 12 hours did not have marked improvement in penetration depths. 340 
CLSM images (Figure-7E) show higher intensities and slightly higher penetration up to viable epidermis 341 
achieved for both the dyes. Although distribution of Alexa Fluor-488® appears uniform for both 6 and 342 
12 h diffusion samples, distribution of lipophilic dye DiI, was not uniform for 12 h samples. For skin 343 
treated with liposomal formulations containing 1% terpenes, much higher intensities were observed for 344 
both the fluorescent dyes in the SC (Figure-7C & 7F). For sample with 6 h incubation, very weak 345 
fluorescence for Alexa Fluor-488® while weak fluorescence for DiI, was observed in the viable 346 
epidermis. For 12 h incubation samples, fluorescence intensity scores were bright-fluorescence at SC 347 
for both the dyes and moderate fluorescence intensities were observed in the viable epidermis. 348 
Surprisingly, the reddish fluorescence continued from the epidermis towards the dermis, indicating a 349 
diffusion of the lipophilic marker. It was observed that liposomal formulations containing terpenes as 350 
penetration enhancer were able to deliver relatively higher amounts of fluorescent labels into the SC, 351 
epidermis and, to a small extent the dermis. In this study we clearly demonstrated the ability of CLSM 352 
to simultaneously image two fluorescent dyes.  353 
2.5. Tracking the penetration of fluorescence labels into hair follicles 354 
2.5.1. Tracking of fluorescently labeled cyclosporin A into rat hair follicles 355 
CLSM has been successfully used to track follicular penetration of drugs. Topical application of the CF-356 
loaded liposomes has been reported to significantly increase the accumulation of CF in the pilosebaceous 357 
units compared to other non-liposomal formulations (Lieb et al., 1992). Using CLSM, Patzelt et al. 358 
demonstrated that follicular penetration for nano-particles was size dependent (Patzelt et al., 2011). The 359 
effect of terpenes as penetration enhancers in liposomes for targeting hair follicles was investigated 360 
using Fl-CyA vesicles (as mentioned above), with and without terpenes, in rat skin. Figure-6 also depicts 361 
the role of the pilosebaceous unit in the penetration of drugs into the skin. A bright fluorescence was 362 
observed in the pilosebaceous units (bright green fluorescent regions in dermis in Fig.6B and 6C 363 
identified as the hair shaft, a part of the pilosebaceous unit) for both formulations, with and without PE. 364 
3XEOLFDWLRQ
42 
 
7KHIOXRUHVFHQFHZDVDOVRYLVXDOL]HGLQWKHRXWHUURRWVKHDWKRIWKHKDLUVKDIW)LJXUH%&	)LJXUH365 
 9HUPD7KH LPDJHVSUHVHQWHGKHUHGHPRQVWUDWH WKDW WKH OLSRVRPDOYHVLFOHV FDQ HQWHU WKH366 
SLORVHEDFHRXVXQLWDQGGHOLYHUWKHLUFRQWHQWWRWKHKDLUIROOLFOHDQGSRVVLEO\WRWKHKDLUEXOE,PSRUWDQFH367 
RIWKLVZDVVWUHVVHGXSRQE\WKHIDFWWKDWHWKDQROLFVROXWLRQRI)O&\$IDLOHGWRGHOLYHUDQ\IOXRUHVFHQFH368 
LQWRWKHVNLQ7KHVH&/60UHVXOWVZHUHVXSSRUWHGE\LQYLYRVWXGLHVZLWK'XQGHH([SHULPHQWDO%DOG369 
5DWVPRGHO9HUPDHWDODQGRWKHUSXEOLVKHGUHSRUWV$JDUZDOHWDO%RKPDQG/XJHU370 
/LHEHWDO1LHPLHFHWDO7KH&/60LQYHVWLJDWLRQVHQDEOHGXV WRYLVXDOL]H WKH371 
DFFXPXODWLRQRIIOXRUHVFHQWODEHOLQWKHSLORVHEDFHRXVXQLWVZKLFKLVQRWSRVVLEOHZLWKWDSHVWULSSLQJ372 
373 
)LJXUH)O&\$OLSRVRPHV WUHDWHGUDWVNLQFURVVVHFWLRQGHPRQVWUDWLQJWKHUROHRISLORVHEDFHRXVXQLWVLQWKH374 
SHQHWUDWLRQRIVXEVWDQFHLQWRWKHVNLQ7KHEDUUHSUHVHQWVP375 
$FFXPXODWLRQRI&)DQG15KR3(ORDGHGOLSRVRPHVLQWKHKXPDQKDLUIROOLFOHV376 
,Q WKLV VWXG\ OLSRVRPDO IRUPXODWLRQV FRQWDLQLQJ &) DQG 15K3( ZHUH SUHSDUHG 9HUPD 377 
/LSRVRPDOIRUPXODWLRQVZHUHDEOHWRGHOLYHUERWKWKHK\GURSKLOLFDQGOLSRSKLOLFIOXRUHVFHQWODEHOVWRWKH378 
KXPDQKDLUIROOLFOHVDVVHHQLQ)LJXUH$DQG%UHVSHFWLYHO\6WXGLHVUHSUHVHQWHGLQ)LJXUHVDQG379 
GHPRQVWUDWHGWKDWWKHSUHVHQFHRIKDLUIROOLFOHVSOD\VDVLJQLILFDQWUROHLQWKHVNLQSHQHWUDWLRQRIGUXJV380 
DVZHOODV WKDW WKHSUHVHQFHRISHQHWUDWLRQHQKDQFHUVKHOSV WKHIRUPXODWLRQLQHQKDQFLQJ WKHIROOLFOH381 
GHOLYHU\RIGUXJV382 
383 
)LJXUH'HOLYHU\RI&)OHIWDQG5KRGDPLQHULJKWHQFDSVXODWHGLQOLSRVRPHVWRWKHKDLUIROOLFOHV384 
7KHHIILFDF\RI'HUPDUROOHUWRHQKDQFHSHQHWUDWLRQLQWRWKHVNLQ385 
&/60ZDVDOVRXVHGWRLQYHVWLJDWHWKHHIILFDF\RIWKHPLFURSHUIRUDWLRQGHYLFHV'HUPDUROOHU+RUVW386 
/LHEO(76)UDQFHLQLQFUHDVLQJWKHVNLQSHQHWUDWLRQRIDIOXRUHVFHQWOLSRSKLOLFPRGHOFRPSRXQG'L,387 
HQFDSVXODWHG LQ OLSRVRPHV 9HUPD  7KUHH W\SHV RI 'HUPDUROOHUV ZHUH WHVWHG LQ WKLV VWXG\388 
Publication-1 
43 
 
namely Dermaroller® C8 0.13-15°, M8 1.5-15° and M8 1.5-30°. Control was provided by the skin not 389 
treated with Dermarollers®.  390 
Bright intensity of fluorescence was observed in SC for all samples treated with Dermaroller and for 391 
control (Figure-10). For control samples however fluorescence intensities in the viable epidermis and 392 
dermis were very low. For Dermaroller® C8 0.13-15°, highest fluorescence was observed in the SC and 393 
fluorescence intensities rapidly decreased in the viable epidermis and dermis (Figure-10B). 394 
Dermaroller® C8 0.13-15° was intended for delivering drugs to the SC whereas Dermaroller® M8 1.5-395 
15° and M8 1.5-30° were optimized for delivering drugs to the deeper regions of skin. Both M8 396 
Dermarollers® did show very high fluorescence intensities in the dermis region (Figure-10C-D). We 397 
observed that, samples treated with both M8 Dermarollers® showed only a weak fluorescence in the 398 
viable epidermis region and showed weak lateral diffusion of the fluorescent label from the pores. This 399 
might be because, Dermaroller® was able to deliver the liposomes into the deeper layers quickly during 400 
application of the Dermaroller but after the application, liposomes probably were not able to diffuse to 401 
a great extent from the surface of the skin to the deeper layers in the skin. In this study we emphasized 402 
on the spatial distribution of the fluorescent label which helped us to get a better understanding of the 403 
mode of action of the micro-perforation device, Dermaroller®.  404 
 405 
Figure-10: Fluorescent micrographs of cross-sections of human abdominal skin pretreated with Dermaroller® and 406 
incubated on a Franz diffusion cell with liposomes containing lipophilic fluorescent label DiI. The liposomes were 407 
applied without occlusion for 3 h. (A) Control; (B) Model C 8 0.13-15°; (C) Model M 8 1.5-15°; (D) Model M 8 408 
1.5-30°. 409 
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3. Two-photon fluorescence microscopy 410 
3.1. Principle of two-photon fluorescence microscopy 411 
As seen from aforementioned studies, CLSM is a very good technique for imaging of biological samples, 412 
however, it suffers from some disadvantages. One of the most important limitations of the CLSM is that 413 
because only a small fraction of the incident light reaches the detector, relatively high intensities of light 414 
are required to achieve high signal to noise ratios. This results in high total energy transfer to the 415 
specimen during imaging. Also the laser beam excites the fluorophores in the specimen above and below 416 
the focal plane that is under investigation and this can cause severe photo bleaching, photo damage and 417 
even dehydration of the biological specimen. Many fluorophores generate free radicles or singlet oxygen 418 
when excited which can be toxic if imaging living cells or tissue. CLSM also suffers from low axial 419 
resolution especially when imaging deep within a thick tissue. The poor axial resolution results from the 420 
scattering of light by the specimen itself, which can lead to detection of light that is not generated from 421 
the observed focal plane. Also CLSM employs short wavelength excitation sources and shorter 422 
wavelengths are scattered stronger (scattering intensity is inversely proportional to fourth power of the 423 
wavelength) hence these excitation sources are not very efficient at deep tissue imaging. Due to 424 
limitations in deep tissue imaging, when adopting a CLSM for imaging skin, the sample must be cryo-425 
sectioned and this is not always possible and desirable. 426 
Multiphoton excitation phenomenon was proposed in 1931, however Kaiser & Garret were able to 427 
validate it only in 1961 after the development of lasers which were sufficiently powerful to generate the 428 
high photon flux required for two-photon excitation. Figure-11A explains the energy transfer during one 429 
photon and two-photon excitation. In single-photon fluorescence, the fluorescence photon is generated 430 
when a high energy photon is incident on the fluorophor which results in raising the energy level of one 431 
of the electron to an excited state. In two-photon excitation, if two low energy photons arrive together 432 
within 10-18 sec of one another, the combined energy transfer of the two low energy photons is sufficient 433 
to raise the same electron to a higher energy level (Dunn and Young, 2006). A low energy photon is too 434 
weak to illicit the two-photon fluorescence phenomenon in the fluorophor. Hence, in order to increase 435 
the probability of simultaneous incidence of photons a laser with very high photon flux is required. 436 
Setup of a two-photon microscope is quite similar to that of a confocal scanning microscope with two 437 
major differences. One is the light source, two-photon microscopes use a tunable Ti-sapphire high 438 
frequency pulsed laser which has a pulse length of approximately a few hundred femtoseconds. Second 439 
important difference is the lack of any pinholes in front of the detector to avoid detecting scattered light 440 
from out of focus plane. 441 
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 442 
Figure-11:(A) Jablonski diagram elucidating the differences between single photon fluorescence and two photon 443 
fluorescence phenomenon. (B) Excitation volume in one-photon and two-photon fluorescence phenomena. 444 
One of the important advantages of 2-PFM is that total energy delivered to the specimen is much lower 445 
as compared to a CLSM. Also the two-photon excitation phenomenon occurs only at a very small focal 446 
volume (Figure-11B) and as a result fluorophores in a very small volume of the specimen are excited 447 
which reduces the probability of photo-bleaching, photo-damage. In addition, no confocal pinhole 448 
aperture is required to block the scattered light from out of focus planes. The near-infrared (NIR) light 449 
source used in a 2-PFM is very efficient at imaging deeper regions of the biological samples, as it is 450 
least scattered and absorbed by the biological samples. These advantages mean that the skin samples 451 
can be studied without cryofixing and cutting. Disadvantages of a two-photon microscope include a 452 
relatively high price of the ultra-short pulsed Ti-sapphire lasers and the fact that they require an elaborate 453 
cooling system. Also, 2-PFM has lower lateral resolution compared to CLSM, but in practice the 454 
difference in their resolution is not significant. 455 
3.2. Application of two-photon microscopy in skin penetration experiments 456 
Carrer et al. used 2-PFM to study the architecture and physical properties of the pig skin epidermis and 457 
permeability of different liposomal formulations in the pig skin (Carrer et al., 2008). In this study, 458 
authors were able to easily distinguish different layers of the pig epidermis based on their morphological 459 
differences without any significant sample preparation. To study the hydration/polarity of different 460 
layers of the epidermis they used Laurdan generalized polarization (Laurdan-GP) values as an indicator 461 
of polarity. As expected, the Laurdan-GP values were highest for SC and decreased for deeper layers of 462 
the skin indicating an increase in fluidity or hydration. The authors report an interesting observation in 463 
the intercluster region (canyons or wrinkles as in human skin), the Laurdan-GP values in the canyons 464 
were quiet high, comparable to that of SC and they did not change with depth (from surface of SC to 465 
dermis), indicating that canyons might show environment similar to SC. To study the penetration of 466 
liposomal formulations, Lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-467 
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phosphoethanolamine, was incorporated in the liposomal membrane. After 16-h diffusion, image stacks 468 
were collected and penetration was measured in the form of ratio of fluorescence intensity of rhodamine 469 
and autofluorescence of the skin. Authors report that the liposomes with lower lipid content (10mg/ml) 470 
were able to deliver more fluorescent label to the lower parts of viable epidermis compared to the 471 
formulations with higher lipid content (25 and 50mg/ml).  472 
van den Bergh et al. elucidated the mechanism of interactions of elastic and rigid liposomal vesicles 473 
with human skin (van den Bergh et al., 1999). Using 2-PFM and different electron microscopic 474 
techniques they studied interactions between skin and various elastic liposomal formulations to 475 
understand the modulation of the skin barrier. They observed that fluorescently labeled elastic vesicles 476 
primarily affected the intercellular lipid lamellae of the SC, while the underlying layers of the viable 477 
epidermis remained relatively unchanged. This effect was visualized using 2-PFM, in the form of small 478 
penetration pathways that were confined to the SC only. Authors also reported that the penetration 479 
enhancing ability of elastic vesicles was dependent on whether vesicles were applied with or without 480 
occlusion.   481 
Oleic acid is a good penetration enhancer and has been found to increase transdermal penetration of both 482 
hydrophilic and hydrophobic drugs by modulating the intercellular lipid domains in the SC. Yu et al. 483 
used a high-speed two-photon microscope with dual channels capable to simultaneous monitoring of 484 
autofluorescence of skin and fluorescence from rhodamine as a model drug (Yu et al., 2003). Treatment 485 
of human skin with oleic acid as a penetration enhancer was found to induce increased intra-corneocyte 486 
diffusion of the hydrophilic model drug (sulforhodamine-B), while causing localization of the 487 
hydrophobic model drug (Rhodamine-B hexyl ester) to the intercellular region. Hence, Yu et al. 488 
provided evidence that for chemical penetration enhancers, intra-corneocyte diffusion is an important 489 
enhancement mechanism along with fluidization of intercellular lipid domains, and physicochemical 490 
properties of the drug would determine which pathway predominates in the penetration enhancement. 491 
In 2002, Jenlab GmbH introduced a dual-channeled non-invasive multi-photon tomograph capable of in 492 
vivo optical biopsies with subcellular spatial resolution based on near-IR femtosecond pulsed laser. 493 
König et al. reported the potential of this microscope to acquire high-resolution images from deep within 494 
the skin in vitro and in vivo (Konig et al., 2006; Schenke-Layland et al., 2006). The microscope utilized 495 
the second harmonic generation (SHG) signal to monitor the position of the microscope in the skin, 496 
while the fluorescence channel was used to detect either autofluorescence from the NAD(P)H, flavins, 497 
melanin etc or to detect exogenous fluorophores. In vivo imaging capabilities of 2-PFM promises great 498 
advances in cancer diagnostics and skin diseases, as well as in understanding the mechanisms involved 499 
in dermal drug delivery. 500 
2-PFM is, as already mentioned, a relatively young technology. Bio-Rad Laboratories (USA) introduced 501 
first commercial two-photon microscope in 1996 and since then this technology has seen exponential 502 
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growth in its use and applications. Its ability to take high-resolution optical biopsies of the intact skin or 503 
even do live imaging in vivo holds a great potential to unlock the secrets that were kept in the dark by 504 
nature.  505 
4. Confocal Raman Microscopy 506 
4.1. Principles of Raman microscopy 507 
Fluorescence microscopy has seen a lot of evolution in the last couple of decades and modern 508 
microscopic techniques, like CLSM, multi-photon microscopy and various imaging modes such as 509 
fluorescence life-time imaging, Förster resonance energy transfer etc., have increased the applications 510 
and flexibility of the fluorescence imaging. However, fluorescence microscopy still has certain 511 
disadvantages; mainly, fluorescence microscopy still utilizes exogenous dyes to label the drug or 512 
formulation. These labels are often toxic or could cause perturbations in the cells or other physiological 513 
processes. The biggest limitation for studying skin penetration is that often the fluorescent label and the 514 
formulation or the drug do not travel together and consequently fluorescence imaging could give 515 
incorrect interpretation of the observations. 516 
Due to the disadvantages of fluorescent labeling to monitor the penetration depth in the skin, label free 517 
vibrational spectroscopic techniques have gained importance. Vibrational spectroscopy is an 518 
identification technique based on the principle that it is possible to interfere with the vibrational state of 519 
a molecule by irradiating it with light of certain frequencies. Such interactions can be recorded in the 520 
form of spectra which are representative of the bonds present in the molecule. Because each molecule 521 
has its unique atomic structure and as a result a characteristic vibrational state, the vibrational spectra 522 
can provide a host of information about the structure of the molecule. Vibrational spectroscopy involves 523 
different techniques such as mid infrared (IR) spectroscopy, NIR spectroscopy, Raman spectroscopy 524 
etc, but for this chapter we shall only review the Raman spectroscopic techniques. In addition, because 525 
water content in the biological specimen interferes strongly with IR spectroscopy, Raman techniques 526 
are more suitable for studying the drug penetration into the skin.  527 
When a monochromatic beam of light is incident on the sample, most of the light is scattered by the 528 
sample such that, the scattered light has the same wavelength as the incident light, this phenomenon is 529 
known as elastic scattering or Rayleigh scattering. However, a small fraction of photons do interact with 530 
the molecules of the sample and as a result, scattered photons have a different energy compared to the 531 
incident photons which manifests in the form of a shift in the wavelength of the scattered photons. This 532 
phenomenon is known as inelastic scattering or Raman scattering. Raman effect was first observed by 533 
C.V. Raman in 1928 (Raman and Krishnan, 1928). It is a very weak phenomenon, about one photon 534 
undergoes Raman scattering in a million Rayleigh scattered photons. Due to low signal to noise ratio, 535 
Raman spectroscopic techniques were not very practical as they needed an intense source of light and a 536 
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sophisticated detection system. After the discovery of lasers and charged coupled detectors (CCD) 537 
however Raman spectroscopy has seen tremendous increase in its application (Hollricher, 2011). 538 
To understand the Raman effect, we shall first have a look at the Rayleigh scatter. According to the 539 
classical theory, when photons are incident on the sample, they are absorbed by the molecules of the 540 
sample and are excited to a virtual state. When molecules relax back, if they relax to the same energy 541 
level as they started in, the emitted photons have the same energy as the incident photons and this type 542 
of scattering is called Rayleigh scattering. This effect is explained schematically in the Figure-12. In 543 
Raman scattering, a molecule relaxes back to a higher energy level after absorbing a photon, and as a 544 
result the emitted photon has lower energy by an amount required to vibrationally excite the molecule. 545 
Reemitted photon exhibits red shift and hence this effect is also called ‘Stokes Raman scattering’. If 546 
after absorbing the photon, molecule loses a fraction of vibrational energy i.e. if molecule relaxes back 547 
to a lower energy state compared to its energy state before absorbing the photon, then the emitted photon 548 
has higher energy compared to the incident photon. This phenomenon is called the ‘anti-stokes Raman 549 
scattering’. Raman spectrum is a plot of wavenumber shifts observed between Raman radiation and 550 
excitation radiation. Raman effect and fluorescence are distinct phenomena, in the later, incident photons 551 
are absorbed and molecules transition from ground state to an electronic excited state due to the 552 
resonance between vibrational frequency of the molecule and incident photons. As a result for a given 553 
molecule, fluorescence can be observed only at a certain fixed frequency range. However, Raman effect 554 
is not a resonant effect and can take place for wider range of excitation wavelengths. In addition, 555 
fluorescence phenomenon lasts much longer in terms of few nanoseconds, while Raman scattering is 556 
much short lived, i.e. less than a picosecond.  557 
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 558 
Figure-12: Jablonski diagram representation of Rayleigh and Raman scattering. 559 
In modern Raman microscopes, light source is provided by a laser and is focused onto the sample with 560 
the help of an objective with high numerical aperture. Scattered light is collected by the same objective 561 
and passed through a diachroic mirror then to a spectrometer to resolve the Raman shifts, which are 562 
detected by a sensitive CCD camera. Raman map of the sample is usually generated by scanning the 563 
sample with the help of a piezo driven stage through the laser beam. In order to improve the signal to 564 
noise ratio most microscopes employ a confocal detection to reduce the scattered light from out of focus 565 
planes. Raman scattering intensity is proportional to fourth power of the frequency of incident photons. 566 
Hence, excitation at 400nm would give a 16 times more intense Raman signal compared to excitation 567 
at 800nm (Hollricher, 2011). However, skin has a very strong autofluorescence in the range of 400-700 568 
nm and hence lower wavelengths are not ideal for Raman mapping of the skin. Higher wavelengths 569 
although useful for imaging thick specimen, according to the Rayleigh criterion, the lateral resolution is 570 
directly proportional to the wavelength, in other words lower wavelength would give better resolution. 571 
As a result selecting the right wavelength of excitation is very important in order to maintain a good 572 
balance between resolution and signal quality. For collecting Raman spectra from skin, usually lasers 573 
with wavelength of 633, 660 or 785nm are preferred. 574 
4.2. Confocal Raman microscopy for skin penetration experiments 575 
There are several studies which report application of confocal Raman microscopy (CRM) in determining 576 
the penetration of various ingredients into the skin, such as retinol (Failloux et al., 2004; Forster et al., 577 
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2011; Mélot et al., 2009), dimethyl sulfoxide (Caspers et al., 2002), water (Caspers et al., 2000), urea 578 
(Wascotte et al., 2007), 5-fluorouracil (Zhang et al., 2007) etc. Xiao et al. demonstrated the ability of 579 
CRM to study and understand the penetration mechanism of phospholipids from liposomal formulations, 580 
in pig skin (Xiao et al., 2005). Penetration of two liposomal formulations was tested, liposomes in gel 581 
crystalline state were prepared from 1,2-dipalmitoyl (d62)-sn-glycero-3-phosphocholine (DPPC-d62), 582 
while liposomes in liquid crystalline state were prepared from 1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-583 
phosphocholine (P-d31OPC). After the application of liposomes to pig skin, Raman spectra were 584 
obtained using a CRM employing laser at 785nm and spectra were recorded in the region of 100 - 585 
3450cm-1. Exogenous phospholipids were monitored by observing the CD2 and CD3 stretching vibration 586 
bands at 2080 and 2220cm-1 respectively, while the skin was monitored using the Phenylalanine-ring 587 
breathing mode at 1004cm-1 and the amide-I band at 1652cm-1. The results indicated that the liquid state 588 
phospholipid P-d31OPC penetrated 40-48µm deep into the skin as compared to the gel state phospholipid 589 
DPPC-d62, which was found to penetrate only 10-15µm deep. 590 
 591 
Figure-13: XZ-profiles recorded on a full thickness human skin treated with deuterated invasomes. (A) Raman 592 
map generated by integrating C-H stretching intensities from 2800 - 3100 cm-1 (B) False color image showing 593 
dissimilar spectral mixing. Red color represents highest C-D signal while blue represents signal from endogenous 594 
skin tissue. (C)The red spectra on the right is representative of the applied P-d31OPC invasomes while blue spectra 595 
representative of the skin. Peaks at 2100 and 2170 cm-1 represent C-D stretching vibrations. Scale bar = 20 µm. 596 
We reported a method for recording depth profiles using CRM in excised human skin biopsies to study 597 
diffusion patterns of drugs and components of the formulation system (Ashtikar et al., 2012). Figure-13 598 
shows a XZ-penetration profile, where every pixel represents intensity of Raman signal obtained from 599 
intact human skin treated with deuterated invasomes (P-d31OPC). The depth profile scans (XZ-scans) 600 
were collected using WITec Alpha 300R CRM. Excitation was provided by 785nm laser and step size 601 
for collecting the depth profiles was 1µm with illumination time of 0.5sec/spectra. In Figure-13B, 602 
penetration profile of deuterated phospholipid is plotted as a gradient from red to yellow, where red 603 
color corresponds to the highest concentration of P-d31OPC. The protein distribution of the skin is 604 
plotted in blue. Spectra corresponding to the invasomes and stratum corneum are represented in Figure-605 
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13C. Penetration profile was constructed using spectral unmixing algorithm, vertex component analysis, 606 
which decomposes a given dataset into fractions of most dissimilar spectral information and reconstructs 607 
the image by plotting their individual abundances (Du et al., 2008; Winter, 1999). P-d31OPC penetrated 608 
to a depth of ~10 to 15µm after application of flexible Invasomes, also it was interesting to note that the 609 
penetration profile of the phospholipid was not uniform throughout the stratum corneum.  610 
Retinol is a common ingredient of the anti-aging creams, which is highly lipophilic and does not 611 
penetrate the skin very well. Raman microscopy is widely employed for studying penetration profiles 612 
of retinol as it has a characteristic Raman peak at 1594cm-1, which can easily be traced through the 613 
various layers of the skin. In vitro penetration profile of retinol in human skin biopsies was studied by 614 
Failloux et al. using CRM. They have reported that retinol penetrated the SC faster when it was applied 615 
in the form of microspheres as compared to an oil in water emulsion (Failloux et al., 2004). Förster et 616 
al. studied the penetration of retinol from various emulsions and also monitored penetration of oil and 617 
aqueous components of the emulsion by using D(26)-n-dodacane and deuterated water respectively. 618 
Their results show that retinol penetration from an emulsion depends on the nature of the surfactant used 619 
and that an emulsified retinol can penetrate deeper in the skin, while micellar retinol is localized in the 620 
SC (Forster et al., 2011). Mélot at al studied the effect of penetration enhancers to deliver retinol into 621 
human skin in vivo. The in vivo measurements were carried out using an inverted Raman microscope 622 
customized for fast in vivo spectral acquisition from volar forearm. Formulations containing penetration 623 
enhancers like oleic acid, polyethylene glycol showed to have improved penetration of retinol into SC 624 
after 6 hours of application time (Mélot et al., 2009). 625 
Caspers et al. used CRM to study the interactions between human skin and dimethyl sulfoxide (DMSO) 626 
in vivo (Caspers et al., 2002). DMSO shows strong C-S-C symmetric and asymmetric vibration modes 627 
at 671 & 702 cm-1, while the position of the microscope in the skin was determined using the natural 628 
moisturizing factor to protein ratio (NMF, 885 & 1415 cm-1). Authors reported that DMSO penetrated 629 
the SC within 20 minutes, however traces of DMSO could be found in the SC even after 72 hours. 630 
Caspers et al. also reported the use of CRM for monitoring in vivo water profiles in the SC. Water 631 
content at various depths was determined by calculating the ratio of the water intensities (3350-3550cm-632 
1) and protein intensities (CH3 stretching mode 2910-2965cm-1). Chrit et al. also reported application of 633 
CRM for in vitro and in vivo measurement of water in human skin, and they were able to demonstrate 634 
the hydration efficiency of a cosmetic product containing hydrating polymers in microcapsules (Chrit et 635 
al., 2007). 636 
CRM was used to follow the penetration of metronidazole dissolved in diethylene glycol monoethyl 637 
(Transcutol®, Gattefossé, France) in human skin (Tfayli et al., 2007). Metronidazole was tracked in the 638 
skin by monitoring (ʋ C-N) stretching vibrations at 1191 cm-1 and 1369 cm-1, while the skin proteins 639 
were tracked from the amide-I, amide-III, Phenylalanine -ring breathing mode and other weaker spectral 640 
features. Spectra were collected from full thickness skin 1 and 2 hours after the application of 641 
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metronidazole solution at different z-planes with 4µm steps. Maximum penetration depth achieved for 642 
metronidazole was ~25µm in the SC. Several changes were noted in the Raman shifts for C-H vibration 643 
bands associated with skin endogenous proteins and lipids. Zhang et al. took advantage of differences 644 
in the Raman spectra of 5-fluorouracil (5-FU) and the prodrug of 5-FU (1-ethoxycarbonyl-5-645 
fluorouracil) to determine the spatial distribution and the transformation of prodrug to 5-FU in skin 646 
(Zhang et al., 2007). 647 
5. Coherent Raman microscopy 648 
In spontaneous Raman microscopy, images are recorded using the mapping mode where Raman spectra 649 
from each point on the sample is collected. Due to the inherent weak nature of the Raman scattering, 650 
acquisition of such images can take several hours. This is a problem for biological samples as they can 651 
undergo dehydration or photo damage due to high exposure to the intense laser radiation. Today several 652 
variants of Raman microscopy are available, such as, coherent anti-Stokes Raman scattering microscopy 653 
(CARS), stimulated Raman scattering microscopy (SRS), surface enhanced Raman scattering (SERS) 654 
etc., which have an advantage of higher S/N ratio. In this part, we would like to introduce CARS and 655 
SRS in brief with some examples of their application in transdermal delivery research, but it is out of 656 
scope of this book to go in depth into the principles and instrumentation of these techniques; further 657 
references can be found elsewhere (Chabay et al., 1976; Cheng, 2007; Eesley, 1981; Nandakumar et al., 658 
2009; Scholten and Scholten, 1989; Scholten et al., 1989) 659 
CARS and SRS are non-linear enhancement techniques, which enhance the weak Raman signal and as 660 
a result reduce the imaging duration to a few minutes or even seconds (Hanson and Bardeen, 2009). In 661 
both techniques the molecular vibrations are excited by using a Stokes and pump laser beams. CARS is 662 
a complex process in which three laser beams stokes (ωs) pump (ωp) and probe (ωpr) interact with the 663 
sample to generate anti-stokes emission. When difference in the ωs and ωp frequencies approach the 664 
vibrational frequency of a molecular bond (ωv), such that; ωv = ωp – ωs, the electrons in the electron 665 
cloud around the molecular bond are in the virtual excited vibrational state. Such vibrational excitations 666 
only take place in small focal volume where both stokes and pump beams are coherently in phase. To 667 
probe the virtual excitations, a third beam (ωpr) is applied, which gets scattered off and generates anti-668 
stokes radiation (ωas) modulated at difference frequency such that, ωas = ωpr + (ωp - ωs) (Min et al., 2011). 669 
The emitted photon is blue shifted and as a result can be easily separated from the incident laser beams. 670 
Due to the nature of the excitation source of CARS microscope, it also generates 2-photon fluorescence 671 
and second harmonic generation (SHG) signal, and a multimodal detection system could be employed 672 
to detect these signals (Le et al., 2007; Potma et al., 2001; Wang et al., 2008).  673 
Capability to identify endogenous and exogenous components by a multimodal-imaging mode is 674 
demonstrated in Figure-14 which shows CARS, SHG and 2-photon fluorescence signals collected from 675 
a human skin cross section (Heuke et al., 2012). Figure-14a shows the anti-stokes Raman shifts recorded 676 
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for C-H stretching mode at 2850cm-1, which are mainly generated by the intercellular lipids and 677 
adipocytes. Figure-14b shows the SHG signal, which is generated mainly from the collagen fibers of the 678 
dermis. Figure-14c shows 2-photon fluorescence detected at 435-485nm, and figure-14d shows a false 679 
color image generated by overlapping all the singals, where CARS signal is represented as green, SHG 680 
as white and two-photon fluorescence as red.  681 
 682 
Figure-14: Multimodal CARS image of an untreated skin cross section to demonstrate the scope of multimodal 683 
microscopy. (A) CARS map for CH2 symmetrical stretching vibrations (B) SHG image (C) two-photon 684 
fluorescence image (D) False color image showing overlap of CARS (green), SHG (white) and two-photon 685 
fluorescence (red) signals. 686 
In vivo real-time video-rate epi-CARS (backscattered CARS) imaging was demonstrated by Evans et 687 
al. on anesthetized female mice (Evans et al., 2005). The excitation source was tuned in order to excite 688 
the CH2 stretching vibrations and anti-Stokes photons were detected with the help of a sensitive PMT 689 
detector. The microscope had lateral resolution of 0.3µm and axial resolution of 1.5µm. Authors were 690 
able to image the mouse skin at various depth up to 100µm and identified lipid rich structures such as 691 
sebaceous glands and adipocytes. Real time diffusion of the topically applied mineral oil was also 692 
observed in the mouse skin. The mineral oil penetrated the SC within 20 minutes, however it remained 693 
confined to the viable epidermis and was not able to penetrate the dermis. Zimmerly et al. used CARS 694 
microscopy to generate quantitative concentration maps of deuterated water and d-glycine in human hair 695 
(Zimmerley et al., 2009), while Breunig et al. demonstrated application of in vivo multimodal CARS 696 
microscopy in healthy and diseased human skin (Breunig et al., 2012). In healthy human skin, they were 697 
able to follow a topically applied emulsion cream, while in skin affected with psoriasis they were able 698 
to identify differences in the SC intercellular lipid domains compared to the healthy skin. 699 
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CARS microscopy is more sensitive than spontaneous Raman microscopy; however, it has some 700 
drawbacks such as presence of non-resonant background and more importantly anti-Stokes shifts are 701 
slightly different from stokes Raman shifts, which makes spectral interpretation more complicated. In 702 
SRS, pump beam and stokes beam coincide the sample such that difference in the frequencies between 703 
Stokes and pump-beams matches a molecular vibration. This results in an increase in the rate of 704 
molecular vibrations. The energy required for this excitation is taken up from the pump laser field and 705 
as a result pump beam experiences loss in intensity (stimulated Raman loss). Stokes beam experiences 706 
a gain in intensity due to the emission of stokes photons as the molecular vibrations return to ground 707 
state (stimulated Raman gain). In SRS microscopy, either stimulated Raman loss or gain can be used as 708 
a contrast mechanism (Min et al., 2011; Nandakumar et al., 2009). Using SRS microscopy, Saar et al. 709 
were able to determine penetration profiles of ibuprofen and ketoprofen from solutions in propylene 710 
glycol applied topically onto mouse skin (Saar et al., 2011). Ketoprofen was tracked in the skin by 711 
following the aromatic C-H stretching vibrations at 1599 cm-1, ibuprofen and propylene glycol were 712 
deuterated and were monitored at 2120cm-1, while skin lipid architecture was imaged from CH2 713 
stretching vibrations at 2845cm-1. Ketoprofen and propylene glycol penetrated the SC mainly via 714 
intercellular lipid pathways and through hair follicles. From time resolved images at various depths, the 715 
authors showed that propylene glycol penetrated deeper and faster than ketoprofen into the skin. In 716 
addition, penetration of propylene glycol via hair follicle was much faster and reached a steady state in 717 
less than 30 minutes compared to ~2 hours via intercellular lipid penetration in the SC to reach similar 718 
levels. Penetration profiles of ibuprofen were similar to that of ketoprofen. Ibuprofen crystals on the 719 
surface of the SC during penetration also indicated faster penetration of the solvent propylene glycol 720 
compared to ibuprofen. Freudiger et al. reported application of SRS microscopy to construct three 721 
dimensional diffusion profiles of DMSO and retinoic acid in mouse skin. From the diffusional profiles 722 
they were able to show that DMSO mainly penetrated the SC via the protein phase while retinoic acid 723 
penetrated mainly via the lipid rich intercellular spaces (Freudiger et al., 2008). 724 
Coherent Raman microscopy is a label free and more sensitive approach of tapping into the advantages 725 
of Raman effect compared to the spontaneous Raman microscopy. Due to the enhancement of the Raman 726 
effect, the image acquisition is much faster and hence more suitable for biological samples compared to 727 
spontaneous Raman microscopy. Also the non-linear excitation approach in the generation of CARS 728 
and SRS signal is limited to a very small focal volume, which increases the resolution of these techniques 729 
without using the confocal detection setup. CARS and SRS microscopic techniques are relatively young 730 
compared to other techniques discussed here. Today these microscopes are mainly confined to the 731 
photonics labs; however, both the techniques hold a great promise for mainstream applications. 732 
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6. Conclusion 733 
Microscopic techniques are very important in understanding the mechanisms involved in skin 734 
penetration as they enable spatial visualization of the drug in the skin. In this chapter we report almost 735 
50 years of development in the microscopic techniques and at least today, no technique holds superiority 736 
in all the aspects of imaging such as resolution, signal quality, specificity, speed, sample preparation, 737 
sample stability etc. These are rather complementary techniques, which are able to provide a host of 738 
information according to the requirements and objectives of the experiments. For skin penetration 739 
experiments, 2-PFM was first to set high standards owing to its ability to acquire high-resolution optical 740 
biopsies, in vitro as well as in vivo. Raman microscopic techniques provide a unique opportunity for 741 
label free imaging. With development of modern Raman variants like CARS and SRS microscopy, 742 
signal to noise ratio has been greatly improved and high speed, label free, 3D imaging is now possible 743 
however complex nature of these microscopes and expensive optics have limited their wide spread 744 
application.  745 
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a b s t r a c t
The stratum corneum is a strong barrier that must be overcome to achieve successful transdermal deliv-
ery of a pharmaceutical agent. Many strategies have been developed to enhance the permeation through
this barrier. Traditionally, drug penetration through the stratum corneum is evaluated by employing
tape-stripping protocols and measuring the content of the analyte. Although effective, this method can-
not provide a detailed information regarding the penetration pathways. To address this issue various
microscopic techniques have been employed. Raman microscopy offers the advantage of label free imag-
ing and provides spectral information regarding the chemical integrity of the drug as well as the tissue. In
this paper we present a relatively simple method to obtain XZ-Raman proﬁles of human stratum cor-
neum using confocal Raman microscopy on intact full thickness skin biopsies. The spectral datasets were
analysed using a spectral unmixing algorithm. The spectral information obtained, highlights the different
components of the tissue and the presence of drug. We present Raman images of untreated skin and dif-
fusion patterns for deuterated water and beta-carotene after Franz-cell diffusion experiment.
 2013 Elsevier B.V. All rights reserved.
1. Introduction
Trans-dermal drug delivery has received considerable attention
over the past decade. Apart from being used in the treatment of
skin diseases, trans-dermal delivery can be a good alternative to
deliver drugs systemically, as skin offers a large surface area to
which drugs can be applied. The non-invasive nature of the appli-
cation, high patient compliance, controlled release kinetics of the
drug etc. are some of the advantages, which make transdermal
application an attractive route for drug administration. A major
hurdle in achieving this is, however, the low permeability of the
skin and especially of the stratum corneum (Walters and Brain,
2002; Walters and Roberts, 2002). One of the most important func-
tions of the skin is to protect the organism against detrimental ef-
fects of the environment; for this purpose stratum corneum has
evolved into a very tight barrier, which has proven difﬁcult to over-
come. First generation transdermal delivery systems such as
creams, gels and patches have been successfully employed to deli-
ver drugs such as ibuprofen (Ibuleve), fentanyl (Duragesic), nic-
otine (Nicotinell). However application of these systems has only
been successful for a limited number of drugs; traditional delivery
systems do not readily cross the stratum corneum and skin perme-
ation was found to be dependent upon the drug’s physiochemical
properties like lipophilicity, molecular weight and molecular shape
(Grice et al., 2010). Recently, 2nd and 3rd generation delivery sys-
tems were developed involving modiﬁcation of the barrier proper-
ties of the stratum corneum by means of chemical penetration
enhancers, iontophoresis, microneedles, laser ablation etc. (Praus-
nitz and Langer, 2008).
The stratum corneum is a 10–20 lm thick tightly packed layer
of ﬂattened cells, called corneocytes, originating from keratino-
cytes in the stratum basale, i.e., the bottom layer of the epidermis.
Intercellular spaces are ﬁlled with laterally packed lamellar lipid
domains (Bouwstra et al., 1991) and play an essential role in the
barrier function but also provide a pathway through which drug
molecules may diffuse during the transdermal delivery. The tradi-
tional method of studying skin penetration is by tape stripping,
where layers of SC are progressively removed and the drug is quan-
tiﬁed by analytical methods such as UV spectroscopy, ﬂuorescence
spectroscopy, and radioactivity measurement (Breternitz et al.,
2007; Pinkus, 1951). Although a very powerful technique, tape
stripping is an invasive technique. In addition, tape stripping is
not an ideal technique for studying penetration pathways of the
drug within the SC over several time points. Microscopic
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techniques such as confocal laser scanning microscopy (Alvarez-
Roman et al., 2004; Fink-Puches et al., 1995; Schatzlein and Cevc,
1998; Verma et al., 2003a), two-photon ﬂuorescence microscopy
(Carrer et al., 2008; Schenke-Layland et al., 2006; van den Bergh
et al., 1999; Yu et al., 2003) have been exploited for studying the
detailed spatial distribution in the SC. A major drawback of both
techniques is that they rely on a ﬂuorescent signal limiting the
method to ﬂuorescent or ﬂuorescently labelled drugs. Also the
attachment of a ﬂuorescent label to the drug might affect its diffu-
sion proﬁle.
Raman microscopy is commonly used to study the biological
composition of especially diseased tissues and has been applied
to tissue biopsies of virtually every organ (Krafft et al., 2009). Ra-
man microscopy as well as the complementary infra-red (IR)
microscopy have been utilised to image skin cross sections. Raman
spectroscopy has also been employed to study the penetration of
caffeine (Franzen et al., 2012) and anti-oxidants (Uragami et al.,
2012). Confocal Raman microscopy provides a useful depth proﬁl-
ing technique as it allows label free imaging (Baia et al., 2002; Sch-
mitt et al., 2003). The obtained spectral information allows
imaging the distribution of substances or tissue features based
on their chemical composition. Apart from penetration depth, the
spectral information could be useful to identify chemical integrity
(Zhang et al., 2007), hydration state (Chrit et al., 2007), oxidative
stress (Ermakov et al., 2004) and the ability to individually track
various ingredients of a formulation (Xiao et al., 2005). In Raman
microscopy, the penetration depth of the excitation light strongly
depends on the wavelength of the employed laser. Best penetration
depths for biological samples are usually achieved in the near in-
fra-red (NIR). Shorter wavelengths are scattered stronger, the
intensity of the scattered light being proportional to the fourth
power of the frequency. For longer wavelengths the absorption of
water becomes a major problem. In this study, we employed a laser
excitation source of 785 nm at constant laser intensity for imaging
stratum corneum and the upper layers of the viable epidermis.
Information on intradermal water distribution is relevant as
water is a natural carrier for hydrophilic compounds. Beta-caro-
tene is of interest for dermatological applications as it has been
suggested to reduce oxidative stresses in the skin related to ultra-
violet and infra-red irradiation (Darvin et al., 2011; Stahl and Sies,
2012). Treatment with beta-carotene has also been shown to re-
duce skin carcinogenesis and is also indicated in the treatment of
erythropoietic protoporphyria (Bayerl, 2008). Beta-carotene is of-
ten chosen as an example derivative of the carotenoid family, be-
cause it exhibits interesting resonance Raman properties. Due to
the resonance effects the sensitivity of the Raman measurements
is enhanced by several orders of magnitude. Measurements includ-
ing quantiﬁcation of b-carotene using resonance Raman effects are
well established (Darvin et al., 2012; Ermakov and Gellermann,
2012). Our study provides a relatively simple methodology to
non-invasively image the SC for distribution of deuterated water
and beta-carotene, following transdermal application.
2. Methods
2.1. Materials
Beta-carotene and dimethyl sulfoxide (DMSO) were purchased
from Sigma–Aldrich (Germany). Deuterated water was purchased
from Dr. Glaser AG (Basel, Switzerland). Salts used in the prepara-
tion of phosphate-buffered saline (PBS), di-sodium hydrogen phos-
phate, potassium dihydrogen phosphate, sodium chloride and
potassium chloride, were purchased fromMerck KGaA (Darmstadt,
Germany). Mayer’s acidic Haemalaun solution and congo red used
for staining the cryo-sections of the skin were purchased from Carl
Roth GmbH (Germany) and Fluka (Germany) respectively. Euparal
used for mounting the sections was purchased from Carl Roth
GmbH (Germany). Calcium ﬂuoride slides used for mounting skin
cross sections were obtained from Crystal GmbH (Berlin,
Germany).
2.2. Human skin preparation
Human skin used in the experiments was obtained from the
plastic surgery clinic (Praxisklinik für Plastische Chirurgie, Kassel,
Germany) after abdominoplasty. Abdominal skin from a 44-year
old Caucasian female was used for all experiments. Immediately
following surgery, subcutaneous fat was removed from the dermis
with a scalpel and the stratum corneum was cleaned using cotton
balls and puriﬁed water. Skin was then cut into suitably sized
pieces and stored at 26 C. All the experiments were performed
within one year of freezing the skin. Written consent from the pa-
tient was obtained before operation for using the excised skin for
experiments. The whole process of obtaining skin tissue was ap-
proved by the Ethics committee of the University Hospital Jena,
Germany.
2.3. Franz-cell experiments
Frozen skin was punched to obtain 30-mm diameter discs
which were thawed to room temperature on a Whatman ﬁlter pa-
per pre-soaked in PBS. Skin penetration experiments were per-
formed on non-jacketed Franz-cells with a diffusion area of
1.76 cm2. Temperature of the penetration experiment was con-
trolled by placing the entire Franz-cell assembly in an incubator
maintained at 32 C. In diffusion experiments of deuterated water,
85 ll/cm2 of deuterated water was applied to the skin. Due to very
poor solubility of beta-carotene in polar solvents, 2.7 mg/ml solu-
tions were prepared in DMSO and 100 ll/cm2 of the solution was
applied to the skin. Beta-carotene solution was applied to the skin
without occlusion. Application of deuterated water was occlusive,
the donor compartment of the Franz-cell was covered with Para-
ﬁlm to avoid evaporation of deuterated water. After 14 h, the ap-
plied substance was removed by repeated, gentle washing of the
surface of the skin with puriﬁed water upon which the skin was
dried with lint-free tissue paper.
2.4. Sample preparation for acquiring XZ-Raman proﬁles
Sample preparation method was inspired from the Saarbrücken
penetration model, originally developed by Loth et al. at the Saar-
land University, Germany (Blasius, 1985; Borchert, 1994; Hailer,
1981; Wagner et al., 2000). After incubation on the Franz cell,
the skin was mounted onto a specially designed aluminium block
(tape stripping block) with a central cavity as shown in Fig. 1.
The skin was ﬁxed onto the cork discs in the central cavity of the
aluminium block with eight stainless steel pins. Sample stability
during the Raman imaging was a major concern and sample prep-
aration was optimised so as to minimise the dehydration of the
skin. The top most cork disc was covered with aluminium foil to
prevent the cork from absorbing water from the skin. In addition,
a thin layer of Vaseline was applied on the top cork disc to ensure
that moisture did not escape from any cracks or crevices around
the cork discs and a Whatman ﬁlter paper soaked in PBS was kept
under the skin in order to prevent drying of the skin. To minimise
exposure of the skin to the environment, an insulating adhesive
tape (TESA, Germany) was used as a mask with a 1-cm diameter
hole exposing enough skin to perform Raman imaging (Fig. 1B).
602 M. Ashtikar et al. / European Journal of Pharmaceutical Sciences 50 (2013) 601–608
64
Publication-2
2.5. Cryo-sectioning and Staining
After the diffusion experiment, skin was frozen in liquid nitro-
gen and 20-lm thick sections were cut with a Reichert-Jung Frigo-
cut-2000 microtome (Germany). Sections were mounted
alternately on calcium ﬂuoride slides for Raman mapping and on
glass slides for staining. Sections were mounted alternately be-
cause during the staining and dehydration processes the sections
mounted on calcium ﬂuoride are at risk of being detached. Sections
were stained using Mayer’s Haemalaun (acidic) and congo red
solutions for 7 and 5 min respectively, dehydrated, mounted in
euparal and examined using a Leica DMRXP light microscope.
2.6. Raman data acquisition
Raman spectra were acquired using a WITec (Ulm, Germany)
Model CRM Alpha-300Rplus confocal Raman microscope. Excita-
tion (approximately 10 mW at the sample) was provided by a
785-nm diode laser (Melles Griot, Carlsbad, CA; Model 532). The
exciting laser radiation was coupled to a Zeiss microscope through
a wavelength-speciﬁc single mode optical ﬁbre. The incident laser
beam was collimated via an achromatic lens and passed a holo-
graphic band pass ﬁlter before it was focused onto the sample
through the objective of the microscope. A Zeiss 50/0.9 NA objec-
tive was used in the studies reported here. The sample was
scanned using a piezo-electrically driven microscope scanning
stage with an x,y-resolution of about 3 nm and a repeatability of
±5 nm, and z-resolution of about 0.3 nm and ±2 nm repeatability.
The sample was scanned through the laser focus in a continuous
line scan at a constant stage speed of fractions of a micrometer
per second. Depth proﬁles were collected employing an x,z-scan
modus starting at the bottom of the image. Spectra were collected
with a 1-lm step size and an illumination time of 0.25 s, using a
300/mm grating. The spectral resolution was about 6 cm1 and
the spectral window ranged from 300 to 3200 cm1.
2.7. Image analysis and data processing
Various algorithms for image analysis of hyperspectral datasets
have been developed. For extracting spectral information, several
factor methods such as principle component analysis (PCA) or vec-
tor component analysis (VCA) have shown high potential for the
evaluation of Raman datasets (Hedegaard et al., 2011; Miljkovic´
et al., 2010). In-house developed spectral unmixing algorithms
were used for performing VCA and PCA on the Raman datasets.
In principle, these algorithms searched for a basis that describe
the spectral variance optimally. Generally, the spectrum of a given
image pixel was assumed to be a linear combination of the spectra
of individual components:
pij ¼
X
k
eikckj;
where pij is the ith band of the jth pixel, eik the ith band of the kth
component spectrum and ckj is the mixing proportion for the jth
pixel of the kth component. The mixing proportions were assumed
to be percentages and the proportions should add up to one:
X
k
ckj ¼ 1:
This new basis then consisted of a few vectors, or in our case Ra-
man spectra, which were used to reconstruct the dataset or image
by plotting their individual abundances. The different algorithms
varied mainly in what constraints were set for this change of basis.
In PCA, for instance, the vectors have to be orthogonal. In VCA the
constraint is that the new vectors, usually referred to as endmem-
bers, have to be all positive or real spectra. These endmembers nor-
mally represent the most dissimilar spectra within a dataset. For
the evaluation of the endmembers an N-FINDR algorithm was em-
ployed (Du et al., 2008; Winter, 1999).
3. Results
3.1. Untreated skin
Fig. 2A shows a stained cross section of a human skin sample.
The stratum corneum is clearly discernible as the top 20 lm of
the cross section. The viable epidermis underneath it consists of
a dense cell layer of approximately 50 lm and appears in dark
blue. The underlying dermis is mainly composed of connective tis-
sue, i.e. collagen and elastin and has a lower cell density. Fig. 2B is a
Raman image of an adjacent 50  50 lm2 cross section of the area
indicated in a box in Fig. 2A. The image was generated by integrat-
ing the intensities of the CAH stretching vibrations between 2800
and 3100 cm1, which are predominant for most organic samples.
The image mainly reﬂects a density proﬁle of the tissue. However,
very high intensities at the bottom of the image are due to ﬂuores-
cence contributions. Fig. 2C was reconstructed by the vertex com-
ponent image analysis described in the methods section while
Fig. 2D represents the associated spectral information. In Fig. 2D,
spectrum (a) exhibits spectral features typical for proteins, which
are discussed in detail in the following section. The distribution
of the spectral endmember is plotted in light blue. The colour
intensities correspond to high or low abundances. Colour mixing
represents the presence of more than one component. Areas with
high ﬂuorescence are observed, especially in the lower part of
the image bordering the epidermis from about 40 lm down. The
ﬂuorescence spectrum is shown in spectrum (b) and areas with
high ﬂuorescence are plotted in yellow. For the obtained images
Fig. 1. (A) schematic representation of the sample used for acquiring Raman spectral maps. (B) Top view of the sample.
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Fig. 2. (A) A Mayer’s Haemalaun (acidic) and congo red stained micrograph shows the stratum cormeum (s.c.), the epidermis (e.d.) and dermis (d.). (B) Raman image of the
region indicated in 1A. The image was reconstructed by plotting the integrated scattering intensities of the C-H stretching region stretching region between 2800 and
3100 cm1. (C) shows the distribution of proteins (light blue) vs. regions with high ﬂuorescence (yellow). The corresponding spectral information is plotted in (D). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. X,Z-proﬁles recorded on untreated skin. (A1–3) represents Raman images generated by integrating the signal intensities of CAH stretching vibrations. (B1–3) Images
generated by VCA where highest lipid intensities are shown in green while regions in blue show spectral features characteristic for proteins. Fluorescent regions are shown in
yellow (C) represents corresponding spectra of the VCA results. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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lower S/N ratios, due to deeper penetration did not affect the VCA
analysis.
Fig. 3 shows Raman images of the X,Z-proﬁles of untreated skin
samples measured on the intact tissue after the Franz-cell incuba-
tion without cutting or processing. The spectra were measured for
areas of 50  50 lm2. Fig. 3A1–3 were generated by integrating the
intensities of the CAH stretching vibrations as mentioned earlier.
The signal intensities generally drop by a factor 5 comparing the
scattering intensities from the top of the stratum corneum with
the intensities originating from 50 lm within the tissue. Below
50 lm the signal quality drastically drops, for the described exper-
imental conditions. The Fig. 3B1–3 are the outcome of the vertex
component analysis. The associated spectra are shown in 3C using
the same colour coding as described before. The light blue spec-
trum 3C (b) shows all spectral characteristics typical for proteins.
Well pronounced are the CAH stretching intensities between
2800 and 3100 cm1 centred at 2930 cm1. The lower wave-num-
ber region between 500 and 1800 cm1 is dominated by scattering
intensities of the bonds of the peptide backbones of the tissue com-
ponents. The band at 1650 cm1 originates from the C@O carbonyl
stretch of the peptide bond. The band at 1450 cm1 is caused by
scissoring modes of the methylene groups of the peptides, and is
followed by other CAH deformations and CAN bending vibrations
between 1250 and 1350 cm1. All other Raman intensities can also
be attributed to vibrations of the protein molecules, but are less
speciﬁc regarding their assignment. Apart from the protein compo-
nents that can be mainly attributed to the corneocytes of the stra-
tum corneum, there are substantial amounts of lipids shown in
green. The spectrum associated with lipids is plotted in 3C (a).
The spectrum shows similar features as the protein spectra, such
as the CAH stretching and other deformational modes. The stretch-
ing of C@C of unsaturated side chains is centred at 1640 cm1 and
the C@O stretching of the ester band of lipids is located at
1740 cm1. Reference spectra and detailed assignments of Raman
spectra of biological molecules are described in the literature (De
Gelder et al., 2007; Diem et al., 2008; Krafft et al., 2005). Strong Ra-
man signals from lipids are mainly found on the top layer of the
stratum corneum and are likely to represent domains of ceramides
and fatty acids within the intracellular matrix. Again, substantial
spectral contributions from ﬂuorescence are observed in the lower
layers of the stratum corneum, which are plotted in yellow. The
spectrum is similar to that observed for the cross sectioned sample.
The ﬂuorescence is likely caused by pigments such as melanin.
3.2. Diffusion of D2O
We selected water as one of the candidates for permeation
experiments as water penetrates the stratum corneum relatively
easily and homogenously. Generally, water has distinct broad Ra-
man band features due to symmetric and anti-symmetric OAH
stretching vibrations between 2900 and 4000 cm1. For technical
reasons associated with CCD cameras used for photon counting,
the spectral region beyond 3100 cm1 is not accessible for an exci-
tation source of 785 nm. However, it was possible to use deuter-
ated water, which basically has the same chemical properties.
Because deuterium is the heavier isotope, OAD stretching vibra-
tions are shifted to a lower wave-number region and appear now
in the region between 2200 and 2600 cm1, where there is no over-
lap with the Raman bands of organic molecules, hence providing a
better spectral contrast. The isotopic labelling also has the advan-
tage that the water of the formulation can be distinguished from
the water of the skin. Fig. 4 shows X,Z-Raman proﬁles of skin sam-
ples treated with D2O on a Franz-Cell over 14 h. Similar to the un-
treated skin samples we can reconstruct the Raman images based
on the main spectral components of the dataset. Images in
Fig. 4A1–3 were constructed by integrating the intensities of
CAH stretching vibrations between 2800 and 3100 cm1. In
Fig. 4B1–3 lipids and areas with high pigment content are plotted
in green and yellow respectively. The endmember spectrum asso-
ciated with the protein matrix of the skin has now noticeable con-
tributions from the OAD stretching intensities. Deuterated water
appeared to penetrate evenly throughout the stratum corneum.
The regions rich in lipids also show the presence of D2O, as can
be clearly noticed in the green spectrum.
3.3. Diffusion of Beta-carotene
Due to the high lipophilicity of Beta-carotene it shows poor skin
permeability (Grosser et al., 2012). DMSO was employed to facili-
tate complete dissolution of beta-carotene. Fig. 5 shows X,Z-pro-
ﬁles of three skin samples treated with a beta-carotene solution
in DMSO for 14 h on a Franz-Cell. Raman images in Fig. 5A are gen-
erated by integrating intensities of CAH stretching vibrations. In
Fig. 5B, the distribution of the beta-carotene is shown in red for
very high concentrations and purple for lower concentrations,
respectively. Penetration of beta-carotene is not homogeneous
and generally decreases rapidly with depth. Beta-carotene exhibits
special spectroscopic features. Due to the electronic properties of
the conjugated double bond sequence it undergoes resonance Ra-
man excitation, whereby an electronic transition and a vibrational
excitation occur simultaneously. As a consequence the observed
intensities are generally much stronger than the protein scattering
intensities. The absorption spectrum of beta-carotene in the visible
range of light suggests maximum resonance effects between 450
and 550 nm. However, resonance Raman spectra have also been
observed in the pre-resonance region (Gaier et al., 1991). The
absorption proﬁle of beta-carotene in the near IR region extends
to about 800 nm. The spectrum of b-carotene is dominated by
three main bands, which can be assigned to C@C stretches ob-
served at 1510 and 1153 cm1 and a CACH3 rocking vibration at
1004 cm1. The main distribution is conspicuously predominant
in the top 10 lm of the stratum corneum, as can be seen in the
associated red and pink endmember spectra. However, it is also
present in noticeable concentrations throughout the lower regions
shown in light blue.
3.4. Discussion
By means of the described method Raman images could be ob-
tained down to 30–40 lm deep into the skin which corresponds to
the stratum corneum and the top layers of the viable epidermis.
For larger penetration depths, higher laser intensity and higher
integration times would be needed to overcome the very low S/N
ratios. The lateral resolution of the images was 1 lm. The resolu-
tion in the axial direction for the upper regions of the stratum cor-
neum is about 1 lm while axial resolution of the lower regions is
less and can only be estimated, because of refraction of the laser
beam due to changes in refractive index. The Raman signals from
the stratum corneum were to a large extent free of ﬂuorescence.
However, deeper regions of the epidermis frequently showed sub-
stantial amounts of ﬂuorescence. The ﬂuorescence observed was
inhomogenously distributed and was not observed for every XZ
proﬁle. The images obtained from cross-sections and the XZ-pro-
ﬁles of intact skin samples are in good agreement. For the cross-
sections ﬂuorescence was also observed in the upper region of
the epidermis. The full thickness skin samples showed very thin
layers of lipids, as shown in Fig. 3B1–3, which we attribute to fatty
acids and ceramides of the intra-cellular spaces. The possibility of
presence of sebum on the skin surface was rejected as the lipid rich
regions were consistent even after thorough cleaning of the stra-
tum corneum (data not shown here). The thin lipid layers were
not observed for the measured cross-sections. Rationale for the
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absence of this layer in cross sections was not completely clear and
further investigations are necessary to look into this matter.
In our experiments, D2O penetration experiments showed a
homogeneous distribution throughout the sample. Effectiveness
Fig. 4. X,Z-proﬁles for skin treated with D2O (A1–3) Raman images generated by integrating the intensities for CAH stretching vibrations (B1–3) Images generated from
corresponding Raman maps shown (A1–3) indicating uniform distribution of D2O throughout the sample. Strong signal due to OAD stretching vibrations can be seen in 2200–
2600 cm1. Green and blue regions correspond to spectra rich in features for lipids and proteins respectively. (C) corresponding spectra generated by the VCA algorithm. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. X,Z-proﬁles for skin treated with beta-carotene solution (A1–3) Raman images generated by integrating the intensities for CAH stretching vibrations (B1–3) Raman
maps generated by VCA indicating inhomogenous distribution of beta-carotene. Concentration of beta-carotene is mapped in red, purple and blue indicating decreasing
concentration in that order. (C) shows spectral fratures corresponding to the VCA. Strong Raman bands centering at 1153 and 1524 cm1 are assigned to C@C stretching
vibrations. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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of the D2O in penetrating the SC might be explained the fact that
water is a penetration enhancer and water content of the SC is only
about 20% of its dry weight. As a result, SC can easily be saturated
with water just by occlusion or prolonged contact with water (Van
Hal et al., 1996; Williams and Barry, 2004). Van Hal et al. have
demonstrated that in water saturated SC, most of the water is ab-
sorbed by the corneocytes, which swell as a result while intercel-
lular lipid matrix showed presence of water rich regions without
substantial changes to the organisation of lipid domains.
Beta-carotene distribution on the other hand showed a steep
gradient, with a rapid decrease in concentration after the ﬁrst
10 lm. We selected beta-carotene for diffusion experiments be-
cause of its high lipophilicity and poor skin permeability (Antille
et al., 2004) and, in combination with the strong resonance Raman
signal, it was an ideal candidate for these studies. In the past it has
been demonstrated that penetration of lipophilic ﬂuorescent mark-
ers in the skin is inhomogeneous, when applied in the form of ﬂex-
ible liposomal vesicles. (Schatzlein and Cevc, 1998; van den Bergh
et al., 1999; Verma et al., 2003b). Raman images generated in this
study exhibit a similar phenomenon with beta-carotene. Beta-car-
otene on its own does not penetrate the skin very well. However,
DMSO is a very well known penetration enhancer and can be effec-
tively employed in increasing penetration of drugs (Christensen
et al., 2009; Roth and Shainhouse, 2004; Williams and Barry,
2004). Although mechanism of penetration is not completely
understood, DMSO is known to alter the skin barrier by changing
the protein conformations in the corneocytes and altering the
packing of the lipid domains (Anigbogu et al., 1995). Although
DMSO might have assisted beta-carotene in penetration, the local-
ised penetration of beta-carotene remains unclear; possibly it is
caused by preferential trans-follicular penetration. Further studies
are needed to clarify this.
One challenging aspect of 3D confocal Raman imaging is the
quantiﬁcation of the observed signal intensities. For synthetic mix-
tures or solutions calibration with known concentrations is possi-
ble. In addition ratios of band intensities can be used to internally
compare concentrations. However, for depth proﬁling these evalu-
ations are critical. One aspect is that a change in refractive index
will have an effect on both, position and shape of the focal volume
(Everall, 2004a,b). Furthermore, the scattering becomes more dif-
fuse with increasing penetration depth. Franzen et al. have recently
introduced a semi-solid matrix system to simulate the optical
properties of skin, which appears to give reliable results (Franzen
et al., 2012).
The most critical aspect of the application of Raman microscopy
for direct imaging is the relatively low penetration depth. Although
this could be improved by higher laser power and substantially
longer integration times, considering the amount of data collected
during an image acquisition, long integration times become
quickly impractical and higher laser intensities are likely to intro-
duce photo damage. Long measuring times are problematic for
imaging applications, because of the associated loss of water. Dry-
ing will not only alter the tissue, it also steadily changes the focal
plane. Excitation within the red region of light is generally ac-
cepted as being least invasive for biological samples (Puppels
et al., 1991). However, to the best of the authors knowledge, persis-
tent studies that relate excitation power with photo toxicity have
not been published.
For the detection of beta-carotene and other carotenoids reso-
nance Raman effects may be utilised for achieving higher sensitiv-
ities. However, previous reports of Raman spectroscopic
investigations of human skin are based on single point measure-
ments (Ermakov et al., 2004; Mélot et al., 2009; Pudney et al.,
2007; Uragami et al., 2012). Although confocal Raman microscopy
for studying skin penetration has already been studied extensively,
these studies usually involve either tissue cross sectioning or
recording optical biopsies in the XY plane at different depths in
the skin (Caspers et al., 2001, 2002; Tfayli et al., 2007) which
may not generate a sufﬁciently detailed map of the diffusion path-
way taken by the drug. With this in mind, we acknowledge that the
method described in this paper might be limited to only the top
layers of the epidermis. Key advantage of the proposed methodol-
ogy is the non-invasiveness of the image acquisition of the stratum
corneum, a major barrier in transdermal drug delivery.
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3.2.1 Unpublished work 
Work that followed the publication-2 is described in this section in brief and also describes difficulties 
faced. At the moment of writing this thesis, this work is not considered for any publication. 
Method development: 
Publication-2 presented the first-insights into the method for non-invasive depth profiling of the SC. 
Depth profiling of the stratum corneum and viable epidermis was of interest to study the co-diffusion of 
liposomal-phospholipid and drug incorporated within the liposomes to comment on the mechanism 
involved in the drug delivery to skin from topical application of liposomes.  
In the second part of this project, further efforts were made to improve the penetration depth achieved 
during Raman imaging and increase sample stability during the measurements. Increased penetration 
depth and sample stability were mainly achieved by the combination of following changes; 
 A water immersion objective (Nikon, 60x, 1.0 NA, NIR) was used instead of an air immersion 
objective (Zeiss, 50x, 0.9 NA) as reported in the publication-2 
 Skin sample holder proposed in the publication-2 was updated from an open-cell design to a 
closed-cell design (Figure 5)  
Water immersion objectives reduce local heating of skin biopsies which greatly increased the stability 
of skin samples enabling longer acquisition times for the Raman spectra. Use of water immersion 
objective prompted us to move away from the open-cell design in order to avoid over-hydrating the skin. 
A closed cell was implemented by using a thin (thickness = 200 µm) 9 mm diameter quartz window on 
top of the skin biopsy. Principle design of the sample holder remained similar to the one described 
previously in publication-2 but rather than aluminum block the assembly was done in a shorter Teflon 
block to accommodate the larger dimensions of the water immersion objective. 
 
Figure 6 and 7 show depth profiles for full thickness untreated human and pig-ear skin respectively. 
Using the updated version of the method spectra could even be collected at higher acquisition time of 1 
or 2 seconds/spectra without any damage to the skin. Vertex component analysis (VCA) of the optical 
Figure 5: Schematic for the modified closed-cell type sample holder.  
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biopsies shows typical spectral features dominant for proteins and lipids. Spectra at the surface had the 
highest intensity however, the biggest improvement was for the spectral quality from the deeper focal 
planes. Compared to the published method, penetration depth achieved was about 60 µm for human skin 
whereas for pig skin it was approximately 70 µm (Figure 7c). With these results, at least a two fold 
increase in penetration depth was achieved. It must be pointed out that despite the higher penetration 
depths achieved, limitations of our method, as discussed in the publication-2, related to quantification 
and resolution at the deeper focal planes due to change in refractive index are still valid. 
 
Measurement of diffusion profiles from deuterated liposomes: 
Chain deuterated d31-palmitoyl-oleoyl phosphatidylcholine (d31-POPC) was employed for the 
preparation of liposomal formulations as C-D stretching vibrations can be easily distinguished between 
the spectral features of skin. For the selection of a model-drug for the diffusion experiments, two criteria 
were applied. The drug must be able to get incorporated within the liposomes and importantly, should 
have a strong Raman signature easily identifiable in the skin. A variety of drugs and chemical 
compounds were scanned, amongst them retinol, beta carotene, tretinoin and ibuprofen were selected 
Figure 6: XZ depth profiles of untreated human skin. (A1-3) images generated by VCA where 
highest intensities showing characteristic spectral features of proteins and lipids (a) are shown in red 
while regions in green show spectral features characteristic mainly for proteins (b). Fluorescence is 
represented by yellow (c) in the deeper regions of the skin. (B1-3) represents Raman images generated 
by integrating the signal intensities for C-H stretching vibrations.  
Unpublished work 
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and formulated to form deuterated invasomes. Composition of invasomes was, 9.3% d31-POPC, 0.7% 
lyso-phosphatidylcholine, 1% terpene and 10% ethanol.  
Figure 7: XZ depth profiles of untreated pig-ear skin. (A1-3) images generated by VCA where highest 
intensities showing characteristic spectral features of proteins and lipids (a) are shown in red while 
regions in green show spectral features characteristic mainly for proteins (b). (B1-3) represents Raman 
images generated by integrating the signal intensities for C-H stretching vibrations. (c) spectral quality 
from various depths of untreated pig skin. 
Unpublished work 
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After hydration, MLVs were extruded through 100 nm polycarbonate membrane. Formulations prepared 
had approximate size of 110 nm and PDI was < 0.1. Full-thickness human skin was mounted on the 
Franz diffusion cell and a 100 µl/cm² dose was applied non-occlusively on the skin. Diffusion was 
continued for 14 hours followed by which applied formulation was thoroughly removed from the surface 
of the skin. Skin was then used without any treatment for the measurement of Raman depth profiles 
using the sample holder as described in figure 5. For a more detailed explanation of the Franz diffusion 
experiments and Raman measurements kindly refer to the publication-2.  
Hurdles in the measurements of the diffusion profiles: 
One of the important objective of the study was to see the diffusion of phospholipid within the skin after 
topical application of liposomes. Unfortunately in the depth profile measurements, topically applied 
deuterated phospholipid could not be detected. Rationale behind this observation could be that 
phospholipids do not penetrate the SC at a sufficient concentration. Coupled this to the intrinsically 
weak nature of the Raman scattering and challenges of depth profiling, a relatively high concentration 
of the deuterated phospholipid penetration in the skin might be required for detection.  
Another aspect of this problem could be related to the formulation. Addition of drug or labels can have 
an effect on the bending energy of the phospholipid bilayer and as a result can change the flexibility 
parameter of the liposomal bilayers. Section 1.3 of this thesis has already highlighted that flexible or 
deformable liposomes tend to be superior at delivering drugs to/through the skin. Although the flexibility 
parameter of liposomal formulations was not measured, invasomes without any drug were applied to the 
skin. Measurement of the depth profiles for empty invasomes revealed no notable improvement in the 
detection of C-D Raman bands. Another formulation related aspect of this issue could be the selection 
of phospholipids itself as POPC selected for these experiments is not a representative phospholipid of 
the soy-phospholipid mixtures usually employed in the preparation of flexible liposomes intended for 
topical application (see table 3 & 4). However, since it was commercially available it was the preferred 
choice for these experiments. Issues in tracking of the topically applied phospholipids present a 
challenge for this study which needs a better understanding of the problem and hopefully these issues 
will be addressed in the future studies. 
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Abstract: 18 
Stratum corneum is the primary skin barrier to percutaneous absorption. Since 1980, topical liposomal 19 
formulations have been proposed and successfully employed for increasing the drug penetration through 20 
the skin. There is no clear consensus on the drug penetration mechanism from topically applied 21 
liposomes, despite a vast amount of research. Interactions between the stratum corneum and liposomes 22 
are at the nanoscale, what makes them difficult to probe. In this study, we have employed tip-enhanced 23 
Raman scattering (TERS) to gain a better understanding at the interactions between the human stratum 24 
corneum and topically applied invasomes. TERS is capable of imaging at sub nanometer spatial 25 
resolution and provides spectral information at nanometer scale. A sample preparation technique was 26 
developed and calibrated to enable TERS on complex stratum corneum samples. Invasomes prepared 27 
from a head deuterated phospholipid were used to aid identification of topically applied phospholipid in 28 
the stratum corneum. The presented results for the first time give strong spectroscopic evidence along 29 
with high-resolution images to show intact invasome vesicles in the stratum corneum. 30 
  31 
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List of abbreviations 36 
ATR-FTIR – attenuated total reflection Fourier transform infrared spectroscopy 37 
d9-DLPC – 1,2-dilinoleoyl-3-phosphocholine-N,N,N-trimethyl-d9 38 
DMPC – 1,2-dimyristoyl-sn-glycero-3-phosphocholine 39 
DPPC – 1,2-dipalmitoyl-sn-glycero-3-phosphocholine  40 
DSC – differential scanning calorimetry 41 
SAXS – Small angle X-ray scattering  42 
SC – stratum corneum;  43 
Soy-LPC – Soy lyso-phosphatidylcholine 44 
 45 
 46 
  47 
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Introduction 48 
Since the emergence of modern medicine, various strategies to deliver drugs to the skin have been 49 
explored. Major hurdle in transdermal delivery is the stratum corneum (SC) which forms the uppermost 50 
layer of the skin. Current strategies for transdermal drug delivery have been classified into first, second 51 
and third generation by Prausnitz and Langer (2008). First generation strategies include traditional 52 
delivery systems such as creams and patches which are mainly suitable for a handful of drugs which can 53 
penetrate the skin easily. Whereas both, second and third generation strategies focus on increasing the 54 
transdermal penetration either chemically, physically or mechanically. Liposomes have an important 55 
place in both second and third generation transdermal delivery systems, as phospholipid bilayers form 56 
excellent solubilizers and nanocarriers for drugs (Essa et al., 2003; Qiu et al., 2008). Liposomes have 57 
been extensively studied for transdermal drug delivery in the last three decades and the superiority of 58 
flexible liposomes over its rigid counterpart has been fairly well established in delivering drugs through 59 
the skin. Despite decades of studies, there is no clear consensus on how liposomes enhance drug 60 
penetration. Working groups around the world have so far proposed five mechanisms to explain drug 61 
delivery to skin using liposomes  62 
El Maghraby et al. (2006) has proposed five different mechanisms based on different liposome-skin 63 
interactions that have been reported. Briefly, 'free drug mechanism', where liposomes only transport 64 
drug up to the SC and drug permeates the skin on its own , 'penetration enhancing mechanism' suggests 65 
that liposomal vesicles cause ultrastructural changes to the SC lipid domains leading to increased drug 66 
penetration . 'Vesicle adsorption/fusion theory' liposomes interact with SC and fuse with the SC lipids 67 
leading to drug release. 'Intact vesicular skin penetration mechanism' suggests liposomes can penetrate 68 
through the skin intact and the 'trans-appendageal penetration' where drug delivery to or via hair 69 
follicles is achieved. It is likely that there is no one single mechanism at work responsible for drug 70 
delivery to skin but rather multiple mechanisms acting at different levels, depending on vesicle size, 71 
charge, mode of application, drug and vesicle composition etc. (Bouwstra and Honeywell-Nguyen, 72 
2002; Cevc and Blume, 1992; Knepp et al., 1987; Knepp et al., 1990; Shah et al., 2015; Verma et al., 73 
2003).  74 
Using ATR-FTIR Hasanovic et al. (2011) have reported that ex vivo application of DPPC liposomes on 75 
human skin resulted in decreased orthothrombic organization in SC lipid domains leading to a decreased 76 
barrier function of the SC. Similar findings have also been reported by Zellmer et al. (1995) using DSC 77 
to study DMPC liposome-treated human skin. Yokomizo and Sagitani (1996) tested penetration-78 
enhancing potential of a range of saturated and unsaturated phospholipids and they demonstrated that 79 
highest penetration enhancement achieved was from formulations containing unsaturated phospholipids. 80 
Ultrastructural changes to the SC lipid organization followed by application of deformable/elastic 81 
liposomal vesicles was also demonstrated by Hofland et al. (1995) using freeze fracture transmission 82 
electron microscopy and SAXS. Therefore both rigid and flexible liposomes have been demonstrated to 83 
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have a penetration enhancing potential, albite to a different degree. Mechanism of phospholipid vesicle 84 
interaction with the intercellular lipids is not well understood. Either phospholipid vesicles can fuse with 85 
the intercellular lipids followed by passive diffusion of phospholipids through the intercellular lipid 86 
domains or penetration of intact liposomes could also affect the organization of intercellular lipids in 87 
the SC. In general, the doctrine that intact liposomal vesicles can penetrate the SC has received a lot of 88 
skepticism. Using freeze fracture transmission electron microscopy the Bouwstra group has reported 89 
changes to the intercellular lipid domains and appearance of flattened vesicular structures in the 90 
intercellular lipid domains, in vitro as well as in vivo, up on treatment with flexible liposomal vesicles 91 
(Bouwstra and Honeywell-Nguyen, 2002; Hofland et al., 1995; van den Bergh et al., 1999). Confocal 92 
fluorescence microscopy studies have suggested presence of inter-cluster pathways in the SC when skin 93 
was treated with fluorescent flexible liposomes (Schatzlein and Cevc, 1998; van den Bergh et al., 1999). 94 
Electron microscopic studies from the Bouwstra group presented a case supporting intact penetration of 95 
liposomes in the SC. However, given the lack of qualitative evidence and complex nature of the sample 96 
preparation in freeze fracture electron microscopic techniques there is still room for speculations. Xiao 97 
et al. (2005) in separate experiments applied deuterated POPC (liquid crystalline phase) and deuterated 98 
DPPC (gel phase) multilamellar liposomes to pig skin and determined the penetration of deuterated 99 
phospholipids in the pig skin using infrared and Raman microscopy. POPC penetrated up to 100 µm in 100 
the pig skin compared to only 10 – 15 µm for the DPPC, although this study does not provide information 101 
about the mechanistic aspect of how phospholipids penetrate these depths in the skin.  More recently, 102 
Brewer et al. (2013) used raster image correlation spectroscopy to study diffusion of liposomes and 103 
Transfersomes® in skin. They found that liposomes and Transfersomes® containing twin fluorescent 104 
labels showed similar diffusion coefficients as observed for the free fluorescent dyes and concluded that 105 
liposomes and Transfersomes® undergo destabilization upon contact with the SC. They also found that 106 
in the SC the fluorescent probes did not travel together. This observation was rationalized as ‘no intact 107 
penetration of liposomes’. However Brewer et al. used bulky fluorescent labels in their study and 108 
transfer of drugs or compounds to skin from liposomal bilayers can be heavily influenced by the partition 109 
coefficient between skin and liposomal bilayers (Shah et al., 2015).  110 
Tracking liposomes in the SC using fluorescence based microscopic techniques is limited by Abbe’s 111 
diffraction limit (Abbe, 1873) and partition of fluorescent label between the SC and liposomal vesicles 112 
needs to be taken in to account. Electron microscopic techniques can get around this problem. However, 113 
electron microscopy usually requires extensive sample preparation and qualitative analysis to 114 
distinguish externally applied lipids and lipids indigenous to skin is difficult. Using Raman microscopy 115 
with isotopic labelling of the phospholipids presents a good opportunity to track nanoparticles with 116 
increased contrast to the natural phospholipid. However, this mode of microscopy is also limited by 117 
Abbe’s diffraction limit and additionally the relatively weak nature of Raman scattering result in longer 118 
acquisition times, which can have an adverse effect on the sample stability. To probe liposomal 119 
interactions with the SC a technique that can image at high lateral resolution and provide spectroscopic 120 
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information at high resolution is desired. Tip-enhanced Raman scattering (TERS) spectroscopy 121 
combines high-resolution scanning probe microscopy, atomic force microscopy (AFM) or scanning 122 
tunneling microscopy (STM) with surface enhanced Raman scattering (SERS) (Anderson, 2000; 123 
Hayazawa et al., 2000; Stöckle et al., 2000b). Raman scattering is a weak inelastic process that can be 124 
enhanced using surface plasmon resonances (SPR) of metals like gold (Au) or silver (Ag) as applied in 125 
SERS and TERS. With TERS, many different biomaterials have been investigated so far, like model 126 
membranes, cells, viruses, bacteria, proteins etc. (Langelüddecke et al., 2014). TERS utilizes metalized 127 
or solid metal tips reaching a lateral resolution of less than one nanometer (Zhang et al., 2013). So far, 128 
the field enhancements in TERS were reported to be up to 1013 and the sensitivity is owing to the sub-129 
nanometer resolution at the single molecule level.(Deckert-Gaudig et al., 2012; Kurouski et al., 2012; 130 
Marr and Schultz, 2013; Sonntag et al., 2012; vandenAkker et al., 2015; Zhang et al., 2013).  131 
Invasomes are flexible liposomal formulation containing lyso-PC as edge activator, ethanol and terpenes 132 
as penetration enhancers. Invasomes have shown potential to deliver drugs such as temoporfin 133 
(Dragicevic-Curic et al., 2008), ferrulic acid (Chen et al., 2010), cyclosporine (Verma and Fahr, 2004), 134 
azelaic acid (Shah et al., 2015) etc. In this study, we treated human skin with empty invasomes and post 135 
application skin samples were investigated using TERS to track the externally applied head-deuterated 136 
phospholipid. Since the interaction between skin and invasomes takes place at molecular scale TERS is 137 
a promising tool to probe these interactions and learn about the fate and behavior of invasomes.  138 
  139 
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MATERIALS AND METHODS 140 
 141 
Materials 142 
1,2-dilinoleoyl-3-phosphocholine-N,N,N-trimethyl-d9 (d9-DLPC) was gifted by Cordon Pharma 143 
(Switzerland). Purity of d9-DLPC was determined to be > 96 % using UPLC-MS and the phospholipid 144 
was used without further purification. TESA SE (Germany) gifted the adhesive used for spin coating 145 
the cover slips. Soy lyso-phosphatidylcholine (soy-LPC) was purchased from Avanti Polar Lipids, Inc 146 
(USA). Citral, cineol and d-limonene were purchased from Sigma-Aldrich GmbH (Germany). All other 147 
chemicals used in the study were of analytical grade. 148 
 149 
Preparation of invasomes 150 
Invasomes were prepared by thin lipid film hydration method. In a round bottom flask, a mixture of 4.65 151 
% w/v d9-DLPC with 0.35% w/v soy-LPC was dissolved in a 2:1 mixture of methanol:chloroform. 152 
Organic solvent mixture was evaporated using a rotary evaporator (Büchi Labortechnik GmbH, 153 
Germany). Lipid film was further dried under flowing nitrogen for 15 minutes. The lipid film was 154 
hydrated using a phosphate saline buffer (PBS) containing 10% w/v ethanol and 1% w/v terpene mixture 155 
containing citral:cineol:d-linonene (9:9:2). Multilamellar vesicles (MLVs) were prepared by thoroughly 156 
vortexing until the entire lipid film was dispersed. MLVs were further bath sonicated for 15 minutes 157 
followed by hand extrusion through 100 nm and 50 nm polycarbonate membranes 41 times to prepare 158 
the large unilamellar vesicles (LUVs). 159 
 160 
Preparation of SERS substrates 161 
SERS substrates were prepared according to Stöckle et al. (2000a) by evaporating glass cover slides 162 
with 6 nm silver and annealing for 60 seconds at 290°C. Before evaporative coating, glass cover slips 163 
were cleaned by placing them for 150 minutes in a mixture of HNO3/H2O2 (3:1) and thoroughly washed 164 
afterwards to assure sufficient cleanliness. 165 
 166 
Preparation of supported membrane bilayers 167 
Supported membrane bilayers were prepared on cleaned glass cover slips to measure TER spectra 168 
originating from invasomes alone. Prior to any lipid deposition, glass cover slips were cleaned using a 169 
mixture containing concentrated HNO3 : 30% H2O2 (3:1) for 2 hours followed by a series of distilled 170 
water washes. Cleaned cover slips were dried under vacuum. Invasomal LUVs prepared above were 171 
diluted with PBS to get final lipid concentration of 1 mg/ml. 20 µl of the diluted lipid dispersion was 172 
spread on a cleaned glass cover slip and was allowed to air dry. Excess lipid was removed by gently 173 
washing the cover slip three times with ultrapure water (Milli-Q® Advantage A10). Washed cover slip 174 
was then air dried and imaged using AFM to ensure successful bilayer formation. AFM tip was then 175 
replaced with a TERS tip and TER spectra are measured as described below.  176 
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Preparation of adhesive coated cover slips: 177 
In tape stripping experiments, it is common practice to use commercially available adhesive tapes like 178 
TESA kristal klar® (Germany), Transpore® 3M (USA), D-squame® CuDerm (USA), for sampling of the 179 
SC. However, in this study application of commercially available adhesive tapes was not a feasible 180 
solution as imaging with an AFM requires sample mounted on a solid substrate. In our preliminary 181 
studies, a kristal klar® TESA adhesive tape was fixed on a glass cover slip using a double sided adhesive 182 
tape however this approach had a major disadvantage as it led to high internal reflections and scattering 183 
leading to poor TERS signal quality. To overcome this we developed a method to coat glass cover slips 184 
with a very thin layer of adhesive. These adhesive covered cover slips could directly be used for 185 
sampling the SC in place of adhesive tapes.  186 
 187 
TESA adhesive mixture typically used in the preparation of kristal klar® adhesive tapes was used for 188 
coating the glass cover slips. A uniform coating of the adhesive was achieved with the help of an in-189 
house custom built spin coating device. Prior to spin coating cover slips were cleaned as described 190 
above. A spin coating protocol was optimized by varying the duration of coating, RPM and amount of 191 
the adhesive placed on the cover slip at the beginning of the coating cycle to ensure thin, clear and 192 
uniform glue coverage on the glass surface. The adhesive was mixed well to ensure a uniform dispersion 193 
and 60 µl of the adhesive was spread uniformly on a glass cover slip attached to the sample holder of 194 
the spin coater. Cover slip was then accelerated uniformly at 85 RMP/sec till 3000 RPM and maintained 195 
for 30 seconds. After coating, cover slips were incubated at 40 °C for 12 hours. Adhesive coated cover 196 
slips were always prepared fresh before the experiment and were used within 48 hours after preparation. 197 
Amount of SC removed by individual adhesive cover slip was assessed by IR-densitometry using D-198 
Squame Scan 850A (CuDerm, USA) as described previously (Franzen et al., 2012; Klang et al., 2011; 199 
Voegeli et al., 2007). 200 
 201 
Skin sample preparation: 202 
To study the interactions between invasomes and the SC preliminary experiments were carried out on 203 
excised human skin using a Franz diffusion model. However, we shifted to in vivo model as removal of 204 
the SC using adhesive cover slips was much more consistent and uniform in vivo compared to the ex 205 
vivo model. Penetration experiments were performed on the volar surface of the left forearm of a 206 
representative subject (male, 30 years old). Area of the forearm was carefully shaved at least four hours 207 
prior to the start of the experiment and was washed again gently with tap water before start of the 208 
experiment. 100 µl/cm² of invasomes were applied to the skin with the help of a pipette. Formulation 209 
was contained in the applied area with the help of a polypropylene disc (with a 14 mm diameter hole) 210 
that was securely glued to the skin. Formulation was applied to the skin for a period of four hours after 211 
which the residual formulation was removed by gently washing the skin under tap water and then 212 
carefully wiping the skin with a lint-free tissue paper until the skin was dry. SC was removed 213 
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progressively using the adhesive coated cover slips. To limit the area for removal of the SC a mask made 214 
of nylon mesh (80 µm pore size, 130 µm thickness) with 14 mm diameter central hole was used. To 215 
ensure good contact between skin and adhesive coated cover slip, a 2 kg weight was placed on top of 216 
the cover slip for 10 seconds. The cover slip was ripped off in one uniform motion along with the nylon 217 
mask. Nylon mask was then removed and the cover slip was stored carefully. The process was repeated 218 
10 times and samples were measured with AFM first followed by TERS. Pseudo absorption before and 219 
after sampling the SC was measured using D-Squame Scan 850A densitometer (Cuderm, USA). 220 
Experiments were approved by the ethical committee of the Friedrich-Schiller-Universität Jena, 221 
Germany. In case of untreated or control experiments, equivalent PBS was applied to the skin and rest 222 
of the sample preparation was carried out exactly like treated samples. 223 
 224 
TERS measurements: 225 
The TERS setup has the bottom illumination/bottom collection geometry as described before 226 
(Rasmussen and Deckert, 2006; Stöckle et al., 2000b). In brief, our TERS setup consisted of Nanowizard 227 
III AFM (JPK Instruments AG, Germany) mounted on an inverted Raman microscope (IX71, Olympus, 228 
Germany). The excitation laser (532 nm) was focused onto the TERS tip and sample from below using 229 
an oil immersion objective (40x; 1.35 NA). Enhanced Raman signal was collected by the same objective 230 
and was directed towards the spectrometer (SP2750A, Acton Advanced, Princeton Instruments 231 
Roper Scientific, USA) through a dichroic beam splitter and a series of mirrors. Spectra were finally 232 
recorded using a CCD camera (Pixis 400, Princeton Instruments Roper Scientific, USA). Skin 233 
samples were mounted on a XY scanning piezo stage (P-733.2DD, Physik Instrumente, Germany). 234 
For all AFM and TERS measurements, AFM was operated in the intermittent contact mode. For standard 235 
AFM operation commercially available tips were used (Budget Sensors, Tap190Al-G) whereas the tips 236 
were evaporated with 25 nm silver for TERS experiments and stored under argon until usage. Skin 237 
samples were first imaged using AFM to gain an understanding of the topographical features of the 238 
sample. Post imaging, the AFM tip was replaced with a TERS tip. Tip-setting was done by aligning and 239 
then fixing the TERS tip in the focus of the excitation laser. After tip-setting, samples were scanned 240 
using the piezo sample scanner while the TERS tip recorded the topography. TER spectra were recorded 241 
by setting a grid of points on the region of interest on the scanned image. The measurement procedure 242 
and technique is described in great detail within a recent publication (Langelüddecke et al., 2015). 243 
During TERS measurements, laser power at sample was approximately 500 µW and acquisition time 244 
for each spectra varied between 3-5 seconds. 245 
 246 
Data analysis: 247 
Raw spectra were analyzed using IGOR Pro 6.36. AFM images were treated with JPK Data Processing 248 
software applying plane leveling and subtracting a polynomial fit from each line independently.  249 
  250 
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RESULTS AND DISCUSSION 251 
Calibration of adhesive coated cover slips and sample preparation 252 
Spin coating protocol used was consistent in producing thin and uniform adhesive coated cover slips. 253 
Average thickness of the adhesive film was 17.6 ± 2.85 µm (n = 15). Among different protocols tested, 254 
the protocol described above offered the best compromise between adhesiveness and film clarity. In 255 
general, subjecting cover slips to a smaller centrifugal force lead to thicker and more adhesive surfaces 256 
but such films were often not transparent. After tape stripping, microscopic evaluation showed an even 257 
distribution of corneocyte clusters on the surface of adhesive coated cover slips. However, clusters were 258 
less dense compared to the kristal klar® TESA tapes. For a quantitative comparison between the two 259 
adhesive devices, pseudo-absorption was measured before and after tape stripping using IR densitometry 260 
to measure the amount of stratum corneum removed during tape stripping. Figure 1 shows cumulative 261 
pseudo-absorption profiles of adhesive coated cover slips compared with kristal klar® TESA adhesive 262 
tapes. Linear profiles with small standard deviation indicate that adhesive cover slips were consistent at 263 
removing similar amounts of SC proteins. Average pseudo-absorption values for adhesive coated cover 264 
slips were 5.60 ± 1.74 units as compared to 9.0 ± 2.8 units for krystal klar® TESA tape, indicating our 265 
in-house adhesive coated cover slips were approximately 62 % as efficient at removing the stratum 266 
corneum compared to the kristal klar® TESA tape.  267 
 268 
 269 
Figure 1: Pseudo-absorption profiles measured at 850 nm using D-Squame Scan 850A densitometer (n = 50). 270 
 271 
Atomic force microscopy of treated and untreated skin: 272 
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Treated and untreated skin samples also showed large oval structures with granular topography (shown 291 
by black arrows in Fig 3a). These structures were likely to be corneodesmosomes, which act as rivets 292 
between the neighboring corneocytes. These structures had size ranging from 150 – 600 nm and had 293 
heights between 15 – 80 nm, these figures agree with the dimensions of corneodesmosomes that were 294 
reported in the literature (Chapman and Walsh, 1990; Harding, 2004). Bouwstra group also reported 295 
such structures in the freeze fracture electron microscopic studies however they anticipate these 296 
structures to be corneodesmosomes or swollen keratin filaments perpendicular to the surface of 297 
corneocytes (Loan Honeywell-Nguyen et al., 2002; van den Bergh et al., 1999). Nevertheless, given the 298 
differences in the sample preparation methods, we consider over-hydration unlikely in our samples and 299 
the frequency of the feature’s occurrence is more consistent with corneodesmosomes than keratin 300 
filaments. Invasomal vesicles could be distinguished from desmosomes based on shape and height 301 
profile. The oval-granular structures of desmosomes were not investigated in detail mainly because they 302 
do not significantly play a role in liposome penetration. Schatzlein and Cevc (1998) while studying 303 
penetration of Transfersomes® in murine skin using confocal laser scanning microscopy described 304 
intercorneocyte pathways between clusters of corneocytes. Loan Honeywell-Nguyen et al. (2002) have 305 
also reported similar channels in treated and untreated human stratum corneum. The Cevc group has 306 
hypothesized that these channels play a role in penetration of transfersomes into the SC. Although we 307 
did not find a substantial evidence for this claim, we did find channels or ridges in both untreated and 308 
treated samples. These channels are highlighted using black lines in Fig 3b in an untreated sample of 309 
layer-8. Black arrows in Fig 3b indicate the intercorneocyte boundary and it can be seen that these 310 
channels were not limited by the corneocyte boundaries. Fig 3c shows a small channel on layer 5 of a 311 
treated sample with three flattened vesicles. We would like to emphasize that although many ‘channels’ 312 
were observed on the surface of corneocytes, presence of vesicles in them as shown in Fig 3c was quiet 313 
rare.   314 
 315 
Figure 3: AFM images showing a) oval-granular structures as observed in layer 9 of untreated skin b) channels 316 
shown by black lines in layer 5 of an untreated skin, arrows indicate intercorneocyte boundary c) channel showing 317 
three flattened invasomal vesicles in layer 5 of invasome treated skin. 318 
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Flattened invasomal vesicles could be found in all 10 layers of the treated samples that were investigated 319 
however, they were more abundant in the lower layers especially from layer 5 to 10. Once regions of 320 
interest were identified in the layer, AFM tip was switched for a TERS tip and TER spectra were 321 
measured on the invasomal vesicles and regions of interest.  322 
TER – spectra of head deuterated invasomes 323 
Deuterated lipids in Raman spectroscopy enable the utilization of the C-D signal at around 2000-324 
2300 cm-1 in the cell silent region. In our case, a big contrast between skin (lipids and proteins) and 325 
invasomal lipids is created. In order to keep the manipulation of the lipid as less as possible we prepare 326 
our invasomes from head-deuterated (d9) lipids. In addition, we think that using d9-lipids is the most 327 
convenient way to use SERS and TERS enhancement in our sample system. SERS and TERS make use 328 
of a strongly distance dependent near-field effect to enhance Raman signals by several orders of 329 
magnitude. In our study, a head-deuterated phospholipid was employed for preparation of invasomes as 330 
the lipid head groups are closest to the SERS substrate or TERS tip. This allows for easier detection in 331 
the experiments compared to chain deuterated phospholipids. The SER spectrum of adsorbed d9-DLPC 332 
bilayers (Fig 4b) shows a similar pattern as the Raman spectrum (Fig 4a) and is strongly enhanced under 333 
SERS/TERS conditions. The most prominent bands of d9-DLPC are marked and assigned in the SER 334 
and Raman spectra according to Bunow and Levin (1977) , which are 1) 2272 cm-1 (CD3 asym. str.); 2) 335 
2181 cm-1 (overtone, combination modes of acyl chains); 3) 2080 cm-1 (CD3 sym. str.); 4) 1763 cm-1 336 
(C=O str.); 5) 1655 cm-1 (C=C str.); 6) 1435 cm-1 (CH2 deform.); 7) 1299 cm-1 (CH2 twist deform.); 8) 337 
1259 cm-1 (PO-2 asym. str.) and 9) 1077 cm-1 (PO-2 sym. str.). For further reference purposes we 338 
investigated supported bilayers of d9-DLPC adsorbed on glass with TERS and found that the TER 339 
spectral pattern differed from standard Raman and SERS. Fig 4c shows a TER spectra measured on d9-340 
DLPC bilayers and it shows only one C-D peak compared to the four peaks seen in the SERS and Raman 341 
spectra. We believe the disparity between the SER/ Raman on the one hand and TER spectra on the 342 
other hand can be explained based on polarization effects due to the strong field gradient in TERS that 343 
results in an unusual polarization geometry (Deckert-Gaudig et al., 2010; Meng et al., 2015; Ossikovski 344 
et al., 2007). Despite such peculiarities, TERS nevertheless allows the detection of the lipid head-345 
deuteration, which is the main message from this experiment.  346 
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flattened invasomal vesicle and showing locally concentrated C-D positive spectra (marked in green); 380 
result indicates diffusion of head-deuterated phospholipid from invasomes into the stratum corneum. 381 
b) AFM image of a skin structure (treated skin) on Layer-5; TERS grid is superimposed (5x8 points; 382 
Δx=50 nm, Δy=62.5 nm); C-D positive spectra are marked in green in the AFM image; spectra correlated 383 
with topography are indicating diffused phospholipids from invasomes.  384 
 385 
Figure 6a shows two flattened vesicles from the 7th layer of the stratum corneum. Four C-D positive 386 
TER spectra are observed in a 10x10 points measurement grid on the lower edges of the particles. In 387 
this image, we present two adjacent spectra to the C-D positive spectra in order to show the intactness 388 
of our TERS tip during the experiment. To show the intactness of our TERS tip we have presented two 389 
adjacent TER spectra to the C-D positive spectra. Usually, the C-D negative spectra show typical 390 
features from skin-own lipids and proteins such as amide II (~1560 cm-1), CH2 deform. (~1430 cm-1), 391 
Amide III α-helix (~1280 cm-1), PO2- asym. str. (~1250 cm-1) and cholesterol str. ring (~700 cm-1), 392 
respectively.  393 
In Fig. 6b another flattened invasomal vesicle from the 5th layer of treated skin was investigated by 394 
measuring TER spectra at 25 points on a grid. We observed 6 C-D positive spectra in this grid. These 395 
six spectra can be nicely correlated with the topography and let us conclude that we probed an intact 396 
invasomal vesicle that penetrated down to the 5th layer of the stratum corneum. 397 
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techniques like ATR-FTIR, DSC, SAXS, electron microscopy etc. TERS provides a unique opportunity 412 
to image and to detect deuterated invasomal phospholipids in the stratum corneum. Theoretically, based 413 
on the mechanisms discussed earlier there were three possible outcomes of the TERS study; a) no 414 
detection of d9-DLPC in the SC b) presence of diffused d9-DLPC in the SC or c) presence of intact 415 
invasomes in the SC. Based on these assumptions we measured TER spectra at multiple points on the 416 
surface of corneocytes. Grids measured on the corneocytes rarely showed presence of d9-DLPC and 417 
only in a few instances we had a strong indication of diffused d9-DLPC in the SC. In all the instances, 418 
the diffused d9-DLPC was detected on the channel-like structures found on the corneocytes. We should 419 
point out that detecting the phospholipid diffused after application of invasomes in the SC was like 420 
‘looking for a needle in a haystack’ because there are no topographical structures to guide the placement 421 
of the TERS grids. Although the fact that it was harder to detect the deuterated phospholipid on the 422 
surface of the stratum corneum might point to either a very particular pathway or more likely point to 423 
the fact that only a small fraction of the applied phospholipid on the skin makes it in to the skin. Highlight 424 
of the present study was the demonstration of imaging and identifying invasomal vesicles penetrated 425 
deep into the SC after topical application. Although presence of flattened vesicles in the SC after 426 
liposomal application was also demonstrated by Hofland et al. (1995); and Loan Honeywell-Nguyen et 427 
al. (2002), our study presents, for the first time a spectroscopic evidence to identify the penetrating 428 
phospholipid vesicles. Based on the AFM studies, a higher density of vesicles was observed for the 429 
deeper layers (layer 5 to 10). Reason behind this observation was not clear but one might speculate that 430 
this phenomenon was either a result of rigorous washing of the skin to remove the residual formulation 431 
or that the formulation penetrates only in the first few minutes after application.  432 
Discrepancies in the quantity of SC removed during tape stripping protocols are well documented 433 
(Holbrook and Odland, 1974; Jacobi et al., 2005; Lademann et al., 2009; Lindemann et al., 2003; 434 
Marttin et al., 1996). We would also like to point out that, it is rather difficult to predict how deep we 435 
can sample the SC using our stripping technique. Based on our densitometry results and our experience 436 
with tape stripping we would conservatively speculate that by layer 10 we should be at least 5 µm deep 437 
in the SC. From all the AFM data analyzed for layer 10, we estimated approximately 130 vesicles per 438 
100 µm² of the SC. This number might seem large however, assuming a homogenous distribution of 439 
vesicles and an average invasome diameter of 80 nm, it means only 0.0003% of the invasomes applied 440 
topically reach the 10th layer. In our opinion, this estimate only emphasizes the barrier function of the 441 
SC. In this study, we employed empty invasomes to shed a light on the role of phospholipid in delivery 442 
to the skin.  443 
 444 
Based on our results transdermal drug delivery from liposomally entrapped drug is likely to be a 445 
multifaceted phenomenon that is likely to include intact liposomal penetration and decreased barrier 446 
function of the SC due to disturbed arrangement of intercorneocyte lipid domains. Given the small 447 
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fraction of invasomes that were observed on the 10th layer it is obvious that these two are not the only 448 
mechanisms involved in transdermal drug penetration. These results also highlight the importance of 449 
physicochemical properties of the drug and the partition coefficient of the drug between the SC and 450 
phospholipid bilayers. The simplicity in the sample preparation presented here coupled with the fact that 451 
samples can be measured at ambient conditions make TERS a very promising tool in carrying out such 452 
investigative studies in the SC.  453 
 454 
Conclusions: 455 
We have successfully demonstrated application of TERS to study the penetration mechanism of 456 
topically applied invasomes. After the invasome treatment, presence of flattened vesicles was 457 
observed on the surface of corneocytes. A head deuterated phospholipid was employed in the 458 
preparation of invasomes to distinguish the externally applied invasomes from endogenous contents of 459 
the SC. We successfully measured C-D TERS bands on the flattened vesicles confirming that 460 
invasomes can penetrate into the SC. Apart from invasomal vesicles we also found evidence of 461 
diffused deuterated phospholipid on the surface of corneocytes.  462 
 463 
  464 
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The present study compares three vesicular systems, cationic LeciPlex, invasomes, and conventional
liposomes for their ability to deliver drugs deep into the skin. Skin penetration ability of the three
vesicular systems was studied for two drugs namely idebenone (antioxidant/anticancer) and azelaic acid
(antiacne). All systems showed sizes in nanometer range with small polydispersity indices. Vesicular
systems were characterized by CryoTEM studies to understand the differences in morphology of the
vesicular systems. Ex vivo human skin penetration studies suggested a pattern in penetration of drugs in
different layers of the skin: LeciPlex showed higher penetration for idebenone whereas invasomes
showed higher penetration of azelaic acid. Ex vivo study using a ﬂuorescent dye (DiI) was performed to
understand the differences in the penetration behavior of the three vesicular systems on excised human
skin. In vitro cytotoxicity studies on B16F10 melanoma cell lines revealed, when loaded with idebenone,
LeciPlex formulations had the superior activity followed by invasomes and liposomes. In vitro
antimicrobial study of azelaic acid loaded systems on Propionibacterium acne revealed high antimicrobial
activity for DDAB leciplex followed by almost equal activity for invasomes and CTAB LeciPlex followed by
liposomes. Whereas antiacne efﬁcacy study in rats for azelaic acid loaded systems, invasomes exhibited
the best antiacne efﬁcacy followed by liposomes and LeciPlex.
ã2015 Elsevier B.V. All rights reserved.
1. Introduction
Drug delivery directed to skin layers is the most sought after
and successful approach in treatment of various conditions like
acne, eczema, psoriasis, keratinization, and skin cancer. Conven-
tional transdermal dosage forms like ointments and gels, although
easier to formulate, are not ideal formulation strategies for
lipophilic drugs. Although creams can incorporate lipophilic drugs
they tend to localize the drug in stratum corneum (Higuchi,1960).
Liposomal vesicular systems on the other hand have an advantage
of incorporating both hydrophilic and lipophilic drugs still
retaining the hydrophilic nature of the system aiding in penetra-
tion of the incorporated active agent and patient compliance. For
any compound applied topically there are two basic mechanisms
that have been suggested viz. transepidermal wherein the
penetration is through the stratum corneum mainly following
the trans-cellular route and trans-appendageal route wherein the
permeation is through the sweat glands and across the hair
follicles (Barry, 2006).
Liposomes are phospholipid based vesicular systems that have
been extensively explored for skin delivery of drugs (Cevc, 1996;
Mezei and Gulasekharam, 1980; Michel et al., 1992; Schaeffer and
Krohn, 1982; Skalko et al., 1992). Advantages of using liposomes
for skin delivery of drugs are well documented. Liposomes have
been shown to have penetration enhancing effect and deliver a
range of drugs with different physicochemical properties and
Abbreviation: Soy PC, soy phosphatidylcholine; Lyso PC, lyso phosphatidylcho-
line; PEG, polyethylene glycol; CTAB, cetyl trimethyl ammonium bromide; DDAB,
didodecyl dimethyl ammonium bromide; PL90G, Phospholipon1 90G; PL90H,
Phospholipon1 90H; PBS, phosphate buffer saline; CryoTEM, cryo transmission
electron microscopy; SUV, small unilamellar vesicles; LUV, large unilamellar
vesicles; DSPC, distearoylphosphatidylcholine; DPPC, dipalmitoylphosphatidylcho-
line; DMPC, dimyristoylphosphatidylcholine; RBF, round bottom ﬂask.
* Correspondingauthor at: BombayCollegeof Pharmacy, Kalina, Santacruz (East),
Mumbai 400098, Maharashtra, India. Tel.: +9122 26670871; fax: +9122 2667 0816.
E-mail addresses: mangal.nagarsenker@gmail.com,
mangal_nag511@yahoo.co.in (M.S. Nagarsenker).
1 These authors have contributed equally in preparation of the manuscript.
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even serve as a depot for sustained delivery of drugs that require
local deposition (Gonzalez-Rodriguez and Rabasco, 2011). Factors
affecting drug penetration from vesicular systems include lipid
composition, size, lamellarity, mode of application whether
occlusive or non-occlusive, lipid concentration etc. (Cevc and
Blume, 1992; Weiner et al.,1989). Verma et al. (2003c) studied the
effect of liposomal size on the penetration behavior of a
hydrophilic and lipophilic ﬂuorescent dye carboxyﬂuorescein
and DiI respectively and concluded that the penetration was
inversely proportional to the size of liposomal vesicles. Another
important factor for dermal delivery is the ﬂuidity of vesicle
membrane. Many authors have reported that increasing the
deformability or elasticity of vesicles lead to deeper penetration of
the drug. This penetration enhancing effect has been attributed to
mixing of the liposomal bilayer lipids with the intracellular lipids
in the stratum corneum (Cevc et al.,1998a; Egbaria et al.,1991; Guo
et al., 2000; Loan Honeywell-Nguyen et al., 2002; Paul et al., 1998;
Planas et al.,1992; van den Bergh et al.,1999). Different theories for
enhanced penetration of drugs delivered from liposomal systems
have been proposed and reviewed (El Maghraby et al., 2008).
These assumed penetration mechanisms can roughly be classiﬁed
into ﬁve pathways. The ‘free drug mechanism’ proposes that the
drug permeates through the skin independently after exiting from
the vesicles (Ganesan et al., 1984). The ‘penetration enhancing
mechanism’ suggests that lecithin causes ultrastructural changes
in the stratum corneum leading to the enhanced transdermal
passage of drug. The mechanism of ‘vesicle adsorption to and/or
fusion with the stratum corneum lipids’ suggests that the vesicles
adsorb/fuse with the stratum corneum leading to increased drug
partitioning in the skin (Bouwstra and Honeywell-Nguyen, 2002).
Whereas ‘intact vesicular skin penetration’ mechanism proposes
the penetration of intact vesicles, especially in case of ultra-
deformable liposomes called transfersomes (Cevc et al., 1998b;
Cevc et al., 2003). The ‘trans-appendageal passage’ once dis-
regarded has also received a lot of attention in the last decade as a
primary penetration pathway (Andrea, 2005; El Maghraby et al.,
2006; Patzelt and Lademann, 2013).
Cationic liposomes have been explored for delivery of many
drugs. The mechanism for enhanced penetration is thought to be
interactions between positively charged liposomal components
with negatively charged components of the stratum corneum,
which induce transfer between the liposome and skin (Kitagawa
and Kasamaki, 2006). Cationic liposomes have been shown to
improve skin delivery of drugs like retinoic acid (Kitagawa and
Kasamaki, 2006), heparin (Song and Kim, 2006), meloxicam
(Duangjit et al., 2013), ﬂuorescent dye rhodamine (Katahira et al.,
1999), acyclovir, and minoxidil (Hasanovic et al., 2010). Kitagawa
and Kasamaki, (2006) demonstrated, up to 3.7 fold increase in
penetration of retinoic acid from cationic liposomes in excised pig
ear skin compared to its neutral counterpart.
LeciPlex is a positively charged phospholipid based vesicular
system that has been explored for oral delivery of quercetin (Date
et al., 2011a,b). The major components of a LeciPlex system are soy
PC, a cationic agent, and a bio-compatible solvent like PEG 300, PEG
400, Transcutol1 HP (diethylene glycol monoethyl ether), glyco-
furol (tetrahydrofurfuryl alcohol polyethylene glycol ether),
Soluphor1 P (2-pyrrolidone) or PharmasolveTM (N-methyl-2-
pyrrolidone) (Date et al., 2011a). The physicochemical properties
of these bio-compatible solvents have been extensively reviewed
(Shah et al., 2014). Earlier, LeciPlex have shown good improvement
in oral bioavailability of quercetinwith improved in vivo anticancer
activity (Date et al., 2011b). The advantage of LeciPlex over
conventional vesicular systems is in simplicity of preparation as it
is a one-step fabrication process that yields nanosized vesicular
systems by simple mixing (Date et al., 2011a). This is the ﬁrst study
that explores its potential in skin delivery of actives.
Invasome is a ﬂexible, neutrally charged, phospholipid based
vesicular system containing a mixture of soy PC, lyso PC, terpenes,
and ethanol. This system has shown to improve skin penetration of
hydrophilic and lipophilic drugs (Chen et al., 2011; Dragicevic-
Curic et al., 2008a; Dragicevic-Curic et al., 2009; Verma and Fahr,
2004; Verma et al., 2003b). Flexibility of the bilayer membrane is
mainly due to the lyso PC acting as an edge activator. Ethanol is a
good penetration enhancer while terpenes have also shown
potential to increase the penetration of many drugs by disrupting
the tight lipid packing of the stratum corneum. (Ogiso et al., 1995;
Ota et al., 2002; Puglia et al., 2001; Vaddi et al., 2002).
Vesicular systems have been studied extensively in conditions
like skin cancer due to their potential to improve skin penetration
and clinical efﬁcacy of drugs like gemcitabine (Moog et al., 2002),
vincristine (Guthlein et al., 2002), 5-Fluorouracil (Kaiser et al.,
2003). According to the World Health Organization (WHO), skin
cancer is one in every three cancers diagnosed with between 2 to
3 million non-melanoma skin cancers and 132,000 melanoma
skin cancer cases occurring globally every year (WHO, 2014).
Acne, a skin condition caused by Propionibacterium acnes infection
is not a life threatening disease but certainly has a signiﬁcant
physical and psychological ramiﬁcation such as permanent
scarring, poor self-image, social inhibition, depression, anxiety,
and in extreme cases suicidal tendency (Date et al., 2005; Gupta
and Gupta, 1998).
The objective of this study was to test and compare the ability
of LeciPlex, invasomes, and conventional liposomes to deliver
drug into the deeper layers of human skin. Conventional
liposomes, (referred as liposomes throughout the text) were
chosen as a control to compare the skin penetration ability of
LeciPlex formulations with respect to ﬂexible liposomal formu-
lation (invasomes). Idebenone (Fig. 1), a coenzyme Q10 analogue,
has antioxidant free radical scavenging properties and has
implications in management of melanoma (Wempe et al.,
2009). Azelaic acid (Fig. 1), an aliphatic nine carbon dicarboxylic
acid, is employed in the management of P. acne induced
inﬂammation of acne (Date et al., 2005; Gollnick, 1993). LeciPlex,
invasomes, and liposomes loaded with idebenone were investi-
gated ex vivo to determine the extent of penetration on excised
human skin and for their in vitro cytotoxicity on melanoma cell
line. The vesicular systems loaded with azelaic acid were
evaluated ex vivo to determine the extent of penetration on
excised human skin, in vitro antimicrobial activity, and in vivo
efﬁcacy study on P. acne induced inﬂammation in rats.
Fig. 1. Chemical structures of idebenone and azelaic acid.
392 S.M. Shah et al. / International Journal of Pharmaceutics 490 (2015) 391–403
102
Publication-4
2. Materials and methods
2.1. Materials
Idebenone and azelaic acid were purchased from Rxn Chem-
icals, India; and Sigma–Aldrich, India, respectively. Phospholipon1
90G and Phospholipon1 90H were gift samples from Lipoid GmbH,
Germany. Transcutol1 HP was a gift sample from Gattefossè India
Pvt. Ltd., India. Cationic surfactant cetyltrimethylammonium
bromide (CTAB) and didodecyldimethyl ammonium bromide
(DDAB) were purchased from Sigma–Aldrich, India. NAT8539
(ethanolic solution containing 75% by weight soybean phospho-
lipid. Phospholipid fraction contained phosphatidylcholine >73%,
lyso PC <7%, phosphatidylethanolamine <7%, phosphatidylinosi-
tol <5%, phosphatidic acid <7%) was purchased from Lipoid
GmbH, Germany. Limonene, citral, and cineole were purchased
from Sigma–Aldrich, Germany. Actinomyces broth was purchased
from Himedia Laboratories, India. Freeze dried P. acne strains were
procured from Microbial Type Cell Culture and Gene Bank (MTCC),
India. B16F10 melanoma cell line was procured from ATCC, USA. All
the other chemicals and reagents used were of analytical grade
unless otherwise speciﬁed.
2.2. Analytical method development
2.2.1. Idebenone
Idebenone was analyzed from skin samples on Hibar1
PurospherTM STAR RP-18e HPLC column (250mm, 4.6mm5mm,
Merck KGaA, Germany) using a Shimadzu (Japan) LC-20AD liquid
chromatography system and a Shimadzu SPD-M20A diode array
detector. Mobile phase consisting of water and methanol in
20:80 ratio was maintained at a ﬂow of 1mL/min (Amorim et al.,
2009). An injection volume of 20mL was injected and the
chromatograms were recorded at 279nm using benzophenone
as an internal standard. Chromatograms were recorded and
processed using LC Solutions data management software.
2.2.2. Azelaic acid
Azelaic acid was analyzed from skin samples on Kromasil1 100-
5C18 column (150mm, 4.6mm5mm, Kromasil, Sweden) using a
JASCO PU-2089 plus quaternary pump, JASCO AS-2055 plus
intelligent sampler, and a JASCO MD-2018 plus photodiode array
detector (Jasco corporation, Japan). Chromatograms were recorded
and processed using ChromNAV CFR v1.18.06 software. Mobile
phase (0.3885g Ammonium acetate in water:methanol ratio of
60:40, pH was adjusted to 5.0 using glacial acetic acid) was
maintained at a ﬂow of 1mL/min (Mansour and Ibrahiem, 2002).
100mL samples were injected and chromatograms were recorded
at 220nm using sebacic acid (Sigma–Aldrich, Germany) as an
internal standard.
2.3. Formulation of nanocarriers
2.3.1. LeciPlex
LeciPlex were prepared using a one-step fabrication process
(Date et al., 2011a,b). DDAB LeciPlex were prepared by dissolving
PL90G, DDAB, and drug in Transcutol1 HP (see Table 1 for further
details). To aid in dissolution, mixturewas heated brieﬂy to 70 C in
a water bath. Aqueous phase maintained at 70 C was added to the
transcutol solution under vortexing (Tarson SPINIX-VORTEX
shaker, India) to form DDAB LeciPlex. To form CTAB LeciPlex
(see Table 1), PL90G along with drug was dissolved in Transcutol1
HP by heating the mixture brieﬂy to 70 C in water bath. CTAB was
dissolved in water and maintained at 70 C and was added to the
Transcutol1 HP solution under vortexing to form CTAB LeciPlex.
2.3.2. Invasomes
Drug was weighed into a RBF and dissolved in about 3mL
mixture of chloroform:methanol (2:1) along with NAT8539
(Table 1). The lipid ﬁlm was formed with the help of Rotavapor1
(Buechi, Germany) with gradual pump down sequence of 500mbar
(5min), 200mbar (5min), 100mbar (5min), and 40mbar (1h at
room temperature). This ﬁlm was further dried under nitrogen for
15min. To the lipid ﬁlm, mixture of terpenes was added followed
by addition of ﬁltered saline phosphate buffer pH 7.4 (PBS) and
ethanol. The lipid ﬁlm was thoroughly vortexed to form multi-
lamellar vesicles (MLVs). MLVs were extruded 41 times through
polycarbonate membranes (Armatis, Germany) with pore diame-
ter of 100nm to ensure homogenous dispersion.
2.3.3. Liposomes
Liposomes were prepared by lipid ﬁlm hydration technique.
Brieﬂy, PL90G, and PL90H were dissolved in chloroform along with
the drug (Table 1). Organic phase was slowly removed on a
Rotavapor1 (Buechi, Switzerland) maintained at 40 C and at speed
of 100 rpm with a pump down sequence of 600mbar (5min),
400mbar (5min), 200mbar (5min), and 60mbar (1h). The dried
lipid ﬁlm was hydrated using Milli-Q1 water (Merck Millipore
Direct-Q13, Germany) and MLVs were allowed to anneal. Size
reduction of liposomes was performed using a bath sonicator
(Trans-O-sonic, D250/IH, India) for a total duration of 10min at
25 C.
2.4. Formulation of nanocarriers gel
All three systems viz. LeciPlex, invasomes, and liposomes had
low viscosity, hence for in vivo experiments, vesicular formulations
were dispersed into a suitable gel. Carbopol1 940, MethocelTM
K4M, and Polaxamer 188 were investigated for their ability to
improve topical applicability. To prepare gels of LeciPlex,
Liposome, and Invasome systems, gelling agents at 2% w/v
concentration were added in small aliquots under agitation to
Table 1
Formulation details of vesicular systems LeciPlex, invasomes, and liposomes.
Components CTAB LeciPlex DDAB LeciPlex Invasomes Liposomes
PL90G 31mg/mL 18.6mg/mL – 27.4mg/mL
PL90H – – – 3.1mg/mL
NAT8539 – – 133mg/mL –
Terpenes (Cineole:Citral:D-limonene in ratio 4.5:4.5:1.0) – – 10mg/mL –
Ethanol – – 100mg/mL –
CTAB 2.9mg/mL – – –
DDAB – 15.1 mg – –
Transcutol1 HP 50mL/mL 50mL/mL – –
Drug (Idebenone or azelaic acid) 2.5mg/mL 2.5mg/mL 2.5mg/mL 2.5mg/mL
Dispersion medium Milli-Q1water Milli-Q1 water PBS, pH 7.4 Milli-Q1 water
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the vesicular systems. Gels were prepared just before application
in the in vivo study and were allowed to hydrate for 1h before use.
2.5. Characterization of nanocarriers
2.5.1. Particle size distribution
Particle size distribution was measured by photon correlation
spectroscopy (N5 Submicron particle size analyzer, Beckman
Coulter Inc., USA) employing a 25mW He–Ne laser (wavelength
632.8nm) incident on the sample at an angle of 90. LeciPlex, and
liposomes were diluted with Milli-Q1 water and invasomes were
diluted with ﬁltered PBS pH 7.4 (0.22mm, Ultipor1N68 Nylon
6,6 membrane, Pall Life Science, Mumbai) to achieve optimal
scattering intensity ((1–10)105 counts/s). Samples were equili-
brated at 24 C before measuring particle size.
2.5.2. Zeta potential
Zeta potential of LeciPlex, invasomes, and liposomes was
evaluated using a Zetasizer (Nano ZS; Malvern, UK) and analyzed
using the Nano ZS version 6.34. Brieﬂy, Leciplex and liposomes
were appropriately diluted with 10mM sodium chloride solution
and zeta potential was measured using a disposable zeta cell DTS
1060C (Malvern, UK). For measuring the zeta potential of
invasomes, PBS was used as a dilution medium.
2.5.3. Entrapment efﬁciency
Entrapment efﬁciency was determined by diluting the delivery
system with saturated sodium chloride solution followed by
ultracentrifugation at 80000 rpm for 45min at 4 C. The superna-
tant was analyzed by using the HPLC method described earlier in
Section 2.2 and % entrapment efﬁciency was calculated.
2.5.4. CryoTEM
Cryo TEM study of various formulations was undertaken to
study the morphology of systems under investigation. For the
electron microscopic investigations, 5mL of each sample was
applied to Quantifoil1 copper grids R1.2/1.3 (Quantifoil, Germany),
coated with a perforated (circular holes with 1.2mm in diameter)
carbonﬁlm. The grids were mounted on a plunger, blotted (blotting
time 2 s) and vitriﬁed in liquid ethane at 180 C. After plunging,
the samples were transferred immediately with a Gatan 626
(Gatan Inc., USA) cryo holder to the Philips (Philips, Netherland)
CM120 transmission cryoelectron microscope (LaB6 cathode
source operated at 120kV accelerating voltage and stage main-
tained at –178 C). Images were recorded with a 1k1k Fast Scan-
F114CCD Camera (TVIPS GmbH, Germany). In order to minimize
the noise, ﬁve images were recorded and averaged to one image.
2.6. Ex vivo human skin penetration study
2.6.1. Preparation of human skin
Excised human skin from female patients who had undergone
abdominal plastic surgery (Praxis für Plastische Chirurgie, Kassel,
Germany) was used to study the ex vivo penetration of idebenone
and azealic acid from different delivery systems. Immediately after
the abdominoplasty, subcutaneous fat was removed and skin was
cleaned to remove any debris of blood or fat. Skin was cut into
manageable pieces and wrapped in aluminum foil and stored at
26 C for later use. Integrity of the skin was checked visually and
by measuring trans-epithelial water loss (Vapometer1, Delﬁn
Technologies Ltd., Finland). All protocols and standard operating
procedures for acquiring and processing of the human skin were
approved by the ethics committee of University Hospital-Jena,
Germany.
2.6.2. Ex vivo penetration experiments
Vertical Franz diffusion cells with diffusion area of 3.14 cm2 and
diffusion volume of 15mL were used for this study. Just before the
penetration experiment, skin discs were punched, thawed for 1h
and then hydrated using PBS for another hour. PBS was used as an
acceptor medium in the Franz cells. PBS was degassed under low
pressure for 30min just before mounting the skin on to the Franz
cells. Skin was mounted with stratum corneum side up. During
mounting, caution was exercised to remove all the air bubbles
between the dermis and diffusion medium. Skin was stretched
uniformly to avoid any wrinkles. Skin surface was maintained at
32 C by circulating water at 37 C through the outer jackets of the
Franz diffusion chambers. Formulations were applied to the skin
non-occlusively (inﬁnite dosing, 100mL/cm2) with the help of a
pipette. Using an inoculation loop, the dose was distributed
uniformly on the skin surface. The applied formulation was
thoroughly removed 6h after application of dose. For dose
removal, the remaining formulation was gently wiped off with a
cotton swab and then the skin surface was further cleaned by
rinsing the surface with 1mL of MilliQ1water three toﬁve times as
required, followed by cleaning with a cotton swab.
2.6.3. Tape stripping
After dose removal, skin was mounted on to a tape stripping
block with the help of cork discs and stainless steel pins. Skin was
gently stretched to remove any wrinkles. With the help of a teﬂon
mask of diameter 1.5 cm, a ﬁxed area of stratum corneum was
removed progressively using 10 adhesive tapes (Kristall Klar1 Tesa,
Germany). An adhesive tape was placed on the skin and a weight of
2kg was placed gently on the tape for 10 s to ensure uniform
contact between the skin and adhesive tape. After 10 s, the weight
was removed and adhesive tape was removed in one quick motion.
Tape strip was transferred to a suitably sized glass vial for further
extraction. For ease of analysis, tape number 1 to 5 and 6 to 10 were
pooled together.
2.6.4. Extraction of drug from skin samples
After tape stripping, viable epidermis (referred to as epidermis
from here on) was removed by careful scraping with the help of a
scalpel. Dermis was then cut into small pieces and collected into
2mL homogenization vials (PEQLAB Ltd., Germany). Each homog-
enization vial was preloaded with a combination of 1.4 and 2.8mm
zirconium beads. The extraction solvent used was a mixture of PBS
and methanol in 1:1 ratio. 2mL extraction solvent was used for
tape strips and 1mL for epidermis and each dermis sample. Vials
containing the tape strips were kept in a bench shaker at room
temperature for 24h. Epidermis and dermis samples were
homogenized using three 6000 rpm cycles (Precellys1 24, Bertin
Technologies, France). Post extraction, homogenate was collected
in microcentrifuge tubes and centrifuged at 13000 rpm (Mini-
Spin1, Eppendorf, Germany) for 10min and the supernatant was
analyzed by analytical methods described earlier.
2.7. Confocal microscopy study for determining distribution of DiI in
human skin
Formulations with lipophilic ﬂuorescent dye DiI [(2Z)-2-[(E)-3-
(3,3-dimethyl-1-octadecylindol-1-ium-2-yl)prop-2-enylidene]-
3,3-dimethyl-1-octadecylindole perchlorate] were prepared to
analyze the penetration behavior of different vesicular systems
and to see if any information pertaining to the penetration
mechanism can be obtained. Vesicular formulations were prepared
as described earlier with 0.65mg/mL of DiI in each vesicular
system. The ﬂuorescent formulations were applied to human skin
mounted on a Franz diffusion cells for duration of 12h. After the
penetration experiment, residual dose from surface of the skin was
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removed as described earlier. Skin was cut into small manageable
pieces and plunged into liquid nitrogen. Vitriﬁed skin was then
mounted onto a cryotome sample holder and 20mm sections were
taken perpendicular to the surface of the skin. The cut sections
were placed on a glass slide and maintained at 26 C until
observation by confocal laser scanning microscopy (CLSM).
Confocal imaging was performed using a Zeiss LSM 510 (Zeiss,
Germany) inverted microscope using an argon laser line at 488nm
as an excitation source. HFT UV/488-5 dichroic mirror was used for
splitting the beam and the reﬂected beam from the sample was
passed through LP560 emission ﬁlter before detection. All images
were recorded using constant gain and incident intensity. The raw
images were processed using ImageJ software 1.48v (Rasband,
1997–2014).
2.8. In vitro cytotoxicity study for idebenone formulations
Deliverysystems loadedwith idebenonewereevaluated for their
cytotoxicity potential using B16F10 melanoma cell line. Cell lines
were grown in Dulbecco’s modiﬁed eagle’s medium (DMEM)
containing 10% fetal bovine serum and 2mM L-glutamine at 37 C,
5% CO2, 95% air and 100% relative humidity for 24h prior to addition
of formulations. Idebenone solution was prepared in 30% v/v
Transcutol1 HP and sterile ﬁltered. Formulations were incubated
for 72h with the cells. After incubation, the microtitre plates were
centrifuged and the supernatant was discarded. The cells that
adhered to the bottomwere treated with [3-(4,5-dimethylthiazolyl-
2)-2,5-diphenyltetrazolium bromide] (yellow tetrazolium MTT) and
were incubated for another 4h. Post incubation, the purple colored
formazan crystals were dissolved in 100mL of DMSO and the plate
was read on a microplate reader at 570nm.
2.9. In vitro antimicrobial study for azelaic acid formulations
P. acne (1105 CFU/mL) was cultured in actinomyces broth as
described by Nakatsuji et al. (2009). Dilutions of azelaic acid
formulations were added to a sterile 96 well plate (90mL bacterial
culture+10mL azelaic acid formulation) such that the concentra-
tion of azelaic acid ranged from 104M to 107M. Blank medium
was used as a negative control. The plates were incubated under
anaerobic conditions at 37 C for 72h. Post incubation plates were
read on a plate reader (MODULUS microplate reader, Turner
Biosystems, USA) at 600nm. % bacterial cell viability was
determined using the readings for untreated control and respec-
tive treated formulation groups (Nakatsuji et al., 2009).
2.10. In vivo efﬁcacy study for azelaic acid formulations
Female Wistar rats (8–10weeks old) in weight range of 200–
250g were used for the to study. After appropriate dilution with
physiological saline, P. acne strainwas injected (20mL equivalent to
1.5107 CFU) using a 30 gauge needle intradermally into the mid-
ventral side of right ear of ether-anaesthetized rats. Ear thickness
was measured using a micrometer screw gauge at different time
points to determine the progression of acne in different animal
groups. Vesicular systems of azelaic acid were dispersed into gels,
as explained in Section 2.4 and were topically applied 1 day after
injection of P. acne and the change in development of acne was
studied for a total period of 10 days. Azelaic acid suspension
(2.5mg/mL) was used as a control and was also dispersed into a gel
as explained in Section 2.4. The reduction in the thickness (mm) of
acne was used to evaluate effectiveness of the formulations.
Animal study was approved by the institutional ethics committee
(protocol # CPCSEA/BCP/2010/05).
2.11. Statistical analysis
Datawere expressed as mean standard errorof mean (SEM) of
multiple determinations along with Student’s t-test using Graph-
Pad Prism 5 (GraphPad Software, Inc., USA). The differences were
considered statistically signiﬁcant if p <0.05.
3. Results
3.1. Analytical method development
Reverse phase HPLC methods adopted could successfully
separate idebenone and azelaic acid from the skin components.
Skin components eluted by 4min of the run time for the given
HPLC conditions and for all samples, the drug eluted after the skin
components.
3.1.1. Idebenone
The retention time for idebenone (LOD: 30ng/mL; LOQ: 100ng/
mL) and internal standard benzophenone were 10.9 and 6.9min,
respectively with benzophenone having a relative retention time
of 0.65. Linearity of response (r2 =0.99) was observed from 0.5mg/
mL to 10mg/mL.
3.1.2. Azelaic acid
The retention time for azelaic acid (LOD: 0.2mg/mL; LOQ:
0.6mg/mL) and internal standard sebacic acid was 7.8 and 17.1min,
respectively with sebacic acid having a relative retention time of
2.20. Linearity of response (r2 =0.99) was observed from 1.0mg/mL
to 50mg/mL.
3.2. Characterization of nanocarriers
3.2.1. Particle size
All the delivery systems were nanosized as observed by
dynamic light scattering (Table 2) and were in accordance with
the size obtained by CryoTEM (Fig. 2 and Fig. 3). LeciPlex
formulations had average sizes ranging from 250nm to 350nm
and PDI from 0.2 to 0.4. Invasomes had a size of about 140nm with
Table 2
Characterization of nanocarriers.
Drug Formulations Particle size (nm)Std Dev/PDIStd Dev Zeta potential (mV)Std Dev % Entrapment efﬁciency
Idebenone CTAB LeciPlex 350.53.8/0.4360.044 +66.80.8 95.75
DDAB LeciPlex 352.04.4/0.1970.100 +64.31.0 98.15
Invasomes 134.41.267/0.0930.003 14.81.61 93.6
Liposomes 288.30.2/0.4000.127 1.62.1 98.18
Azelaic acid CTAB LeciPlex 263.81.6/0.4530.002 +64.96.7 97.3
DDAB LeciPlex 296.83.0/0.2080.020 +64.78.0 95.2
Invasomes 139.20.080/0.0720.006 13.61.05 92.1
Liposomes 147.00.4/0.4330.056 +3.63.0 97.2
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PDI <0.1. Idebenone liposomes had an average size of 288nm with
PDI of 0.4 while azelaic acid liposomes were smaller at 147nm and
with a PDI of 0.4. Higher sizes and PDIs of LeciPlex formulations
were because they were mainly prepared using a single step
mixing without homogenization.
3.2.2. Zeta potential
The zeta potential for both idebenone and azelaic acid loaded-
CTAB LeciPlex or DDAB LeciPlex was more than +60mV (Table 2).
High positive zeta potential for LeciPlex system gives it a good
colloidal stability. Liposomal formulations were neutral as there
were no charge imparting components. Idebenone loaded lipo-
somes had a zeta potential of 1.6mV and azelaic acid loaded
liposomes had a zeta potential of +3.6mV. Invasomes had slightly
negative zeta potential around 13mV which was probably due to
the presence of phosphatidic acid and phosphatidylinositol
present in NAT8539.
3.2.3. Nanocarrier gels
For in vivo experiments, azelaic acid vesicles were incorporated
into a 2% MethocelTM K4M gel. Governing choice in selection of the
gelling agent was ease of gel formation, adequate viscosity and
homogeneity of the ﬁnal gel formulation. Although we did not
measure the viscosity of the ﬁnal vesicular gels, viscosity was
acceptable for topical application and had adequate applicability in
an in vivo efﬁcacy study.
3.2.4. % Entrapment efﬁciency
The entrapment efﬁciency for both idebenone and azelaic acid-
loaded vesicular systems was more than 90% (Table 2). Idebenone
as well as azelaic acid were loaded in liposomes, invasomes, and
LeciPlex at a concentration of 2.5 mg/mL, despite different drug to
lipid ratios, all formulations were loaded with equal amount of
drug to keep the same concentration gradient of drug for ex vivo
skin penetration study.
3.2.5. CryoTEM
CryoTEM images of vesicular systems loaded with idebenone
and azelaic acid are shown in Fig. 2 and Fig. 3. LeciPlex had a very
unique and a distinguishable feature. CTAB LeciPlex showed
mostly unilamellar and plurilamellar vesicles. DDAB Leciplex
showed well-deﬁned special plurilamellar systems, with the
lamellas arranged in a deﬁnitive pattern resembling concentric
rings, which are characteristically apart from each other. This
system is different from the multilamellar liposomes in which the
lamellas are very closely packed. These special structures could be
triggered by the presence of CTAB or DDAB as formulation
components and Transcutol1 HP as a biocompatible cosolvent.
Fig. 2. CryoTEM investigation of LeciPlex, invasomes, and liposome loaded with idebenone. A unique feature of LeciPlex prepared using CTAB is presence of multivesicular
liposomes (white solid ﬁlled arrows), which are unilamellar in nature. A unique feature of LeciPlex prepared with DDAB is the presence of well differentiated concentric rings
of each lamella (white arrows) suggesting presence of special plurilamellar vesicles.
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Liposomes and invasomes showed the traditional morphology of
soy PC vesicles. Invasomes were mostly unilamellar showing a
mixture of SUVs and LUVs, although a few vesicles were
oligolamellar. Liposomes were mostly unilamellar vesicles with
a few oligolamellar structures. Incorporation of drug did not seem
to affect the shape of the vesicular systems under study.
3.3. Ex vivo human skin penetration study
3.3.1. Idebenone
Total idebenone penetration in the skin (Fig. 4B) in descending
order was from CTAB LeciPlex, DDAB LeciPlex, liposomes and
invasomes, respectively. Total idebenone delivered by CTAB
LeciPlex was signiﬁcantly higher than that of invasomes. In the
Fig. 3. CryoTEM investigation of LeciPlex, invasomes, and liposome loaded with azelaic acid. Both cationic formulations exhibited mixture of unilamellar and plurilamellar
vesicles.
Fig. 4. (A) Ex vivo human skin penetration (mg/cm2) of vesicular systems loaded with idebenone. Signiﬁcant difference in idebenone content between invasomes (*),
liposomes (#) and CTAB LeciPlex, DDAB LeciPlex was observed. (B) Total idebenone (mg) recovered from all layers of the skin. Signiﬁcant difference between invasomes (*) and
CTAB LeciPlex. Error bars represent SEM (n=6).
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stratum corneum (Fig. 4A), CTAB LeciPlex delivered the highest
concentration of idebenone. In the epidermis, a trend similar to
that of stratum corneum was observed for penetration of
idebenone, with no statistically signiﬁcant differences. In dermis,
maximum idebenone penetration was achieved by liposomes
followed by CTAB LeciPlex, DDAB LeciPlex, and invasomes,
however, no statistically signiﬁcant differences were observed
among the formulations at the 5% signiﬁcance niveau. Idebenone
was not detected in the receptor ﬂuid. CTAB LeciPlex deposited the
highest amount of idebenone with 0.7% of the total applied drug
reaching different layers of the skin.
3.3.2. Azelaic acid
Total azelaic acid deposition in the skin from different
formulations (in descending order) was from, invasomes, lipo-
somes, DDAB LeciPlex, and CTAB LeciPlex (Fig. 5B). There were
signiﬁcant differences between all vesicular systems except among
liposomes and DDAB LeciPlex. In the stratum corneum, azelaic acid
from invasomes penetrated the most, followed by DDAB LeciPlex,
liposomes, and CTAB LeciPlex. Azelaic acid from invasomes showed
a signiﬁcantly higher penetration compared to all formulations.
There was a signiﬁcant difference between azelaic acid quantity
delivered into the skin by liposomes and CTAB LeciPlex as well as
between the two LeciPlex systems. In epidermis and receptor ﬂuid,
highest azelaic acid was delivered from invasomes followed by
liposomes, DDAB and CTAB LeciPlex, without signiﬁcant differ-
ences. Dermis also showed a similar trend although with
signiﬁcant differences in amount delivered by liposomes, inva-
somes and CTAB LeciPlex as well as between CTAB LeciPlex and
DDAB LeciPlex. Although it appears that azelaic acid penetration
was higher in dermis than in epidermis, the trend can be explained
by the fact that dermis is a much thicker tissue compared to the
epidermis (thickness of dermis was approximately 2mm com-
pared to approximately 100mm for epidermis). Azelaic acid loaded
invasomes deposited 5.75% of the total drug applied and could be
detected in different layers of the skin.
3.4. Ex vivo human skin distribution using confocal microscopy
Ex vivo distribution of DiI monitored using CLSM revealed a
marked contrast in the penetration behavior of different vesicular
systems. Fluorescence intensity observed was highest for the
cationic LeciPlex formulations followed by invasomes and lipo-
somes. Cationic LeciPlex particles appeared to have followed a
transfollicular route of penetration which resulted in deeper
penetration and accumulation of ﬂuorescent dye in the dermis as
evident from Fig. 6. There is an intense ﬂuorescence of DiI in the
stratum corneum for CTAB and DDAB LeciPlex. Although the DiI
ﬂuorescence is not as intense for invasomes, they did appear to
reach the deep hair follicles although in much lower concentration.
Liposomes on the other hand, showed only a weak ﬂuorescence
intensity in the stratum corneum. The ﬂuorescence intensity was
semi-quantitatively blind-scored (Verma et al., 2003c; Waring
et al., 1993) by four colleagues and scored as: (0) no ﬂuorescence;
(1) very weak ﬂuorescence; (2) weak ﬂuorescence; (3) medium
ﬂuorescence; and (4) bright ﬂuorescence. A summary of ﬁnal score
for all the formulations is presented in Table 3.
3.5. In vitro cytotoxicity study of idebenone formulations
In vitro cytotoxicity study was conducted to determine the
cytotoxic potential of different vesicular systems loaded with
idebenone on B16F10 melanoma cell line. Formulations containing
idebenone in the range of 0.001mM to 10mM were applied to the
cells (Fig. 7). High cytotoxicity was observed for LeciPlex
formulations at all the idebenone concentrations tested. There
were signiﬁcant difference between all the systems at all
concentrations except between invasomes and DDAB LeciPlex at
10mM idebenone and between invasomes and CTAB LeciPlex at
0.1mM idebenone. DDAB LeciPlex had the highest cytotoxicity
while liposomes had the least cytotoxicity for all the concen-
trations.
3.6. In vitro antimicrobial assay of azelaic acid formulations
As azelaic acid is indicated against acne, in vitro microbial assay
was performed for formulations containing azelaic acid. All the
formulations showed minimum to no antimicrobial activity at
concentrations of 0.1 and 1mM of azelaic acid. However, as
concentration of azelaic acid increased to 10 and 100mM a
relatively stronger antimicrobial activity could be seen. DDAB
LeciPlex showed the maximum antibacterial activity, with
invasomes and CTAB LeciPlex showing similarantibacterialactivity
at 10mM and 100mM azelaic acid concentration (Fig. 8). Lipo-
somes showed the lowest antimicrobial activity. At azelaic acid
concentration of 10mM and 100mM, signiﬁcant differences were
observed between all the delivery systems except between CTAB
LeciPlex and invasomes, and azelaic acid solution and liposomes.
Fig. 5. (A) Ex vivo human skinpenetration (mg/cm2) of vesicular systems loaded with azelaic acid. A signiﬁcant difference in azelaic acid content in stratum corneum between
invasomes (*) and all other vesicular systems was observed as well as in stratum corneum between liposome (#) and CTAB LeciPlex; DDAB LeciPlex (**) and CTAB LeciPlex. In
dermis, signiﬁcant difference between CTAB LeciPlex (j) and liposome, invasomes, and DDAB LeciPlex (C). (B) Total azelaic acid penetration from all layers of the skin. A
signiﬁcant difference between invasomes (*) and other vesicular systems was detected as well as between liposome (#) and CTAB LeciPlex, DDAB LeciPlex (**) and CTAB
LeciPlex. Error bars represent SEM (n=6).
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3.7. In vivo efﬁcacy study of azelaic acid formulations
Azelaic acid invasomal gels showed the highest in vivo activity,
with liposomal gels and DDAB LeciPlex gels showing similar
activity and CTAB LeciPlex gels showing the least activity (Fig. 9).
Therewere signiﬁcant differences between the azelaic acid-treated
formulations and the untreated control on all days except day 1.
Invasomal gels showed signiﬁcantly faster and better activity as
compared to other delivery systems from day 2 through day 7. By
day 10, all the delivery systems had achieved similar antiacne
activity but at different rates. Drug suspension had the least anti-
acne activity which might be due to slow diffusion in the stratum
corneum. Even untreated control showed reduced inﬂammation
which is expected as the immune system of the animal ﬁghts
against the infection. All the systems had statistically signiﬁcant
better in vivo activity when compared to azelaic acid suspension.
4. Discussion
In this study, we evaluated three fundamentally different types
of vesicular systems viz cationic LeciPlex, invasomes, and
liposomes for their ability to deliver idebenone and azelaic acid
using in vitro,ex vivo, and in vivo models. In ex vivo human skin
penetration study, idebenone vesicular systems followed a
descending order of idebenone deposition in different skin layers
starting with CTAB LeciPlex, DDAB LeciPlex, liposomes, and
invasomes. When the vesicular systems were loaded with azelaic
acid, under similar set of conditions the results were reversed. This
was an interesting result as although the two drugs were loaded at
the same concentration into same vesicular systems and were
evaluated under the same set of conditions for ex vivo studies,
marked differences were observed in penetration behavior of the
two drugs. This difference in the penetration behavior was an
indication either that different penetration mechanisms were
involved in the skin penetration of both drugs or that the two drugs
change the carrier system characteristics in different ways. The
ﬁrst rationale was substantiated by the CLSM studies where both
cationic LeciPlex formulations showed much higher ﬂuorescence
in the hair follicles. Although in this study we did not quantify the
ﬂuorescence intensity in the hair follicles, ﬂuorescence intensity
was an order of magnitude higher for LeciPlex formulations
followed by invasomes, while for control liposome formulation, no
ﬂuorescence was detected in the hair follicles. From this
observation, we can predict that LeciPlex employs a dual pathway
for skin delivery-transfollicular and intercellular compared to
mainly intercellular pathway for invasomes and control liposomes.
This ﬁnding is also supported by the ﬁndings from Jung et al.
(2006) where they compared different liposomal formulations
with a conventional cream for the delivery of ﬂuorescent dyes
carboxyﬂuorescein and curcumin to hair follicles. According to
Jung et al. (2006), surface charge, especially cationic, was an
important parameter for follicle delivery whereas size of vesicles
and transition temperature of phospholipids were of relatively less
importance.
Idebenone deposition in skin was signiﬁcantly higher from
CTAB and DDAB LeciPlex compared to invasomes. This contrast
might be explained by the interaction of idebenone with the
phospholipid membrane. Idebenone is a small molecule (molecu-
lar weight 338Da) which is practically insoluble in water and with
a pKa value of 15.19 (Li and Ge, 2012), it will have a neutral charge
within the phospholipid membrane and will prefer a lipophilic
environment. Fresta et al. (1998) have shown that idebenone is
fully inserted into a phospholipid membrane. The interaction of
idebenone with membranes is further enhanced by negatively
charged headgroups, which are present in the NAT8539 in the form
of phosphatidic acid and phosphatidylinositol. They also observed
a phase segregation in DMPC and DPPC liposomes containing
idebenone beyond a molar fraction of 0.09. Above a certain drug:
Table 3
Summarized blind average intensity scoring from confocal study described in
Section 3.4 for different vesicular systems using DiI as the ﬂuorophore on excised
human skin.
Delivery System Stratum corneum Epidermis Dermis Total Score
CTAB LeciPlex 3 2.25 3.5 8.75
DDAB LeciPlex 3.25 3 2.5 8.75
Invasomes 1.25 1.5 2 4.75
Liposomes 2.5 1.75 0.75 5
Fig. 6. Fluorescence micrographs showing cross sections of human skin treated with different formulations loaded with DiI. Every image is divided in twoparts, the left image
is a brightﬁeld image and the one on the right shows ﬂuorescence image. White arrows indicate the accumulation of the DiI in the hair follicle/sweat gland.
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lipid ratio, both idebenone rich and poor domains could therefore
be expected in the liposomal formulations. In CTAB and DDAB
LeciPlex, the idebenone molar fraction is 0.15 and 0.13, respective-
ly, compared to 0.056 for invasomes. This difference in the drug:
lipid ratio will have a big impact on the dynamics of drug transfer
from liposomal membranes to biological membranes. Drug release
from vesicles is an important step and it can inﬂuence transdermal
ﬂux (Chen et al., 2010; Honeywell-Nguyen and Bouwstra, 2003).
Fresta et al. have also shown that the rate-limiting step for
idebenone transfer from liposomal membrane to biological
membrane is diffusion through the aqueous compartment. Due
to higher drug:lipid ratio, idebenone will readily partition out of
the phospholipid membrane compared to invasomes and its
diffusion across the aqueous compartment might be facilitated by
presence of transcutol in LeciPlex formulations. Both these factors
explain higher deposition of idebenone from the cationic LeciPlex
formulations. Although liposomes had high drug:lipid ratio like
Leciplex formulations, liposomes did not perform equally to the
cationic formulations suggesting the presence of cationic surfac-
tants had a crucial role in increased deposition of idebenone from
Leciplex.
Azelaic acid (molecular weight 188Da) is a dicarboxylic acid
which is slightly soluble in water. Bossi et al. (1990) have shown
that in distearoylphospocholine (DSPC) bilayers, azelaic acid gets
completely inserted into the bilayers. Geometry of these bilayers
was found to be dependent on the drug:lipid molar ratio and
temperature. Below the transition temperature and above drug:
lipid molar ratio of 0.2, an interdigitated lamellar gel phase with
lamellar repeat distance of 5.25nm (decreased from 6.83nm for
conventional Lb phase) was witnessed. Above the transition
temperature, however, La lamellar phase was observed at all drug:
lipid ratios. They have also shown that azelaic acid strongly
interacts with phosphate in the phospholipid head groups and only
weakly interacts with the fatty acid chains, therefore chain melting
in DSPC was relatively unaffected by the presence of azelaic acid.
Due to the nature of phospholipids employed in the present study,
all the azelaic acid vesicular systems at experimental conditions
can be expected to be in La lamellar phase. In the ex vivo
penetration study, azelaic acid penetrated to the highest extent
when applied by loading in invasomes followed by liposomes,
DDAB LeciPlex, and CTAB LeciPlex. Lower penetration of azelaic
acid from LeciPlex formulations might be due to interactions
between the cationic surfactants and carboxylic groups of the
azelaic acid which would retard partitioning of azelaic acid out of
the LeciPlex vesicles. Differences between CTAB-LeciPlex and
DDAB-LeciPlex are difﬁcult to explain and we can only speculate
that they might have been due to differential skin penetration
enhancement abilities of individual surfactants. Duangjit et al.
investigated the link between chain length of cationic surfactants
and skin penetration by studying skin penetration ability of
Fig. 7. In vitro cyto-toxicity of idebenone solution and idebenone loaded CTAB LeciPlex, DDAB LeciPlex, invasomes, and liposomes at different molar concentrations of
idebenone. Signiﬁcant differences were observed between all vesicular systems at all concentrations except at 10mM between invasomes and DDAB LeciPlex (X); at 1mM,
0.1mM, 0.01mM, 0.001mM idebenone between solution and CTAB LeciPlex (h); at 0.1mM, 0.001mM idebenone between solution and invasomes (V); at 0.1mM between
invasomes and CTAB LeciPlex (F); and at 0.001mM between invasomes and DDAB LeciPlex (d). Error bars represent SEM (n=6).
Fig. 8. In vitro anti-microbial study of CTAB LeciPlex, DDAB LeciPlex, invasomes, and liposome loaded with azelaic acid. Error bars represent standard error of mean (n=6).
Blank medium served as control with % cell viability of 100%.
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meloxicam loaded cationic liposomes. They found that liposomes
containing 16 carbon chain surfactant penetrated better than
liposomes containing 12 carbon chain surfactant (Duangjit et al.,
2014). Our results however, are at variance with their ﬁndings as
DDAB-LeciPlex (C12) showed higher penetration of azelaic acid
than CTAB-LeciPlex (C16). However we must point out that
Duangjit et al. (2014) have used alkyl pyridinium based surfactants
compared to CTAB and DDAB tested in this study. To gain an
understanding into the differences in the penetration behavior of
CTAB and DDAB LeciPlex, further systematic studies are required.
In the past, Fahr et al. have successfully demonstrated that
invasomes can deliver hydrophilic and lipophilic drugs deeper into
the skin layers (Dragicevic-Curic et al., 2008b, 2009; Verma and
Fahr, 2004; Verma et al., 2003a). The penetration ability of
invasomes is believed to be due to higher deformability of the
vesicles. Deformability to invasomes vesicles is imparted by
terpenes and by lyso PC which is one of the components of the
NAT8539. Effect of lyso PC on bending elasticity of phosphatidyl-
choline membrane is well known (Fuller and Rand, 2001; Vitkova
et al., 2014), effect of terpenes on the ﬂuidity of the invasomes was
investigated using electron spin resonance spectroscopy and a 1%
mixture of citral:cineole:limonene (4.5:4.5:1) was found to be
optimal for topical delivery of temoporﬁn to deeper layers of skin
(Dragicevic-Curic et al., 2011; Dragicevic-Curic et al., 2008b).
In vitro cytotoxicity study of idebenone loaded vesicular
systems on B16F10 melanoma cell line gave an indication of
superior activity of LeciPlex followed by invasomes and liposomes.
An important contributing factor to the superior activity of
LeciPlex is the presence of cationic surfactant CTAB or DDAB,
which are known to have cytotoxic activity (Cui et al., 2006). Blank
formulations of invasomes, CTAB LeciPlex, and DDAB LeciPlex
showed weak cytotoxic activity in the cell line investigated (Data
not shown). Cytotoxicity of blank invasomes could be due to the
presence of ethanol.
All azelaic acid formulations showed antimicrobial activity
above 10mM and 100mM azelaic acid concentration except
liposomes which did not show any signiﬁcant antimicrobial
activity at 10mM azelaic acid concentration. Highest activity
was seen for DDAB LeciPlex at 10mM and 100mM azelaic acid
concentration. In vitro antimicrobial study on P. acne revealed that
at concentration of 10mM and 100mM, signiﬁcant differences
were observed between all the delivery systems except between
CTAB LeciPlex and invasomes, and between liposomes and azelaic
acid solution. In vivo antiacne efﬁcacy study showed signiﬁcant
differences in the effectiveness of different azelaic acid loaded
delivery systems. Invasomal gelswere the best performing delivery
system followed by liposomes and DDAB LeciPlex gels, while CTAB
LeciPlex gels was the slowest to exert its antiacne effect. P. acne is
often found in the microcomedone that is a precursor of acne
vulgaris, which is characterized by hyperkeratinisation, formation
of keratin plug, and increase in sebum production by sebaceous
glands. P. acne stimulates the production of pro-inﬂammatory
cytokines (Nakatsuji et al., 2011). Because of increased penetration
facilitated by invasomes which is also evident from ex vivo
penetration study, more amount of azelaic acid could have been
available at the site of inﬂammation of P. acne leading to faster
therapeutic action. There were signiﬁcant differences between all
the vesicular systems and untreated control on all days starting
from day 2. A signiﬁcant difference between activity of azelaic acid
as invasomes and liposome from day 2 through day 7 was
Fig. 9. In vivo efﬁcacy study of CTAB LeciPlex, DDAB LeciPlex, invasomes, and liposome loaded with azelaic acid. Bonferroni’s multiple comparison test was applied to
determine statistical difference between delivery systems on different days, which are tabulated. Error bars represent SEM (n=6).
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observed, after which the baseline activity was attained for both
systems. Liposomal gels were closely followed in activity by DDAB
LeciPlex gels which were followed by CTAB LeciPlex gels. In
essence, although CTAB LeciPlex performed well in the in vitro
antimicrobial study, it was the slowest of all formulations in in vivo
efﬁcacy study. This slow response for cationic formulations is likely
due to the fact that CTAB and DDAB are known to cause some
inﬂammation on topical application (Smith and Maibach, 2006)
and acne being a condition where skin is inﬂamed due to
inﬂammatory cytokines, the therapeutic efﬁcacy of azelaic acid
could have been reduced due to inﬂammation caused by CTAB or
DDAB itself. A few factors that need careful consideration while
correlating ex vivo and in vivo efﬁcacy are (a) the ex vivo
penetration study was performed on intact excised human
abdominal skin, (b) the in vivo efﬁcacy was performed on rat
ear skin, and (c) the in vivo studies are performed in P. acne induced
inﬂamed skin. Human skin is less permeable than rat skin (Van
Ravenzwaay and Leibold, 2004) and this physiological difference
could also be a determining factor. An important correlation
observed in these studies was that azelaic acid loaded in invasomes
penetrated the most in ex vivo study on human skin and also
showed high in vivo efﬁcacy compared to other vesicular systems.
5. Conclusion
In this bicentric study, vesicular systems loaded with two
actives differing in physicochemical properties were successfully
developed and characterized. LeciPlex increased delivery of
idebenone whereas invasomes increased delivery of azelaic acid
in ex vivo experiments. In vivo efﬁcacy study for azelaic acid
formulations supported this hypothesis. Intracutaneous delivery of
actives is presented based on drug properties, properties of
formulation components, and properties of the formulation as a
whole.
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4. Discussion 
 
The last couple of decades have seen an enormous growth in microscopic techniques available for 
biomedical research. Adopting such new technologies, various secrets of nature can be revealed. The 
first application of liposomes for drug delivery to skin was demonstrated back in 1980 by Mezei and 
Gulasekharam (Mezei and Gulasekharam, 1980) and even after 35 years, mechanism for liposomal drug 
delivery to skin still remains ambiguous. Studies presented in this thesis were designed to probe the 
mechanisms of drug delivery to skin from topically applied liposomes. Studies presented in publication-
2 and 3 not only probe the liposome-skin interactions but also present relatively easy sample preparation 
techniques which could be adopted easily by the scientific community to expand their research further.  
 
4.1 Application of confocal Raman microscopy to probe liposome-skin interactions 
Theoretically there are five mechanisms by which liposomal drug delivery to the skin can be envisaged. 
In brief, these mechanisms include a) free drug penetration mechanism, where liposomes only act as 
carriers of the drug up to the skin and drug penetrates on its own; b) penetration enhancing mechanism, 
where liposomal components cause an ultrastructural change to the SC structure resulting in enhanced 
drug penetration; c) vesicle adsorption or fusion, where liposomes are adsorbed or fused with the surface 
of the SC releasing the drug in the stratum corneum; d) intact penetration, liposomal vesicles penetrate 
the skin intact carrying the drug along with them and e) transfollicular penetration, liposomal 
penetration via the follicles where drug is released. Given the vast variation in the penetration 
mechanisms, experiments described in this thesis were designed to probe the liposome-skin interactions 
and gain a better understanding of the possible penetration mechanisms for the drug delivery from 
topical application of invasomes. Mendelsohn’s group using infrared and Raman microscopy has 
previously mapped phospholipids in pig skin following topical application of deuterated liposomes 
(Xiao et al., 2005a; Xiao et al., 2005b). However, their approach involved cryo-sectioning the skin 
before the measurements, an approach which is rather difficult to employ for high resolution Raman 
imaging. Lunter and Daniels (2014) have employed a similar technique for investigating delivery of 
procaine in the pig skin. 
Understanding the diffusion of phospholipid along with the drug can be a crucial part of the puzzle in 
understanding the mechanism of drug delivery to skin from liposomes especially as each mechanism 
points to subtle differences in the drug-phospholipid diffusion profiles. The ‘penetration enhancing 
mechanism’ and ‘intact penetration mechanism’ suggest a relatively high penetration of phospholipid at 
least in the upper SC. In both mechanisms, phospholipid and drug would diffuse together. If liposomal 
drug delivery followed ‘the free drug mechanism’ then the SC should not have any phospholipid but the 
drug should be relatively uniformly distributed in the SC. ‘Vesicle adsorption or fusion mechanism’ 
would have shown the uppermost layers of the SC to have a very high phospholipid deposition and a 
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relatively homogenous distribution of the drug in the deeper stratum corneum. If the primary mechanism 
of penetration was ‘transfollicular’ then diffusion of phospholipid should exhibit a columnar diffusion 
and should be relatively diffused around the follicles deeper in the SC or in viable epidermis.  
Many scientific groups have studied the interactions between liposomes and skin in the past. Most 
notable microscopic techniques employed were confocal fluorescence microscopy (Alvarez-Roman et 
al., 2004; Schatzlein and Cevc, 1998; van Kuijk-Meuwissen et al., 1998; Verma et al., 2003), two-
photon microscopy (Carrer et al., 2008; van den Bergh et al., 1999) and freeze fracture electron 
microscopy (Bouwstra and Honeywell-Nguyen, 2002; Hofland et al., 1995; van den Bergh et al., 1999). 
Freeze fracture electron microscopy although can provide high magnification images, sample 
preparation is extremely complicated which makes FFTEM rather unsuitable for studying the liposome-
skin interactions. Fluorescence based techniques on the other hand have to rely on fluorescent labels. 
Fluorescent labels tend to be bulky and can also partition out of the liposomal membrane and diffuse 
independently in the SC.  
Confocal Raman microscopy (CRM) on the other hand allows for a label-free imaging of the biological 
tissues and can even produce spectral mapping of the sample, which can be useful in determining the 
penetration profiles of the liposomal contents. However, high resolution non-invasive Raman depth 
profiling of ex vivo human skin is quiet challenging as long acquisition times required for Raman 
imaging can result in very high-energy transfer to the skin, which affects sample stability. Publication-
2 presents for the first time a method with minimum sample preparation for acquiring high resolution 
non-invasive Raman depth maps of treated and untreated ex vivo human skin. Using the method 
described Raman mapping down to approximately 30 µm deep in the full thickness human skin was 
possible. Improvements in the penetration depth would require higher laser power or increased 
acquisition times, both of which compromise sample stability. To achieve this, two important changes 
were made to the method: 1) a water immersion objective was employed and 2) closed cell-design was 
used which not only reduced the skin dehydration rates but also tissue damages due to local heating was 
reduced as heat can dissipate more efficiently. Closed-cell design approach also avoids over-hydration 
of the SC from the water required for the water immersion objective. Figure 8 presents a comparison of 
the two methods. Using the closed-cell design Raman depth mapping up to a depth of 60 µm for full 
thickness human skin and up to 70 µm for full thickness pig skin was possible. At deepest focal planes 
the quality of Raman spectra did deteriorate. Lateral resolution achieved with this method was 1 µm 
whereas axial resolution at least for the upper SC was 1 µm however for deeper focal planes due to 
changes in the refractive index (Xiao et al., 2004) the resolution was lower than 1 µm.  
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Publication-2 demonstrated that method can be employed for diffusion mapping of beta-carotene and 
deuterated water. Penetration of deuterated water in the Raman depth profiles appears to be uniform 
which was no surprise as water is known to penetrate the skin very well. However, application of beta-
carotene solubilized in DMSO to human skin showed non-homogenous penetration of beta-carotene. 
Reason for such non-homogeneity from a solution was not completely obvious. But one can speculate 
that it might be a function of localized concentration of DMSO and water as beta-carotene precipitates 
quickly in presence of water.  
An interesting aspect observed in the depth profile measurements was the presence of localized 
fluorescence in human skin. In human skin, stratum corneum was always fluorescence free however at 
about 15-20 µm in the skin isolated islands of fluorescence were observed. These patches of 
fluorescence were probably originating from the skin pigments present in the viable epidermis. Another 
interesting aspect was observed during human skin selection. During the course of the experiments 
human skin from different patients was used and skins which appeared to have a spray tan showed much 
greater levels of fluorescence to an extent that measurements even in the SC were heavily affected. 
Similar results were observed even for dark-toned skin. Therefore for the Raman depth profiling, 
untanned Caucasian skin was preferable.  
Raman depth maps obtained constitute a complex dataset and spatial distribution of various spectral 
components was determined by vertex component analysis (VCA). In untreated human skin samples, 
the endmembers obtained mainly consisted of spectral features typical of proteins, lipids and 
fluorescence (kindly refer publication-2, page-67, for specific band assignments). In pig skin no 
fluorescence was observed as pig skin naturally lacks melanin pigments which are main source of 
fluorescence in human skin especially at 785 nm. For beta-carotene treated human skin samples, VCA 
Figure 8: A schematic showing comparison of an open-cell (taken from publication-2) and a closed-cell sample 
holder design used for in the measurement of Raman depth profiles. 
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was able to map high-low concentrations of beta-carotene in the skin along with intrinsic components 
of the skin such as proteins, lipids and fluorescent pigments.  
All the above results demonstrated that the method had the technical capability to determine the co-
diffusion of the drug and liposomal-phospholipid from a topical application to skin. However, upon 
treating human skin with invasomes containing deuterated phospholipids (for composition of invasomes 
kindly refer to section 3.2.1), we could not detect diffusion of deuterated phospholipid in the skin. In 
order to reason with this issue, dose of deuterated invasomes applied to the skin was increased coupled 
with to increased diffusion time on the Franz cells however it did not make a significant difference. 
Possible rationale for this observation are; 
 Only a small amount of phospholipid penetrates the SC and CRM is not sensitive enough to 
detect the phospholipid that has penetrated in the SC.  
 Deuterated phospholipid (d31-POPC) employed for preparation of invasomes in this study was 
not an ideal phospholipid and does not impart a significant penetration enhancing effect on the 
skin.  
If phospholipids do not penetrate the SC at all then skin penetration mechanism for invasomes points at 
a ‘free drug mechanism’ for delivering drug to the skin. However this is rather unlikely as there is an 
evidence that invasomes increase penetration of hydrophilic compounds in the skin (Chen et al., 2010; 
Verma et al., 2003) compared to their aqueous solutions. Also given the vast amount of literature 
suggesting that liposomes can cause changes to the SC lipid organization (Bouwstra and Honeywell-
Nguyen, 2002; Hasanovic et al., 2011; Hofland et al., 1991; Honeywell-Nguyen and Bouwstra, 2005; 
Loan Honeywell-Nguyen et al., 2002; van den Bergh et al., 1999), it is more likely that the CRM is not 
sensitive enough to detect the d31-POPC that has penetrated the full thickness human skin. 
 
4.2 Tip-enhanced Raman scattering spectroscopy to probe the interactions between skin and 
invasomes 
While confocal Raman microscopy was employed to explore diffusion of phospholipids, tip-enhanced 
Raman scattering (TERS) allowed to probe the liposome-stratum corneum interactions at resolution 
much greater than a Raman or infrared microscope would allow. TERS experiments in the publication-
3 were inspired by the work of the Bouwstra group who has demonstrated, using freeze fracture electron 
microscopy, that liposome treated skin shows changes in the intercellular lipids and also shows 
penetration of intact liposomal vesicles in the stratum corneum (Bouwstra and Honeywell-Nguyen, 
2002). Although freeze fracture microscopy can provide a very good lateral resolution, it cannot 
qualitatively identify the externally applied phospholipid. Also extensive sample preparation required 
for freeze fracture technique makes it rather vulnerable to introduction of artifacts. Therefore, an 
ambition in this study was to keep the sample preparation to a minimum so as to minimize the risk of 
introduction of any artifacts and measure in ambient conditions to avoid issues with sample stability.  
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TERS presented a unique opportunity where samples could be imaged at ambient conditions with sub-
nanometer lateral resolution and also provided spectroscopic information at high resolution. Findings of 
these experiments would allow us to comment on the interactions between the SC and invasomes. One 
of the biggest challenge in the TERS measurements was the sample preparation. AFM-head required 
the sample to be rigid and the bottom illumination for TERS meant sample had to be transparent in order 
to allow for the collection of TERS signal (Deckert et al., 2015). These requirements eliminated the 
possibility of measuring a full thickness skin directly and tape-stripping was chosen for sampling of the 
SC. To take in to account the requirements of the TERS setup, a protocol for spin coating glass cover 
slips using a proprietary adhesive was developed successfully in-house. Using the adhesive coated glass 
cover slips, the stratum corneum could be progressively removed just like in case of tape stripping 
(Lademann et al., 2009). However extreme care was required during tape stripping as any excess force 
and the adhesive glass cover slip cracked. To overcome this issue a Teflon mesh was introduced in the 
form of a mask on to the skin which not only limited the area of sampling the SC but also aided in 
smooth and fast removal of the adhesive cover slip. Based on densitometry data for 50 adhesive cover 
slips, the in-house developed stripping technique was about 62% as effective in removing SC as krystal 
klar® TESA adhesive tape which is regularly used for tape stripping.  
In order to identify topically applied phospholipid, invasomes were prepared using a head deuterated 
phospholipid 1,2-dilinoleoyl-3-phosphocholine-N,N,N-trimethyl-d9 (d9-DLPC) (kindly refer to 
publication-3 page 83, for formulation details). d9-DLPC was selected for preparation of invasomes 
because, enhancement of Raman signal in TERS is strongly distance dependent and deuteration at the 
head groups allowed for a higher enhancement factor compared to chain deuterated phospholipid 
bilayers in our preliminary experiments. Another factor in lipid selection was that 1,2-dilinoleoyl 
phosphatidylcholine represents a major fraction (~ 65%) of natural soy-phosphatidylcholine NAT8539 
which is employed in the preparation of invasomes (kindly refer to table 4 for composition of 
NAT8539).  
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To demonstrate the proof of concept, TER spectra were measured on supported lipid bilayers and 
compared with Raman and surface enhanced Raman scattering (SERS) spectra. In all three techniques 
bands observed between 2000 – 2300 cm-1 were representative of the C-D vibrational modes. 
Differences between Raman/SERS and TERS spectra were due to the inhomogeneity of the field 
enhancement and polarization effects in TERS (Deckert-Gaudig et al., 2010). Due to these phenomena 
not all bonds experience equal enhancement effect in TERS which often gives rise to a disparity between 
Raman and TERS spectra.  
After 4 hour application of invasomes, skin was thoroughly cleaned under running water to ensure 
complete removal of topically applied formulation. After removal of 10 layers of SC, all the layers were 
first subjected to atomic force microscopy (AFM) to identify the regions of interest and were followed 
by TERS measurements for identification of structures of interest. In the AFM measurements, a marked 
difference between the treated and untreated samples was observed. In invasome treated samples, there 
was a persistent presence of flattened vesicles throughout all the samples. Such flattened vesicles were 
about 5-10 nm in height indicating vesicles were flattened and consisted of one or two phospholipid 
bilayers. Although, whether vesicles penetrated in flattened state or vesicles were flattened after 
stripping of the SC could not be established based on the current studies. These flattened vesicles were 
very similar to the features reported by Bouwstra’s group (Figure 9) in human SC treated with 
deformable liposomes (Bouwstra and Honeywell-Nguyen, 2002). Since studies by Bouwstra’s group 
were carried using freeze fracture electron microscopy, there was no opportunity for a qualitative 
analysis, as in freeze fracture technique the original sample is destroyed (Severs, 2007). Flattened 
vesicles were present on the surface of corneocytes in all 10 layers analyzed. Apart from vesicles, 
corneodesmosomes were observed in both treated and untreated samples and could be easily 
distinguished from flattened vesicles on the basis dimensions.  
Figure 9: Comparison of the flattened vesicles in stratum corneum followed by treatment with 
liposomes reported by (A) Bouwstra and Honeywell-Nguyen (2002) using freeze fracture electron 
transmission electron microscopy (B) AFM image of invasome vesicles on the surface of corneocyte 
reported in publication-3.  
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AFM analysis identified the regions of interest in the skin samples and was followed by TERS 
measurements. The biggest advantage of the current study was that the skin samples could be 
qualitatively measured by investigating the figure print spectra of the invasomal head deuterated 
phospholipid. TER spectra were measured mainly on the flattened vesicles and channels or ridges on 
the surface of corneocytes. TER spectra measured on the surface of the vesicles showed Raman bands 
positive for C-D vibrations. When spectra were measured on adjacent points outside the vesicles, Raman 
bands typical for proteins and lipids in the skin were observed without any C-D bands. This observation 
established the integrity of the TERS tip and also confirmed that the flattened vesicles present on the 
surface of the corneocytes were indeed topically applied invasomes. TER spectra were also measured 
on ridges and surface of corneocytes where there were no vesicular structures present. These 
measurements were intended to quench the curiosity to find deuterated phospholipid that might have 
diffused from topically applied invasomes. It must be stressed that such measurements were like 
searching for a needle in a haystack as there were no topographical features to guide the placement of 
TERS grids like in case of measurements on vesicles. Despite the odds, on few occasions deuterated 
phospholipid was detected on the ridge like structures in corneocytes. Points where deuteration was 
detected did not have any topographical feature resembling a vesicle. On one occasion, along with 
deuteration spectra were also positive for 700 cm-1 cholesterol band indicating that these spectra were 
measured in the intercorneocyte lipids. 
TERS results together with the high resolution AFM studies presented in publication-3 give a strong 
evidence that invasomes can in fact penetrate the human SC although not in a great number as only a 
very small fraction of the topically applied vesicles could be identified in the skin. One limitation of the 
study was that actual penetration depth for the invasomal vesicles was rather difficult to predict. A rather 
conservative speculation is that by 10th layer the sampling technique has reached depth of at least 5 µm 
in the SC. Stratum corneum of the forearm in healthy humans is about 10 to 20 cell layers thick (Ya-
Xian et al., 1999) with stratum disjunctum accounting for the first 3-5 cell layers. Therefore it was very 
likely that sampling technique described here was able to also probe the stratum compactum present 
below the stratum disjunctum.  
TERS is a very complex technique and has been shown to have capability to detect even single 
molecules (Treffer et al., 2011). Ideally for TERS, samples should be as flat as possible as this ensures 
easy access for the TERS tip to the sample surface. Skin samples measured in the current study were far 
from ideal samples and despite this we could demonstrate application of TERS on complex skin samples. 
In this study a sample preparation technique was developed and interactions between the SC and 
invasomes were successfully probed. However, few answers raise more questions. A more 
comprehensive study to compare different topical liposomal formulations and a thorough investigation 
to see how deep intact vesicles can be seen in the SC makes a quiet appealing outlook for this project. 
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4.3 Mechanism behind invasomal drug delivery to skin 
Based on the results published in this thesis, it is foreseeable that mechanism involved in drug 
penetration from topical invasomal application would involve a combination of ‘penetration of intact 
vesicles’ and ‘penetration enhancement mechanism’. The above predictions are mainly based on the 
publication-3 where effect of empty invasomes on the stratum corneum was studied. Although, Hofland 
et al. (1995) provided the first evidence for intact liposomes penetrating the SC using freeze fracture 
electron mcroscopy, we have presented for the first time a strong spectroscopic evidence along with 
imaging to support the claim. Although intact invasomal vesicles were observed in the SC, a claim 
cannot be made that this is the main mechanism for drug penetration in the skin. This skepticism arises 
from the fact that only a very small fraction of vesicles could be detected in the SC, compared to what 
was applied topically to the skin. If this small fraction is able to make a big enough impact on the SC 
barrier function is not clear. Also the state in which these vesicles penetrate the SC was not clear and 
whether they would be able to carry drug deeper along with them will need future investigations. The 
TERS study also points towards the ‘penetration enhancement mechanism’ which is one of the well 
accepted mechanism for liposomal drug penetration (El Maghraby et al., 2006). In this mechanism 
components which make up the liposomal vesicles penetrate the intercorneocyte lipids either in the form 
of individual molecules or in smaller molecular arrangement.  
Studies in publication-4 emphasized that, during formation development a close attention should be 
given to the interactions between the drug and phospholipid bilayer. For highest drug penetration in the 
skin, it will be important for the drug to partition out of the lipid bilayer and enter the intercorneocyte 
lipids. Once the drug has partitioned out, further movement of the drug will be determined by 1) 
physicochemical properties of the drug 2) components of the liposomes. Components of the liposomes 
play an important role as they would influence the extent of disruption of the intercorneocyte lipids. 
Higher the extent of disruption, higher will be the drug penetration. However first the drug must be able 
to partition out of the liposome bilayer and into the SC lipids. If drug is involved in electrostatic 
interactions with the liposomal bilayer as seen in the publication-4 or if the drug is so lipophilic that it 
prefers to stay associated with the bilayer then using a liposomal system for delivering such drugs would 
rather hamper the drug delivery rather than enhancing it.  
In general, liposomes in topical delivery do not offer a ‘one-stop’ solution. For example, ibuprofen gel 
with penetration enhancers would far outweigh ibuprofen-liposome system. Cost factors and long term 
stability also make topical liposomal formulation a little impractical. Topical liposomal systems would 
be rather more suitable in instances where conventional systems cannot be applied successfully. 
Summary 
121 
5. Summary 
 
Stratum corneum forms the most significant part of the skin barrier for topically applied substances. 
Various invasive and non-invasive strategies such as chemical penetration enhancers, iontophoresis, 
microneedles etc. can be employed to increase drug penetration through the skin. Liposomes have also 
been shown to enhance the penetration of a variety of drugs in the skin. Invasomes is a soy-
phosphatidylcholine based liposomal system that was developed by the Fahr group for drug delivery to 
skin. When drug substances are applied on the skin in solution form, drug penetration mainly depends 
on the physicochemical properties of the drug however, incorporation of drugs in the liposomes results 
in a rather complex interaction between the stratum corneum, phospholipid membrane and drug. Studies 
in this thesis were designed to probe the interactions between the stratum corneum and invasomes in 
order to gain a better understanding of the mechanisms involved in the drug delivery to skin from 
invasomes.  
Confocal Raman microscopy was employed to study the co-diffusion of liposomally entrapped drugs 
and the phospholipids forming the liposomal bilayers. The study was based on a premise that if diffusion 
patterns of both, drug and phospholipid could be studied in the skin then it might allow us to comment 
on the underlying mechanism responsible for penetration of drug as each mechanism should give rise to 
a different diffusion profile. Confocal Raman microscopy was the preferred choice of imaging technique 
as it facilitated possibility of a label-free identification. Biggest challenge in such measurements was to 
keep the sample stable. A method was developed to obtain non-invasive Raman depth profiles in ex vivo 
human skin. Optical biopsies of untreated skin were measured along with diffusion profiles of skin 
treated with beta-carotene and deuterated water. The maximum penetration depth achieved for the 
optical biopsies was about 30-35 µm, which was subsequently improved to increase the penetration 
depth achieved to about 60 µm. This method was unfortunately not sensitive enough to measure the 
diffusion of deuterated phospholipid applied topically in the form of invasomes. 
A more sensitive method to probe the interactions between liposomes and the stratum corneum was 
required. Tip-enhanced Raman scattering (TERS) was the tool of choice as TERS is not limited by the 
Abbe’s resolution limit and is an excellent tool for providing chemical and structural information. 
Conventional tape stripping technique was adopted to allow application of TERS. In vivo human skin 
was treated with deuterated invasomes and the stratum corneum was progressively removed. TERS and 
atomic force microscopy measurements revealed that intact invasome vesicles did penetrate the stratum 
corneum. Vesicular structures were flattened and were observed in all 10 layers which were analyzed in 
the measurements. For the first time spectroscopic evidence along with high resolution imaging 
confirmed that intact liposomes can penetrate the human stratum corneum. 
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Further, in a bicentric study, three vesicular systems viz. cationic LeciPlex, amphoteric invasomes and 
conventional liposomes were compared for their ability to deliver idebenone and azelaic acid into the 
deeper layers of human skin. All formulations were also characterized and their efficacy was measured 
using in vitro cell assays and in vivo animal model. Observations were discussed based on the drug-
liposomal membrane interactions. 
Based on results of studies discussed in this dissertation, it is anticipated that drug delivery to skin from 
topically applied invasomes would encompass a combination of mechanism of penetration enhancement 
and transport by intact vesicle penetration.  
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Zusammenfassung 
 
Das Stratum corneum bildet den wichtigsten Bestandteil der Hautbarriere für topisch applizierte 
Substanzen. Verschiedene invasive und nicht-invasive Strategien, wie z.B. chemische 
Penetrationsverstärker, Iontophorese, Mikronadeln usw., können angewandt werden, um die 
Wirkstoffpenetration durch die Haut zu verbessern. Es wurde auch gezeigt, dass Liposomen die 
Penetration einer Vielzahl von Medikamenten durch die Haut verbessern können. Invasomen sind ein 
auf Soja-Phosphatidylcholin basierendes Liposomensystem, das von der Arbeitsgruppe um A. Fahr für 
den Wirkstofftransport durch die Haut entwickelt wurde. Werden Wirkstoffe in Form einer Lösung auf 
die Haut appliziert, hängt die Penetration hauptsächlich von den physikochemischen Eigenschaften der 
Substanz ab. Werden sie dagegen in Liposomen eingearbeitet, führt dies zu einer ziemlich komplexen 
Wechselwirkung zwischen dem Stratum corneum, der Phospholipidmembran und dem Wirkstoff. Die 
in dieser Arbeit durchgeführten Studien wurden konzipiert, um die Wechselwirkungen zwischen 
Stratum corneum und Invasomen zu untersuchen, um dadurch ein besseres Verständnis der 
Mechanismen zu erhalten, die an der Wirkstoffabgabe aus den Invasomen in die Haut beteiligt sind. 
Konfokale Raman-Mikroskopie wurde verwendet, um die Codiffusion von liposomal eingeschlossenem 
Wirkstoff und den dazugehörigen, den liposomalen Bilayer formenden, Phospholipiden zu untersuchen. 
Diese Studie basiert auf der Voraussetzung, dass man, falls das Diffusionsmuster von Wirkstoff und 
Phospholipid in der Haut untersucht werden kann, eine Erklärung darüber äußern kann, welche 
Mechanismen für die Penetration des Wirkstoffes verantwortlich sind, da jeder Mechanismus ein  
unterschiedliches Diffusionsprofil hervorruft. Konfokale Raman-Mikroskopie war dabei das bevorzugte 
Bildgebungsverfahren, da es eine Identifikation ohne vorherige Substanzmarkierung ermöglicht. Die 
größte Herausforderung bei solchen Messungen war es, die Probe stabil zu halten. Es wurde ein 
Verfahren entwickelt, um nicht-invasive Raman-Tiefenprofile in menschlicher Haut ex vivo zu erhalten. 
Optische Biopsien von unbehandelter Haut und ein Diffusionsprofil von, mit Beta-Carotin und 
deuteriertem Wasser, behandelter Haut wurden aufgenommen. Die maximale Eindringtiefe, die bei 
dieser Gewebeuntersuchung anfänglich erreicht wurde, lag bei ungefähr 30-35 µm und wurde 
anschließend auf ungefähr 60 µm verbessert. Dennoch war diese Methode leider nicht sensitiv genug, 
um die Diffusion von deuterierten Phospholipiden, die topisch in Form von Invasomen appliziert 
wurden, zu messen. 
Daher wurde eine empfindlichere Methode benötigt, um die Interaktionen zwischen Liposomen und 
Stratum corneum zu untersuchen. Tip-Enhanced Raman Scattering (TERS) war das Mittel der Wahl, da 
TERS nicht durch das Auflösungsvermögen nach Abbe limitiert ist und ein exzellentes Werkzeug 
liefert, um chemische und strukturelle Informationen zu erhalten. Die konventionelle Tape-Stripping-
Methode wurde modifiziert, um die Anwendung von TERS zu ermöglichen. Dabei wurde menschliche 
Haut in vivo mit deuterierten Invasomen behandelt und das Stratum corneum anschließend schrittweise 
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entfernt. TERS und Atomkraftmikroskopie (AFM) zeigten, dass intakte Invasomvesikel das Stratum 
corneum penetrieren können. Vesikuläre Strukturen wurden abgeflacht und konnten in allen 10 
Schichten, die in den Studien untersucht wurden, beobachtet werden. Dadurch konnte erstmals mit Hilfe 
von spektroskopischen Hinweisen, in Kombination mit einer hochauflösenden Bildtechnik, bestätigt 
werden, dass intakte Liposomen das menschliche Stratum corneum penetrieren können.  
In einer bizentrischen Studie wurden drei vesikuläre Systeme – kationische LeciPlex, amphotere 
Invasomen und herkömmliche Liposomen – auf ihre Fähigkeit untersucht, Idebenon und Azelainsäure 
in die tieferen Schichten menschlicher Haut zu transportieren. Alle Formulierungen wurden 
entsprechend charakterisiert und ihre Wirksamkeit mit Hilfe von in vitro-Zellassays und in vivo-
Tiermodellen gemessen. Die hierbei gemachten Beobachtungen wurden auf Grundlage von 
Wechselwirkungen zwischen Wirkstoff und liposomaler Membran diskutiert. 
Auf Grundlage der Ergebnisse aller Untersuchungen dieser Arbeit ist anzunehmen, dass der 
Mechanismus für die Wirkstoffabgabe topisch applizierter Invasomen in die menschliche Haut eine 
Kombination aus Penetrationsbeschleunigung und der Penetration intakter Vesikel umfasst.
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